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i 
Material Abstract 
 
 
The unfolded protein response (UPR) detects the presence of misfolded proteins in 
the endoplasmic reticulum (ER) and subsequently relieves ER stress by increasing 
the folding capacity of the ER. The secretory pathway substrate HLA-B27 is highly 
associated with the chronic inflammatory disease ankylosing spondylitis (AS) and 
has a tendency to misfold in the ER. Here, we show that overexpression of HLA-B27 
and non-disease associated HLA-B7 in immortalised cell lines leads to heavy chain 
misoxidation, which is accompanied by upregulation of BiP and splicing of XBP1, a 
key step in the IRE1 pathway of the UPR which is increasingly being linked with 
intestinal inflammation.  
 
We also demonstrate that different cell lines respond to different ER stress stimuli in 
distinct ways. We establish that HT1080 cells inefficiently induce a UPR in response 
to tunicamycin and that this has consequences for cell survival. However, inefficient 
activation of the UPR in HT1080 cells can be overcome by secondary signals, since 
co-administration of the tyrosine kinase inhibitor genistein leads to activation of 
XBP1. Furthermore, we show that genistein can inhibit UPR induction of BiP in 
response to a range of ER stresses indicating that the cancer drug genistein can 
inhibit or activate the UPR depending on the environment and cell type. This has 
implications for inflammatory disease since regulation of the UPR is important in 
determining a cell’s tendency towards apoptosis. 
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1. SUMMARY 
 
 
 
 
 
 
 
 
 
Summary  2 
 
1. Summary 
 
The major histocompatibility complex (MHC) class I heavy chain human leukocyte 
antigen (HLA)-B27 is highly associated with the development of the chronic 
inflammatory group of diseases known as the spondyloarthritides (SpA). HLA-B27 
is unusual since it can form homodimers both at the cell surface and in the 
endoplasmic reticulum (ER). Homodimer formation of HLA-B27 in the ER is 
believed to be a consequence of the propensity of HLA-B27 to misfold. Recently, 
induction of the unfolded protein response (UPR) has been associated with HLA-B27 
misfolding in the B27/human 2-microglobulin (h2m) transgenic rat model. UPR 
induction has been linked to the pathogenesis of inflammatory diseases since UPR 
activation can lead to activation of nuclear factor (NF)-B, a master regulator of 
inflammation, immune responses and apoptosis and c-Jun N-terminal kinase (JNK). 
 
Our results demonstrate that overexpression of the MHC class I heavy chains HLA-
B27 and HLA-B7 lead to misoxidation and the formation of high molecular weight, 
disulfide-linked complexes. Formation of misoxidised class I heavy chains (cI HC) is 
accompanied by XBP1 splicing, a key step in the activation of the IRE1 branch of the 
UPR. This is important in the context of SpA since XBP1 activation is increasingly 
being linked with gut inflammation, a component of SpA. Furthermore, I 
demonstrate misoxidation-induced upregulation of BiP, a major target of the UPR 
indicating that misoxidation of HLA-B heavy chains can trigger downstream effects. 
Stable transfection of HLA-B27 in C58 cells however does not lead to XBP1 splicing 
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but may decrease the sensitivity of these cells to secondary stress implying that 
chronic misfolding may pre-sensitise cells to further bouts of ER stress. 
 
I also describe cell specific differences in the UPR induction in response to the 
pharmacological agent tunicamycin, which triggers ER stress by inhibiting 
glycosylation. HT1080 cells do not initiate XBP1 splicing or BiP induction in the 
face of tunicamycin. Interestingly, HT1080 cells also do not initiate expression of 
CCAAT/Enhancer-binding protein (C/EBP) homologous protein (CHOP). Since 
CHOP is a proapoptotic transcription factor, I studied the effects of tunicamycin on 
cell survival of HT1080 and found that these cells exhibit increased cell survival over 
HeLa cells, which promote CHOP expression in the face of tunicamycin. However, 
the weak response of HT1080 to tunicamycin can be overcome by serum deprivation, 
indicating that HT1080 cells may have mechanisms of UPR regulation which are not 
as highly expressed in HeLa cells. Taken together, these results demonstrate that 
there are differences in how certain cells respond to different stimuli and that these 
responses can have an impact on cell survival. 
 
Furthermore, I also demonstrate that UPR-driven transcriptional activation of BiP – a 
major downstream target of the UPR – by DTT, tunicamycin and thapsigargin can be 
inhibited with the use of the isoflavone genistein. Genistein has previously been 
demonstrated to inhibit BiP upregulation in response to thapsigargin but I 
demonstrate that genistein can inhibit transcriptional activation of BiP by a range of 
ER stresses in HeLa cells. Furthermore, I propose that this action is due to the 
tyrosine kinase inhibitory activity of genistein since the isoflavone diadzein, which 
lacks the tyrosine kinase inhibitory activity, does not regulate BiP expression in the 
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face of ER stress. Furthermore, I show that HT1080 cells can initiate tunicamycin-
driven, but not thapsigargin- or DTT-driven XBP1 splicing in the presence of 
genistein further indicating that there are cell specific differences in the regulation of 
the UPR. This has implications for SpA and inflammatory disease since regulation of 
the UPR is involved in controlling the cell’s tendency towards survival or death.  
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2. General Introduction 
 
2.1 The molecular fate of polypeptides 
In order for proteins to carry out their intended task, they must acquire the correct 
three-dimensional structure necessary for their function. Evolutionary pressure, along 
with the vast number of possible unique protein structures, is responsible for 
generating the level of structural and functional diversity seen in the human 
proteome. The structure of a protein is determined primarily by its amino acid 
sequence; however, the majority of proteins require further processing to achieve 
functionality. A polypeptide chain of amino acids needs to be converted into a 
tightly-folded, compact, energetically-favourable structure where hydrophobic amino 
acids are buried within the soluble protein and hydrophilic residues are found in the 
solvent-accessible positions. This stable, ‘correctly’ folded, functional conformation 
is known as the native structure and will comprise secondary structural elements – -
helixes and -sheets – as well as stabilising hydrogen bonds and electrostatic van der 
Waal’s interactions. Oxidative folding and the addition of disulfide bonds contribute 
to the tertiary structure of secretory proteins (Sevier & Kaiser, 2002).  
 
Achieving the native structure requires finding the state at which the protein is most 
stable under physiological conditions. According to Levinthal’s paradox, it is 
impossible for a protein to systematically sample all of the possible confirmations 
before settling on the most stable (Dill & Chen, 1997). This is especially unlikely 
when you consider that protein folding events need to occur within a biologically 
practical timescale.  As a result, the concept of energy landscapes, which describes 
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the free energy of a polypeptide chain as a function of its conformational state, was 
born. This theory describes the maturity of an unfolded polypeptide chain along an 
energy landscape to the final compact, native structure (Jahn & Radford, 2008).  
 
Just as each protein will exhibit its own unique three-dimensional structure when at 
its native conformation, so too does each protein exhibit a unique energy landscape 
determined by the multitude of possible conformational states. Energy landscapes for 
small, relatively simple proteins appear funnel-shaped since many of the 
conformational options available lead reliably towards the native state. However, 
more complex proteins exhibit elaborate, highly dynamic energy landscapes where 
many intermediate conformations – or partially folded species – may journey 
towards or indeed away from the final native structure. These intermediates are 
sometimes referred to as on- or off-pathway species (Brockwell & Radford, 2007). 
An example of an energy landscape of a complex folding protein can be seen in 
Figure 1. 
 
The energy landscape of a folding protein illustrates the wide variety of 
conformational states and folding pathways available to the polypeptide. However, 
the relative depth of each energy well is not simply dependent on the polypeptide 
sequence alone, but takes into consideration temperature, solution conditions and 
protein concentration (Jahn & Radford, 2008). 
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Unfolded
state 
Native 
state 
Folding 
intermediate 
Ordered 
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Oligomer 
Amyloid fibril 
Energy 
 
Figure 1. A combined energy landscape diagram for both protein folding and 
protein aggregation. Unfolded polypeptide chains progress along the energy landscape 
towards the compact native structure (Left hand side). Alternatively, polypeptide chains can 
form intermolecular protein associations, increasing the ruggedness of the energy landscape 
(Right hand side) and potentially resulting in the formation of low energy oligomeric and 
amyloid fibril states. Based upon a figure published by Jahn & Radford, 2008. 
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As polypeptide chains get larger, an assortment of factors, including an increased 
number of hydrophobic domains, may lead polypeptides to form large regions of 
non-native like structures, even when highly native-like segments have been formed 
(Dobson, 2004). This situation may trap the protein, albeit transiently, in a misfolded 
state. The appearance of species with a significant number of persistent non-native 
interactions is not considered part of the normal protein folding pathway since the 
architecture of these species is distinct from that of the native protein. However, a 
folding intermediate participating in the normal folding process of a protein is rather 
termed ‘unfolded’, not ‘misfolded’, even though they may contain non-native regions 
and similarly have higher free-energy than the native confirmation (Dobson, 2004).  
 
An increase in population of a species with persistent non-native interactions, or 
indeed partially folded proteins, enhances the probability of species-specific 
intermolecular interactions between aggregation-prone regions (Ferguson et al., 
2006). The key residues for aggregate formation are thought to be different from 
those guiding correct folding of the polypeptide chain (Chiti et al., 2002). However, 
certain key amino acids have been indentified which influence the on- or off-
pathway fate of specific proteins (Wigley et al., 2002) indicating the importance of 
the polypeptide sequence in defining its folding fate (DuBay et al., 2004). Aggregate 
formation is nucleation-dependent and requires a transiently populated aggregation 
nucleus. The lag phase of protein aggregation – determined by the rate of nucleation 
– can be eliminated by the addition of pre-formed fibrils in a process known as 
‘seeding’ (Harper & Landsbury, 1997). Once nucleus formation arises, aggregate 
growth occurs rapidly by the addition of further ‘monomers’. Although the formation 
of the nucleus is unfavourable, once underway, elongation of the aggregate is highly 
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favourable and rapidly leads to the formation of fibril structures with characteristic 
cross- structures. However, the progression of amyloid fibril formation will depend 
on the specific energy landscape of that protein. 
 
The formation of so-called amyloid fibrils represents an alternative, stable folding 
destination for polypeptides. The energy landscapes discussed earlier, therefore, are 
only part of the protein folding narrative, since the formation of a non-native, 
energetically-stable fibril, which is distinct from the native protein, can be achieved. 
Thus, a double-funnel diagram with two energetically favourable destinations seems 
more appropriate, since this view recognises the effects of aggregation on productive 
folding processes and the potential destinations of unfolded and misfolded 
intermediates (Fig. 1).  
 
An increasing number of human diseases have been linked with protein misfolding, 
protein aggregation and amyloid fibril formation in different tissues and organs 
(Dobson, 2001). Termed ‘protein misfolding’ or ‘protein conformational’ diseases; 
these pathological conditions include, but are not limited to, neurodegenerative 
disorders such as Alzheimer’s disease and Parkinson’s disease (Tan et al., 2009; 
Meraz-Rios et al., 2010), type II diabetes (Gotz et al., 2009), cystic fibrosis 
(Chaudhuri & Paul, 2006) and 1-antitrypsin deficiency (Perlmutter, 2006). Some of 
these diseases, such as cystic fibrosis, are the consequence of specific misfolded 
proteins not being able to carry out their intended function (Thomas et al., 1995) 
whereas the formation and build up of protein aggregates within cells or in the 
extracellular space characterises Alzheimer’s and Parkinson’s disease. Aggregate 
formation, in the case of the neurodegenerative disorders, confers cytotoxicity on 
General Introduction  11 
 
neuronal cells due to a gain-of-function (Caughey et al., 2003). Inappropriate 
interactions of fibrillar aggregates may lead to sequestration of cellular proteins into 
disease-specific deposits such as inclusion bodies or plaques leading to cell death. 
However, in the case of Alzheimer’s disease, smaller, multimeric aggregates have 
been described, which correlate with the early stages of the disease in a mouse model 
suggesting that early-stage aggregation of specific protein species can have 
pathological consequences (Berger et al., 2007). 
 
2.2 Assisted protein folding 
Although it is possible, under optimised conditions, to reconstitute simple, 
monomeric proteins to their native conformation in vitro, this process is still too slow 
to occur in the cell. Renaturation of bovine pancreatic ribonuclease (RNase) – 
containing 124 amino acids and 8 sulfhydryl groups – under favourable pH, 
temperature and protein concentration still takes around 20 minutes after reduction of 
disulfide bridges and disruption of the tertiary structure (Goldberger et al., 1963). It 
had been established that the synthesis of native RNase in a higher organism should 
take around 2 minutes (Dintzis, 1961; Cranfield & Anfinsen, 1963). Thus, it was 
realised very early on that cells must possess special mechanisms to increase the 
efficiency of protein folding. This realisation was further reinforced by observations 
that if RNase concentrations were increased to mimic physiological concentration, 
the yield of native protein was markedly low and that some chains become trapped 
with incorrect disulfide pairings (Anfinsen et al., 1961; Goldberger et al., 1963). The 
resulting non-native proteins were likely to be the result of incorrect formation of 
intrachain disulfides as well as interchain disulfides.  
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Since the intrinsic features of the polypeptide chain – despite being critical – do not 
seem to guarantee the reliable manufacture of functional proteins or preclude the 
threat of protein aggregation, the cell must possess a system that addresses these 
issues in the crowded cellular environment. The cell’s quality control machinery 
ensures the correct folding of nascent polypeptides and the rapid removal and 
degradation of inappropriately folded, or misfolded, proteins. This multitude of 
folding enzymes and molecular chaperones prevent proteins getting trapped in off-
pathway intermediates and inhibit unproductive interactions with other proteins, 
increasing the likelihood of reaching the native conformation. 
 
2.2.1 Cytosolic chaperone system 
Nascent polypeptides may interact with a number of different molecular chaperones. 
A chaperone is defined as a protein which interacts, stabilises or helps a non-native 
protein acquire their native conformation but is not incorporated into the functional 
structure. A protein destined for the cytoplasm will encounter two systems of 
chaperone action (Albanèse et al., 2006) which act to a) stabilise nascent proteins on 
the ribosome and initiate folding (Kramer et al., 2009) and b) aid downstream 
folding events to the native conformation (Bukau et al., 2000; Hartl & Hayer-Hartl, 
2002). Upon emergence from the ribosome, nascent polypeptides – in mammals – 
initially interact with the specialised ribosome-associated complex (RAC) 
comprising the heat shock protein 70 (Hsp70) homolog Hsp70L1 and the Hsp40 
homolog Mpp11 (Otto et al., 2005). The RAC provides a role similar to that which is 
provided by bacterial trigger factor (TF) in the early stages of prokaryotic protein 
folding (Chang et al., 2007; Tang et al., 2007). Together, these early-stage 
chaperones bind to hydrophobic regions, preventing compaction of the polypeptide 
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chain. This keeps the chain in an elongated state, delaying constructive folding 
events until sufficient structural information – inherent within the emerging 
polypeptide chain – is available.  
  
2.2.1.1 The Hsp70 system 
In higher eukaryotes, the constitutively expressed Hsp70 homolog, heat shock 
cognate 70 (Hsc70) mediates co- or post-translational folding of polypeptides 
through ATP-regulated binding cycles (Hartl & Hayer-Hartl, 2009). Members of the 
Hsp70 family are able to couple ATP hydrolysis to the binding and release of 
substrate molecules in a co-factor dependent manner. Binding of ATP to the N-
terminal ATPase domain of Hsp70 family members causes a conformational change 
in the C-terminal domain, opening the peptide binding cleft, allowing the rapid 
binding and release of substrates. Hydrolysis of ATP to ADP however, closes the 
substrate binding cleft, resulting in an ADP-bound state that binds tightly to peptide 
substrates (McCarty et al., 1995; Szabo et al., 1994). In eukaryotes, the chaperone 
co-factor Hsp40 activates the ATPase activity of Hsc70, promoting the retention of 
substrates as well as targeting those substrates to Hsc70 (Tsai & Douglas, 1996). 
This system is analogous to the well-studied bacterial DnaK/DnaJ system (Hartl, 
1996; McCarty et al., 1995; Szabo et al., 1994). The bacterial system also includes a 
nucleotide-exchange factor (GrpE in E. coli) co-factor which promotes the release of 
ADP from DnaK (Liberek et al., 1991). Recent studies however, have highlighted a 
number of other regulatory co-chaperone components of the Hsc70/Hsp40 system 
including BAG-1 which stimulates Hsc70’s ATP hydrolysis activity (Höhfeld & 
Jentsch, 1997) and Hip, an oligomeric protein which both stabilises the ADP-bound 
state of Hsc70 by interacting with its ATPase domain and binds directly to peptide 
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substrates, acting itself as a molecular chaperone (Höhfeld et al., 1995). The 
regulated stabilisation and release of unfolded substrates within the Hsp70 system 
both prevents aggregation and aids in the formation of the native state.  
 
2.2.1.2 Chaperonins 
Downstream from the Hsp70 folding system are the chaperonins, a distinct group of 
sequence-related proteins characterised by their large, oligomeric, double-ring 
complexes of around 800 kD. Chaperonins promote substrate folding by global 
protein encapsulation and, like Hsp70, are ATP-regulated. The chaperonins can be 
split into two separate groups (Horwich et al., 2007). Group I chaperonins, also 
known as Hsp60s, are found in bacteria, mitochondria and chloroplasts. They 
comprise seven rings and cooperate with members of the Hsp10 proteins to form the 
lid of a folding cage, also known as an Anfinsen folding cage (Saibil et al., 1993). 
Group II chaperonins are cytosolic proteins with eight- or nine-membered rings. This 
group of chaperonins is Hsp10-independent and encapsulates its substrate using 
specialised -helical extensions which are part of the ring structure (Hartl & Hayer-
Hartl, 2009). 
 
The best characterised group I chaperonin system is bacterial GroEL and its cofactor 
GroES (Hartl, 1996; Horwich et al., 2007; Horwich et al., 2009). GroEL is a 
tetradecamer assembled as two back-to-back rings, each with a central hydrophobic 
cavity which can bind non-native polypeptide substrates (Braig et al., 1994). The co-
chaperonin GroES associates with either end of the GroEL in an ATP-dependent 
manner, forming an enclosed cavity (Weissman et al., 1996; Hunt et al., 1996). 
Isolation of unfolded monomers, in this system, serves to protect them from 
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unproductive aggregation events, allowing folding to occur unimpaired by the 
crowded, outside environment. Accordingly, the main purpose of the chaperonin 
cavity is to prevent aggregation (Horwich et al., 2009). Furthermore, the 
environment within the Anfinsen folding cage is critical in accelerating folding and 
rearrangement steps of non-native polypeptides (Tang et al., 2006). This is believed 
to be down to the cavity lining which provides a non-stick surface which compels the 
non-native chain to “follow its intrinsic folding pathway without providing any 
general or substrate-specific direction to the process” (Horwich et al., 2009). 
Nevertheless, not all proteins require entry into the GroEL/GroES system in addition 
to the DnaK/DnaJ-mediated folding. Ellis and Hartl used temperature-sensitive 
mutants to knock-out GroEL in E. coli; an experiment which indicated that a 
maximum of 30% of bacterial proteins require GroEL to reach their mature structure 
(Ellis & Hartl, 1996).  
 
The group II chaperonins, found in eurkarya and archaea is represented by TCP-1 
Ring Complex (TRiC) or chaperonin-containing TCP-1 (CCT). TRiC/CCT is 
arranged in a double-ring structure but, unlike group I chaperonins which are homo-
oligomeric, each TRiC/CCT ring comprises eight different subunits. Each 
polypeptide-binding domain has evolved to bind a diverse set of polypeptide 
substrates (Kim et al., 1994). Generally, TRiC/CCT substrates tend to be large 
hydrophobic proteins with the most abundant substrates being identified as the 
cytoskeletal proteins actin and tubulin (Lewis et al., 1996; Yam et al., 2008). In a 
key paper by Spiess and colleagues, the TRiC substrate VHL tumour suppressor was 
used to identify the binding sites in TRiC in order to further understand how the 
chaperonin engages its substrates (Spiess et al., 2006). It was established that 
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different subunits in the complex are specialised to recognise distinct but overlapping 
substrates resulting in the ability to facilitate the folding of a range of eukaryotic 
proteins. However, despite recent advances in our understanding of the structural 
architecture of the group II chaperonins, the functional mechanisms underlying their 
chaperone activity are still not fully understood (Bosch et al., 2000; Shomura et al., 
2004; Pappenberger et al., 2006). 
 
2.2.1.3 Hsp90 
The cytosolic chaperone Hsp90 differs from other eukaryotic chaperones in its 
substrate specificity. Hsp90 is known to preferentially interact with signal 
transduction proteins, typified by the steroid hormone receptors and signalling 
kinases (Picard, 2002; Xu & Lindquist, 1993). Therefore, Hsp90 is essential for the 
maintenance of signal transduction networks. Unlike the Hsc70/Hsp40 system, 
Hsp90 family members do not interact with nascent polypeptide chains but rather 
bind downstream of the Hsc70/Hsp40 system, recognising a subset of client proteins 
that have neared their native conformation (Jakob et al., 1995). However, much the 
same as Hsp70 family members, Hsp90 is ATP-dependent, relying on cycles of ATP 
hydrolysis to regulate the binding and release of substrates (Obermann et al., 1998; 
Prodromou et al., 2000). Loading of the substrate onto Hsp90 requires Hsp70 
(Hutchinson et al., 1994) and is aided by the co-chaperone Hsp-organising protein 
(Hop/p60) (Scheufler et al., 2000).  
 
Together, the Hsp70/Hsp40 system, chaperonins and Hsp90 provide an essential 
cytosolic system for proteins to reliably and efficiently traverse the energy landscape, 
preventing aggregation and guiding them towards the native conformation. 
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Mutational studies of key chaperones and co-factors reveal that many of them are 
lethal or associated with protein-conformational diseases (Senderk et al., 2005; 
Chapman et al., 2006; Polier et al., 2008; Hainzl et al., 2009), highlighting the 
importance of the cytosolic chaperone system. 
 
2.2.1.4 The bacterial periplasm 
Gram-negative bacteria also possess a vast cell membrane-bound compartment – the 
periplasm – which is specialised for protein biosynthesis of extracytoplasmic 
proteins (Pugsley, 1993). The periplasm, or periplasmic space, is bounded by the 
inner cytoplasmic membrane and the porous outermembrane of gram-negative 
bacteria. Gram-positive bacteria also possess a periplasm but this is located between 
the outer plasma membrane and an outer peptidoglycan layer. The periplasm in 
gram-positive bacteria also tends to be less pronounced. The two membranes which 
bound the periplasm in gram-negative bacteria are distinct in both composition and 
structure. The inner membrane is a phospholipid bilayer which contains integral 
membrane proteins which typically span the membrane as hydrophobic -helices 
whereas the outer membrane is an asymmetric bilayer consisting of phospholipids 
and lipopolysaccharides (LPS) and contains integral membrane proteins which exist 
as cylindrical -strand-containing -barrels with a hydrophobic interior (Bos et al., 
2007). 
 
The membranes which form the boundary of the periplasmic compartment contain 
many proteins which are essential for several cell functions including the sensing and 
signal transduction of environmental stimuli and the uptake and secretion of 
biological substrates (Facey & Kuhn, 2010). Since these proteins are translated in the 
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cytosol, they require coordinated targeting to the periplasm and subsequent 
translocation across the membrane – in the case of outer membrane proteins – or 
insertion into the membrane – in the case of inner membrane proteins. Furthermore, 
within the periplasm exists molecular chaperones which facilitate the folding and 
assembly of these proteins (Miot & Betton, 2004).  
 
The synthesis of bacterial integral membrane proteins takes place on ribosomes in 
the cytosol. Proteins destined for outer- or inner-membrane insertion are recognised 
by the highly conserved signal recognition particle (SRP) shortly after synthesis. 
SRP delivers the polypeptide to the Sec translocase for transport across the inner 
membrane into the periplasm or for insertion into the inner membrane (Keenan et al., 
2001; Ullers et al., 2003). Both these tasks are carried out by the SecYEG complex 
which has to switch between a transversal opening – for allowing secretory proteins 
in to the periplasm – and a lateral opening – to allow for the insertion of 
transmembrane proteins. SecA, the motor subunit of the SecYEG complex, is 
required for both the translocation of secretory proteins and the insertion of inner-
membrane proteins (Facey & Kuhn, 2010). However, there is evidence of the 
insertion of small inner-membrane proteins occurring in a SecYEG-independent 
manner via YidC (Samuelson et al., 2000; Chen et al., 2002).  
 
Secretory proteins, on the other hand, are targeted to the inner membrane 
translocation machinery by the cytoplasmic chaperone SecB. Much like SRP-
mediated membrane targeting, SecB also scans the nascent polypeptide for a signal 
sequence which targets the polypeptide to the inner membrane. SecB, binds to the 
unfolded polypeptide after dissociation from TF, shortly after synthesis (Muller, 
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1996). Secretory proteins are then delivered to the SecYEG complex in a 
translocation competent conformation. 
 
Chaperones and protein folding catalysts exist within the periplasm, which serve to 
promote the formation of native structures and prevent aggregation (Surrey & Jahnig, 
1995). Most cytoplasmic chaperones utilise ATP to drive cycles of protein substrate 
binding and release, however, the periplasm lacks ATP. Few periplasmic chaperones 
have been identified thus far, but the general chaperone Skp is one which is well 
studied. The trimeric Skp chaperone can keep periplasmic substrates in a soluble and 
unstructured conformation by forming stable complexes with substrates, thus 
preventing aggregation (Bulieris et al., 2003). Furthermore, the folding rate of the 
periplasmic substrate OmpA is increased in the presence of Skp. However, Skp null 
mutants only cause a moderate decrease in the levels of properly folded outer 
membrane proteins, indicating that other folding factors may be involved in outer 
membrane protein maturation (Chen & Henning, 1996). SurA is also a periplasmic 
chaperone, but exhibits cis-trans peptidyl prolyl isomerase (PPIase) activity - which 
catalyses the cis-trans isomerisation of peptide bonds. The null mutant of SurA too 
exhibits diminished levels of folded outer membrane proteins indicating a role in the 
folding and assembly of outer membrane proteins for SurA (Lazar & Kolter, 1996). 
The chaperone activity of SurA was inferred by the deletion of the PPIase I and 
PPIase II domains, which are responsible for the isomerase activity of the enzyme. 
This double mutant almost complements wild type function in vivo, indicating that 
the N- and C-terminal domains exhibit chaperone activity (Behrens et al., 2001). 
Furthermore, SurA selectively binds outer membrane proteins since it preferentially 
recognises peptide sequences containing aromatic amino acids in the sequecne Ar-X-
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Ar, which occur more frequently in membrane proteins than cytoplasmic and other 
soluble proteins (Bitto & McKay, 2003).  
 
The periplasmic serine protease DegP (also called high temperature requirement A 
(HtrA) or protease Do) unusually also functions as a chaperone (Spiess et al., 1999; 
Ortega et al., 2009). DegP is an ATP-independent heat shock protein that can 
degrade and refold misfolded proteins in the periplasm. DegP can discriminate 
between misfolded and folded substrates due to the dimensions of its inner cavity 
which excludes folded substrates (Clausen et al., 2002). DegP is required for 
bacterial survival at high temperatures and for the degradation of aberrantly folded 
periplasmic proteins (Lipinska et al., 1988; Strauch & Beckwith, 1988). 
Interestingly, DegP can switch between its chaperone activity, at low temperatures, 
and protease activity, at high temperatures perhaps allowing it to respond to 
environmental changes (Skorko-Glonek et al., 1995; Spiess et al., 1999). The 
chaperone activity of DegP is physiologically relevant since the proteolytically 
inactive degPS210A mutant can complement the lethality of the surA degP double 
mutant (Rizzitello et al., 2001). Taken together, these results suggest that a 
functional chaperone network exists in the periplasm that is essential for protein 
folding and degradation. Further work is required to identify additional members of 
this chaperone network. 
 
In addition, protein disulfide isomerases exist within the periplasm to pass on 
disulfide bonds to substrate proteins, which provides them with structural stability. 
Protein disulfide isomerases and the formation of disulfide bonds will be examined 
in more detail when discussing protein folding in the endoplasmic reticulum. The 
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periplasmic disulfide isomerases DsbA and DsbC function together with the inner 
membrane proteins DsbB and DsbD to allow the oxidation, reduction and 
isomerisation of disulfide bonds in the oxidising environment of the bacterial 
periplasm. DsbA has two cysteine residues and is a potent catalyst of disulfide bond 
formation (Wunderlich et al., 1993; Zapun and Creighton, 1994). When in an 
oxidised form (i.e. when there is an intramolecular disulfide bond between the two 
cysteines), DsbA is able to transfer its intramolecular disulfide bond to substrate 
proteins in the periplasm leading to reduction of DsbAs disulfide to two thiol groups 
(-SH). However, DsbA may catalyse the formation of non-native disulfides in 
substrates. If this occurs, DsbC-mediated isomerisation of these bonds allows for the 
rearrangement of disulfides and the formation of native structures (Zapun et al., 
1993; Rybin et al., 1996; Sone et al., 1997). Evidence of this comes from studying 
proteins targeted to the periplasm. Urokinase, a protein that contains 12 disulfide 
bonds is undetectable in the DsbC null mutant. However, the yield of alkaline 
phosphatase, which only contains two disulfide bonds, is only lowered by 15% 
(Rietsch et al., 1996). After passing on the disulfide bond from DsbA to the 
substrate, the disulfide bond on DsbA is ‘recharged’ by DsbB which delivers 
electrons to the electron transport chain (Kobayashi et al., 1997). DsbD, on the other 
hand, maintains DsbC and DsbG in their reduced forms – thus allowing them to carry 
out reduction and isomerisation of non-native disulfides – by receiving electrons 
from cytoplasmic thioredoxin (Chung et al., 2000; Joly and Swartz, 1997). Together, 
periplasmic chaperones and protein disulfide isomerases function to form native 
disulfide bonds and assist in the folding and insertion of substrate proteins in the 
periplasm.  
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2.2.2 Protein folding in the ER 
Protein folding in the endoplasmic reticulum (ER) has been studied extensively in 
the last two decades. The ER is similar to that of the bacterial periplasm since 
substrate proteins can undergo the addition of covalent disulfide bonds between two 
cysteine residues. However, the eukaryotic ER boasts a further feature which is not 
present in cytosolic and bacterial protein folding: the introduction of N-linked 
oligosaccharide chains to the folding protein. As a consequence, the ER requires its 
own specialised set of components to assist in the correct folding of substrate 
proteins in order to reach the native conformation (Jonikas et al., 2009). However, 
since many of the principles of protein folding in the cytosol apply to protein folding 
in the ER, there also exists a set of ER-resident chaperones and folding enzymes with 
homology to cytosolic, mitochondrial and periplasmic folding factors (Christis et al., 
2008; Hartl & Hayer-Hartl, 2002). 
 
A considerable proportion of the proteome is destined for the extracellular space 
(Clark et al., 2003; Chen et al., 2005). These proteins are intended for secretion by 
the cell into the extracellular environment or to be incorporated into membranes to 
act as cell surface receptors, for example. Similar to the periplasm, the signal peptide, 
located at the N-terminus of nascent polypeptides is recognised by the signal 
recognition particle (SRP) and directs the mRNA/ribosome/nascent polypeptide 
complex to the ER membrane. This enables cotranslational translocation into the ER 
via the Sec61 translocon, where newly synthesised secretory/membrane-bound 
proteins can acquire their native conformation (Sakaguchi, 1997; Walter & Johnson, 
1994). However, recent evidence has highlighted the ability of mRNAs to localise to 
the ER membrane in the absence of SRP indicating intrinsic localisation 
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determinants within the mRNA sequence (Pyhtila et al., 2008). Once all folding 
events are completed, native proteins are then trafficked to the Golgi where 
additional modifications may take place before being further compartmentalised or 
secreted.  
 
2.2.2.1 The endoplasmic reticulum 
The ER is a convoluted bilayer membrane enclosing a continuous lumenal space 
which provides an optimal environment for protein folding, disulfide bond 
formation, the removal of signal sequences, the acquisition of N-linked glycans and 
oligomeric assembly of proteins destined for the extracellular environment. 
Furthermore, the ER is responsible for the synthesis of glycosylphosphatidylinositol 
(GPI)-anchored proteins and fatty acylation of proteins. The ER is loaded with 
numerous chaperones and folding enzymes which outnumber the client proteins that 
require folding, reaching millimolar concentrations (Lyles & Gilbert, 1992). Activity 
of ER-resident chaperones and folding enzymes is highly dependent on the localised 
environment of the organelle.  
 
The ER is the principal Ca2+ store of the cell and Ca2+ levels are regulated in an 
ATP-dependent manner by inositol 1,4,5-triphosphate receptor type 1, 2 and 3 and 
the ryanodine receptor Ca2+ release channels which allows the release of large 
quantities of the cation in response to extracellular stimuli (Meldolesi et al., 1998; 
Berridge et al., 2000). However, the Ca2+ channel inositol 1,4,5-triphosphate receptor 
type 1 (IP3R1), which mediates Ca2+ release from the ER, is regulated by the ER 
protein disulfide isomerase-like protein ERp44 through direct binding to its third 
lumenal loop (Higo et al., 2005). Regulating Ca2+ ion concentration in the ER is 
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crucial for productive protein folding since many chaperones, such as calreticulin, 
rely upon Ca2+ binding to regulate protein-protein interactions (Corbett et al., 1999; 
Michalak et al., 2009). Thus, perturbations in Ca2+ concentration crucially affect 
protein folding and maturation (Berridge et al., 2003). 
 
2.2.2.2 Oxidative protein folding 
Anfinsen and colleagues in the 1960s showed that disulfide bond formation can 
occur spontaneously in vitro in the presence of O2 (Anfinsen et al., 1961). However, 
shortly after, it was observed that folding of secretory proteins was facilitated in the 
presence of microsomal extracts (Goldberger et al., 1963). These vesicles are now 
known to contain machinery involved in protein folding as well as having the ability 
to generate a redox potential conducive to disulfide bond formation (Gething & 
Sambrook, 1992; Hwang et al., 1992; Ruddon & Bedows, 1997). Thus, in vivo, the 
formation of disulfide bonds is an enzyme-catalysed event which takes place in the 
specialised environment of the ER.  
 
Key to the conferment of disulfide bonds is the reduction/oxidation (redox) 
environment within the endoplasmic reticulum. In terms of redox potential, the ER is 
similar to the extracellular environment providing an appropriate folding location for 
proteins destined for the extracellular space since if a protein is unable to reach a 
stable formation in the ER, it is unlikely to be stable in the extracellular environment. 
Comparatively, the bacterial and eukaryotic cytosol are poor environments for the 
production of multiple disulfide bonds since these locations are highly reducing. The 
redox environment of the ER, however, is highly oxidising and is illustrated by the 
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ratio of reduced glutathione (GSH) to oxidised glutathione (GSSG), which is ~3:1 in 
the ER compared with ~100:1 in the cytosol (Hwang et al., 1992; Bass et al., 2004).  
 
The role of glutathione in the ER is still not fully understood. Oxidised glutathione 
was initially believed to provide oxidising equivalents for the formation of disulfide 
bonds via the oxidation of the oxidoreductase protein disulfide isomerase (PDI). 
However, it is now largely believed that the ER flavoprotein Ero1 is responsible for 
the oxidation of reduced PDI (to be discussed in more detail later). However, there is 
evidence of glutathione having a role in disulfide bond formation, since lowering the 
level of glutathione in the cell results in an increase in disulfide bond formation. This 
is accompanied by an increase in non-native disulfide bond formation and an 
increase in the time required for disulfide bond isomerisation (Chakravarthi & 
Bullied, 2004; Molteni et al., 2004). These results may imply a role for reduced 
glutathione in disulfide bond isomerisation.  
 
Furthermore, reduced glutathione can reduce the PDI family member ERp57 
indicating that GSH may be involved in maintaining oxidoreductases in their reduced 
form allowing them to carry out the reduction and isomerisation of non-native 
disulfides in ER substrates (Fratelli et al., 2002). In addition, glutathione can be 
found in mixed disulfides with proteins (Bass et al., 2004). These are either formed 
during the reduction of substrate disulfides by GSH or the oxidation of substrate 
disulfides by GSSG (Cuozzo & Kaiser, 1999). Together, these results show that 
glutathione may have a direct or non-direct role in native disulfide bond formation 
and that this may influence the redox buffering system in the ER.In the highly 
oxidising environment of the ER, disulfide bond reduction and isomerisation is 
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crucial to avoid getting trapped in off-pathway intermediates on the way to the native 
conformation (Jansens et al., 2002). It was therefore evident that in eukaryotes, the 
correct formation and arrangement of disulfide bonds was catalysed by an ER-
resident enzyme (Givol et al., 1964).  
 
2.2.2.3 Protein disulfide isomerase 
Protein disulfide isomerase, or PDI, mentioned earlier, catalyses the formation and 
isomerisation of disulfide bonds in the eukaryotic ER. PDI is a highly abundant ER-
resident protein, making up approximately 0.8% of total cellular protein (Freedman 
et al., 1994). PDI is highly conserved between species and is essential for eukaryotic 
oxidative protein folding as illustrated by its requirement for S. cerevisiae viability 
(Farquhar et al., 1991). 
 
Due to recent extensive research into PDI and its homologs, we now have a 
reasonably detailed understanding of the structure and enzymatic properties of this 
protein (Edman et al., 1985; Xiao et al., 2004; Gruber et al., 2006; Tian et al., 2006). 
PDI comprises four thioredoxin-like domains (a, b, b’, a’, an anionic tail domain 
called c and a linker region between b’ and a’ called x) (Fig. 2). The a and a’ 
domains show both sequence- and structural-homology to thioredoxin – an -fold 
with a mixed -sheet core – (Ferrari et al., 1998), each containing an independent 
active site. These active sites consist of two cysteine residues – in the sequence 
WCGHCK – which are responsible for PDIs enzymatic activity (Edman et al., 1985). 
This short, cysteine-containing sequence is sometimes called the active-site motif. 
The b and b’ domains do not have active sites. However, the b and b’ domains may 
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be important for substrate recognition and peptide binding activities of PDI 
(Kemmink et al., 1997; Klappa et al., 1998a).  
 
 
 
 
 
 
 
 
 
 
 
 
The CXXC active-site motif is key to PDIs oxidase and isomerase activity. When the 
cysteines are oxidised, the disulfide can be transferred to a reduced protein substrate, 
reducing the disulfides of the active site. When the active site is in the reduced state 
however, substrate disulfides can be transferred to PDI and the active site becomes 
oxidised. The function of PDI-family members is defined by the biochemistry of the 
sequence both immediately surrounding and within the active site, as well as the 
residues and features of the three-dimensional space directly surrounding the active 
site. The pKa value of the reactive N-terminal cysteine in the active site is 4.5. This 
value has been shown to be influenced by both the histidine residue in the 
thioredoxin fold and by partial positive charges from the N-terminus of an -helix 
Figure 2. PDI domain structure. PDI consists of two active site thioredoxin-like 
domains a and a’ and two non-reactive thioredoxin-like domains b and b’. The boundaries 
for the domains a and b are those defined by NMR (Kemmink et al., 1999).  
a 
219 120 4 115 217 462 491 352 350 463 
b b’ a’ c x 
CGHC CGHC 
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close to the active site (Kortemme and Creighton, 1995). This generates a PDI 
disulfide which can promote the oxidation of substrate proteins.  
 
The body of evidence indicating isomerases activity of PDIs is significant (Walker 
and Gilbert, 1997; Gilbert, 1998; Schwaller et al., 2003). The process of 
isomerisation requires the breaking of a substrate disulfide for rearrangement. Thus, 
there is no net change in substrate redox state but rather the protein moves closer 
towards its native state. Therefore, isomerisation requires PDI to be in the reduced 
state so it may attack substrate disulfides, catalysing their rearrangement. Recent 
work from Kulp and colleagues highlighted an asymmetry in the functionality of 
PDIs active sites which contribute to its isomerase activity (Kulp et al., 2006). Their 
studies showed that oxidation of the N-terminal active site, in the first catalytic 
domain (a), is subject to substrate-mediated inhibition whereas the C-terminal active 
site – in the a’ domain – is readily oxidised. This asymmetry is not intrinsic to the 
individual active sites but rather occurs in the context of the full-length protein. The 
asymmetry of active site motifs permits the two thioredoxin-like domains to exhibit 
two distinct functional roles. The disparity in rates of oxidation ensures the a’ 
domain is in the oxidised state, ready to promote substrate oxidation while the a 
domain is in the reduced state and can promote disulfide isomerisation. How PDI 
recognises non-native disulfides is still not fully understood but the requirement of 
the non-redox active domains (b and b’) for oxidase and isomerase activity on 
bovine pancreatic trypsin inhibitor (BPTI) (Darby et al., 1998) may suggest that one 
or both of these domains is important in recognising non-native proteins requiring 
isomerase activity.  
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The crystal structure studies of PDI reveal that the two active sites are located on two 
flexible arms which are connected to a rigid base formed by the b and b’ domains 
(Tian et al., 2006; Tian et al., 2008). This molecular flexibility can allow for 
different conformations, allowing the protein to accommodate an array of structurally 
diverse substrates. Furthermore, the flexibility of the two arms may be required for 
the isomerisation of non-native disulfides since it might ensure that the active sites 
can locate incorrect disulfide bonds in the substrate (Tian et al., 2008). 
 
2.2.2.3.1 PDI homologs 
The protein disulfide isomerase family now extends to around 19 proteins 
(Appenzeller-Herzog & Ellgaard, 2008). The most well studied PDI family members 
are: ERp29 (Demmer et al., 1997; Mkrtchian et al., 1998; Hermann et al., 2004; 
Rainey-Barger et al., 2007; Barak et al., 2009), ERp44 (Anelli et al., 2002; Anelli et 
al., 2003; Wang et al., 2008), ERp57 (Oliver et al., 1997; Oliver et al., 1999; 
Antoniou et al., 2002; Peaper et al., 2005; Jessop et al., 2006; Santos et al., 2007; 
Zhang et al., 2009), ERp72 (Mazzarella et al., 1990; Shaiff et al., 1992; Miyaishi et 
al., 1998; Forster et al., 2006; Menon et al., 2007; Kozlov et al., 2009), ERdj5 
(Cunnea et al., 2003; Dong et al., 2008; Ushioda et al., 2008; Thomas & Spyrou, 
2009), PDIp (Desilva et al., 1997; Volkmer et al., 1997; Klappa et al., 1998b; 
Ruddock et al., 2000; Klappa et al., 2001) and PDILT (van Lith et al., 2005; van Lith 
et al., 2007). Members of the PDI family are defined by the presence of the 
thioredoxin-like domain but vary greatly in the arrangement and number of these 
domains. The variation of domain arrangement is thought to modulate the function of 
PDI family members. The diversity of human PDI family member domain structure 
can be seen in table 1.  
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Table 1 – The structural diversity of some of the key members of the human PDI family  
       
Member 
name 
Accession 
Number 
Length ER 
localisation 
motif 
Number 
of a-type 
domains 
Active site 
sequence 
Domain 
composition 
       
       
PDI P07237 508 KDEL 2 2x CGHC a-b-b’-a’ 
       
ERp29 P30040 261 KEEL 0 - b-D 
       
ERp44 Q9BS26 406 RDEL 1 CRFS a-b-b’ 
       
ERp57 P30101 505 QEDL 2 2x CGHC a-b-b’-a’ 
       
ERp72 P13677 645 KEEL 3 3x CGHC ao-a-b-b’-a’ 
       
ERdj5 Q8IXB1 793 KDEL 4 CSHC, 
CPPC, 
CHPC, 
CGPC 
J-a’’-b-ao-a-
a’ 
       
PDIp Q13087 525 KEEL 2 CGHC, 
CTHC 
a-b-b’-a’ 
       
PDILT Q8N807 584 KEEL 2 SKQS, 
SKKC 
a-b-b’-a’ 
       
ERp18 O95881 172 EDEL 1 CGHC a 
       
ERp27 Q96DN0 273 KVEL 0 - b-b’ 
       
EndoPDI/
ERp46 
Q8NBS9 432 KDEL 3 3x CGHC ao-a-a’ 
       
P5 Q15084 440 KDEL 2 2x CGHC ao-a-b 
       
PDIr Q14554 519 KEEL 3 CSMC, 
CGHC, 
CPHC 
b-ao-a-a’ 
       
TMX Q9H3N1 280 Unknown 1 CPAC a 
       
TMX2 Q9Y320 296 KKDK 1 SNDC a 
       
TMX3 FLJ20793 454 KKKD 1 CGHC a-b-b’ 
       
TMX4 Q9H1E5 349 RQR 1 CPSC a 
       
       
The D-domain in ERp29 is a C-terminal -helical domain. The J-domain in ERdj5 is a BiP-
binding domain. The ao and a’’ domains are variants of the active site domains. Taken from 
data in Appenzeller-Herzog & Ellgaard, 2008 and Ellgaard & Ruddock, 2005. 
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Although the archetypal protein disulfide isomerase, PDI, is responsible for directly 
catalysing disulfide bond formation, it is not necessary for PDI family members to 
exhibit oxidase or isomerase function. Rather, membership into this group is 
dependent – amongst other things – on structural features as opposed to functional 
ones. Typical examples of this are ERp27 and ERp29 which are non-catalytic since 
neither contains catalytic a-type domains (Ferrari et al., 1998; Alanen et al., 2006). 
Most PDI family members however, do contain at least one a-type domain (Ellgaard 
& Ruddock, 2005) (Table 1).  
 
PDILT, a testis-specific PDI homolog has the same domain organisation as PDI – a-
b-b’-a’ – but lacks the canonical CXXC active site motif – instead possessing an 
SXXC motif. Accordingly, PDILT has no oxidoreductase activity in vitro (van Lith 
et al., 2005). Recently, PDILT has been shown to be involved in a specialised, 
spermatogenesis-specific, chaperone system with the testis-specific calnexin 
homolog, calmegin (van Lith et al., 2007). Thus, although not redox active, PDILT 
still has a role in protein maturation. Similarly, ERp44 boasts a non-canonical active 
site motif – CRFS – and, despite covalently interacting with the ER oxidoreductase 
Ero1-L - which will be discussed in depth later – and substrate proteins, it is not 
fully understood whether it exhibits oxidoreductase activity (Anelli et al., 2002; 
Anelli et al., 2003). However, ERp44 has a role in PDI oxidation since it helps retain 
Ero1-L and Ero1-L in the ER (Otsu et al., 2006). Furthermore, as mentioned 
earlier, ERp44 can inhibit the Ca2+ channel IP3R1, regulating ER Ca2+ levels (Higo et 
al., 2005). Thus, in line with the divergent oxidoreductase capacity within this group 
of proteins, PDI family members show differences in their ability to complement a 
PDI-deficient yeast strain (Gunther et al., 1993).  
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The majority of PDI family members are constitutively expressed, however, in 
addition to PDILT, a few other family members exhibit tissue-specific distributions. 
EndoPDI is a PDI-like protein containing three CXXC active site motifs and is 
highly expressed in endothelial cells (Sullivan et al., 2003). EndoPDI expression is 
induced upon hypoxia and is thought to protect endothelial cells from hypoxia-
induced apoptosis.  
 
The pancreatic acinar cell-specific PDI, PDIp shares the same domain organisation 
as PDI but lacks the acidic C-terminal region (Desilva et al., 1997; Volkmer et al., 
1997). PDIp has two canonical CXXC active site motifs but it is the b-like, non-
redox active domains which have been the subject of extensive research. Soon after 
identification, PDIp was reported to bind both peptides and misfolded proteins – 
including those not containing any cysteine residues (Klappa et al., 1998b). 
Furthermore, studies with peptide substrates revealed that tyrosine and tryptophan 
residues are the recognition motifs for binding to PDIp (Ruddock et al., 2000). 
Studies using cross-linkers to trap non-peptide ligands showed that hydroxyl groups 
are the structural motifs for the binding of PDIp (Klappa et al., 2001). However, 
studies comparing the b’ domains – thought to be important for peptide binding – of 
PDI and PDIp reveal that they can interact with many of the same substrates 
indicating that there is an overlap in substrate specificity (Klappa et al., 1995; Klappa 
et al., 2001). This finding is strange since PDI has been shown to colocalise with 
PDIp in acinar cells (Dias-Gunasekara et al., 2005). The existence of tissue-specific 
PDI homologs may be due to the requirement for the folding of tissue-specific 
proteins, however, it seems some functional redundancy does exist at least in the case 
of PDIp. Ruddock and colleagues postulate that co-expressed members of the PDI 
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family do not act on distinct proteins but rather cooperate by interacting with 
different parts of the polypeptide (Ruddock et al., 2000). 
 
ERp57, together with PDILT and PDIp, shares a common domain architecture with 
PDI. ERp57 is considered the closest known homolog of PDI, containing two 
canonical active site motifs (Freeman et al., 1994; Koivunen et al., 1996). Unlike 
PDI, however, ERp57 almost exclusively catalyses the disulfide bond formation of 
glycoproteins (Elliott et al., 1997; Oliver et al., 1997; Ellgaard & Frickel, 2003). The 
redox activity of ERp57 was investigated soon after its discovery and ERp57 was 
shown to exhibit thiol-dependent reductase activity and form mixed disulfides with 
glycoprotein substrates (Bourdi et al., 1995; Hirano et al., 1995; Molinari & 
Helenius, 1999). However, the mechanism for the recognition of these specialist 
substrates is more complex. In 1999, Oliver and colleagues demonstrated the non-
covalent binding of ERp57 to the ER-resident lectins calnexin and calreticulin 
(Oliver et al., 1999), whilst further investigation by Russell and colleagues showed 
that the b’ domain of ERp57 – thought to be involved in substrate binding – has been 
adapted to specifically interact with ER lectins (Russell et al., 2004). Recently 
evidence suggests that the specificity of ERp57 for client proteins is determined by 
its interaction with the calnexin cycle and that these client proteins tend to share 
similar structural motifs (Jessop et al., 2007; Jessop et al., 2008). I shall talk about 
these two lectins in more detail later but in brief, calnexin and calreticulin are 
chaperones capable of recognising one or more monoglucosylated oligosaccharide 
side chains on unfolded proteins (Rodan et al., 1996). Thus, ERp57 recognises 
glycoproteins in concert with the ER lectins calnexin and calreticulin to catalyse 
disulfide bond formation in monoglucosylated glycoproteins (Zapun et al., 1998). 
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Also of note is the fact that ERp57 binds glycoproteins lacking any cysteine residues, 
indicating that the oxidoreductase may function as a more general chaperone within 
the ER lumen (Elliot et al., 1997; Oliver et al., 1997).  
 
The most well-studied example of ERp57-mediated protein folding is in the 
maturation of the major histocompatibility complex (MHC) class I molecule. Here, 
ERp57, calnexin and calreticulin form part of a series of complexes that are 
responsible for the correct folding, oxidation and maturation of the immune molecule 
(Dick, 2004; Zhang & Williams, 2006). The folding and maturation of the MHC 
class I molecule as well as its role in the immune system will be discussed in greater 
detail later. 
 
2.2.2.4 ER oxidoreductin (Ero) protein 
The existence of a protein disulfide isomerase does not provide a complete model for 
the formation of correct disulfide bonds since disulfides requiring rearrangement 
may have been oxidised by another oxidation mechanism and, more importantly, an 
additional oxidant is required for the reoxidation, or recharging, of PDI itself.  
 
An abundance of recent work provides evidence suggesting that glutathione is not 
essential for oxidative protein folding in the ER and that disulfide bond formation 
relies upon a different electron acceptor (Frand and Kaiser, 1998; Pollard et al., 
1998; Cuozzo and Kaiser, 1999). Using S. cerevisiae to genetically dissect oxidative 
protein folding, Frand and Kaiser and the Weissman lab isolated endoplasmic 
reticulum oxidoreductin 1 (ERO1) which encodes a novel but conserved ER 
membrane protein essential for the net formation of protein disulfide bonds (Pollard 
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et al., 1998; Frand & Kaiser, 1998). It was suggested that ERO1 could introduce 
oxidising equivalents – utilised during disulfide bond formation – via its two pairs of 
conserved cysteines (CXXCXXC), since introduction of the thiol oxidant diamide 
restored viability in ero1-1 mutants – defective in disulfide bond formation – and 
overexpression of ERO1 confers resistance to otherwise toxic levels of the reductant 
dithiothreitol (DTT) (Frand and Kaiser, 2000). 
 
Further investigation from this group led to the isolation of mixed disulfide 
intermediates between yeast Ero1p and Pdi1p which was presented in a key paper in 
1999 (Frand and Kaiser, 1999). Direct, covalent interaction between the two ER-
resident proteins was representative of the transfer of disulfide bonds from Ero1p to 
Pdi1p and the passing of oxidising equivalents to Pdi1p to sustain it in its disulfide 
form. Thus, the recharging of Pdi1p – that is, the direct oxidation of the reduced 
CXXC motif – is carried out by Ero1p.  
 
As with PDI, the two active sites of Ero1p exhibit discrete properties which are 
crucial for functional activity. The N-terminal CXXCXXC active site – containing 
the so-called shuttle cysteines at Cys100 and Cys105 – is responsible for transferring 
oxidising equivalents to PDI (Frand & Kaiser 2000). Further mutational studies and 
the elucidation of the crystal structure of yeast Ero1p by Gross and colleagues 
revealed that the N-terminal active site motif is then likely to transfer electrons to the 
latter two residues – Cys352 and Cys355 – of the C-terminal CXXCXXC motif (Gross 
et al., 2004; Sevier & Kaiser 2006). This is possible because of the presence of a 
disulfide relay where Cys100 and Cys105 are located on a flexible loop. This loop is 
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capable of changing conformation by 17Å, bringing Cys105 within disulfide-bonding 
distance of Cys352 (Gross et al., 2004).  
 
This paper, however, still left the question unanswered of how the C-terminal active 
site of Ero1p becomes reoxidised. In the bacterial periplasm, reoxidation of DsbB – 
the functional equivalent of Ero1p – occurs primarily via the transfer of electrons to 
molecular oxygen at the later stages of the respiratory electron transport chain via 
cytochrome bd or bo oxidase (Kobayashi and Ito, 1999; Kobayashi et al., 1997). 
Ero1p however, uses a flavin-dependent reaction to pass electrons directly to 
molecular oxygen (Tu and Weissman, 2002). Thus, oxidative folding in yeast is 
dependent on the levels of cellular FAD (Tu et al., 2000). Ero1p is a novel FAD-
binding protein confirmed by the presence of an FAD-binding domain in close 
proximity to the C-terminal active site (Gross et al., 2004). Under anaerobic 
conditions, excess free FAD cannot drive Ero1p-catalysed disulfide bond formation 
(Tu and Weissman, 2002). Thus, FAD is not thought to be the terminal electron 
acceptor. Rather, the bound FAD-cofactor can shuttle the electrons to molecular 
oxygen in a reaction that produces hydrogen peroxide in stoichiometric amounts to 
the disulfides formed (Tu & Weissman, 2002; Gross et al., 2006). Interestingly, a 
few groups have shown that disulfide bond formation can proceed via FAD in 
anaerobic conditions, suggesting the existence of alternative electron acceptors 
(Gross et al., 2006; Farrell & Thorpe, 2005). 
 
2.2.2.4.1 Human Ero protein 
Human homologs of the yeast Ero1p have recently been described and have been 
termed Ero1-L and Ero1-L (Cabibbo et al., 2000; Pagani et al., 2000). Both 
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homologs are capable of rescuing the S. cerevisiae ero1-1 thermosensitive mutant 
and catalysing the oxidation of substrate proteins (Cabibbo et al., 2000; Pagani et al., 
2000; Mezghrani et al., 2001). Both proteins contain the conserved CXXCXXC 
motif  and are involved in the transfer of oxidising equivalents to PDI (Benham et 
al., 2000; Cabibbo et al., 2000; Dias-Gunasekara et al., 2005; Mezghrani et al., 2001; 
Pagani et al., 2000). The CXXCXXC motif of Ero1-L is also important for the 
folding and structural integrity of Ero1-L as well as the stability of the Ero1-L-
PDI complex (Benham et al., 2000). Recent complementary studies by Ellgaard and 
colleagues and Bullied and colleagues highlighted the role of a non-catalytic 
disulfide bond between the redox active Cys94 residue and Cys131 in Ero1-L 
(Appenzeller-Herzog et al., 2008; Baker et al., 2008) the formation of which is 
responsible for regulating the redox activity of Ero1-L in an oxidising environment. 
This strong disulfide bond inactivates Ero1-Ls redox activity until there is an 
increased demand for oxidative activity, as determined by the presence of reduced 
PDI (Sevier et al., 2007). Hence, PDI is acting as a key regulator of ER redox 
homeostasis. 
 
The reasons why higher eukaryotes contain two different Ero proteins, whilst S. 
cerevisiae only requires one, is not yet fully understood. Induction of the expression 
of Ero1-L is induced by ER stress, possibly suggesting separate regulation 
pathways (Pagani et al., 2000). However, Ero1-L and Ero1-L do differ in their 
tissue distribution, with Ero1-L highly expressed in the oesophagus, whilst Ero1-L 
is more abundant in the pancreas, stomach, testis and pituitary gland (Dias-
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Gunasekara et al., 2005; Pagani et al., 2000).  Thus, different human Ero proteins 
might participate in tissue-specific oxidation pathways. 
 
2.2.2.5 Glycosylation 
The second modification to polypeptides afforded by the endoplasmic reticulum, in 
addition to disulfide bond formation, is the addition of N-linked oligosaccharides to 
form so-called glycoproteins. Upon translocation, the oligosaccharyltransferase 
complex (OST) scans the polypeptide chain for asparagine residues in the sequence 
Asn-x-Ser/Thr. The 8 subunit OST enzyme covalently transfers a preformed 
triglucosylated oligosaccharide (GlcNAc2Man9Glc3), known as the core 
oligosaccharide, from dolicholpyrophosphate to the Asn residue of the polypeptide 
(Abeijon and Hirschberg, 1992) (Fig. 3). Soon after, the terminal glucose is trimmed 
off by the membrane-bound -glucosidase I (GI) enzyme (Kornfeld & Kornfeld, 
1985). The remaining two glucose molecules are removed by the ER soluble 
glucosidase II (GII) enzyme leaving a GlcNAc2Man9 stalk. This, however, is not an 
irreversible step, since the ER enzyme UDP-Glc:glycoprotein glucosyltransferase 
(GT) is able to add a glucose unit onto the terminal mannose residue. Thus, GII not 
only trims glucose residues after GI trimming but removes single glucose units added 
by UDP-Glc.  
 
The explanation for this deglucosylation, reglucosylation cycle was revealed in the 
mid 90s (Hebert et al., 1995). Binding of the ER lectins calnexin and calreticulin to 
oligosaccharide side chains requires the trimming of the first two glucose units while 
the release of substrates from these lectins is determined by the trimming of the third 
glucose unit. Thus, glucose trimming by the -glucosidases GI and GII and 
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reglucosylation by UDP-Glc serves to regulate the association of folding 
polypeptides with the ER lectins calnexin and calreticulin. Calnexin is a Ca2+ 
binding, type-I membrane protein of the ER. Calreticulin, on the other hand, is a 
soluble ER protein with both high and low affinity Ca2+ binding sites and a C-
terminal KDEL signal (Michalak et al., 1999; High et al., 2000). A homolog of 
calnexin, calmegin is expressed in the testis and can interact with the non-redox 
active PDI homolog, PDILT (van Lith et al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The N-linked core oligosaccharide. The core glycan has 14 saccharides: 3 
glucose, 9 mannose and 2 N-acetylglucosamine. The terminal glucose (n) is removed by 
glucosidase I. The m and l glucose residues are then removed by glucosidase II. However, 
a glucose residue can be added to the terminal mannose residue, at position l, by UDP-
Glc:glycoprotein glucosyltransferase (GT). The ER -mannosidase I enzyme removes the 
terminal i mannose as a countdown timer for glycoprotein folding. 
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Regulation of lectin binding is important for the maturation of protein substrates 
since encouraging lectin binding allows the retention of the substrate protein in the 
ER lumen, preventing partially folded or misfolded proteins from traversing the 
secretory pathway. As such, the monoglucosylation/deglucosylation cycle has 
implications for protein quality control. Local structure around the glycan is 
responsible for determining GT association although it may recognise unstructured 
regions not in the vicinity of the N-glycan (Taylor et al., 2004). If areas surrounding 
the glycan exhibit unstructured, non-native features they are targeted by GT 
(Trombetta & Helenius, 2000), allowing another round of lectin association which 
may promote constructive folding events. This cycle continues – if native portions of 
the unfolded protein exist – until the substrate has reached its conformational 
maturation. Thus, in proteins which normally undergo multiple lectin binding events, 
deletion of GT results in the premature release of substrates from calnexin and may 
contribute to lower folding efficiency. However, calnexin-substrates only requiring 
one binding events are not affected by GT knock-out (Solda et al., 2007). 
 
The addition of an oligosaccharide side chain to a newly synthesised polypeptide 
initially serves to increase the hydrophiliy of the unfolded protein. The consequential 
binding of calnexin/calreticulin prevents aggregation of the unstructured polypeptide 
chain and promotes ER retention. As previously mentioned, the ER oxidoreductase 
ERp57 is able to interact directly with glycoproteins as well as the ER lectins 
calnexin and calreticulin (Elliott et al., 1997; Oliver et al., 1997). The importance of 
these ER components is demonstrated by the fact that mouse knock-outs of 
calreticulin and ERp57 are both embryonic lethal (Mesaeli et al., 1999; Garbi et al., 
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2006; Solda et al., 2006). Knock-out of calreticulin alone leads to disruption of heart 
development despite allowing normal development of the other embryonic organs. 
The calnexin knock-out leads to premature death due to impaired growth and motor 
disorders (Denzel et al., 2002).  However, knock-out studies with calnexin and 
calreticulin have demonstrated that they are unable to compensate for the loss of each 
other indicating that they have unique functions (Masaeli et al., 1999; Nakamura et 
al., 2001; Denzel et al., 2002). Calreticulin has an important role to play in the 
modulation of Ca2+ homeostasis. Calreticulin-deficient cells have impaired Ca2+ 
homeostasis leading to a reduction in the free Ca2+ concentration in the ER whereas 
overexpression of calreticulin results in an increase in the ER concentration of free 
Ca2+ and an increase in the Ca2+ capacity of the ER (Bastianutto et al., 1995; Mery et 
al., 1996; Arnaudeau et al., 2002; Molinari et al., 2004).  
 
2.2.2.6 Chaperones of the ER 
In addition to calnexin and calreticulin, many other chaperones exist in the ER lumen 
to monitor and facilitate the folding of substrate proteins. Many members of the PDI 
family are postulated to have chaperone activity in addition to, or in lieu of 
oxidoreductase activity (Ferarri et al., 1999). There are many chaperones which aid 
the folding of specific client substrates such as tapasin – which will be discussed 
later. Here I discuss the chaperone activities of PDI, BiP and Grp94. 
 
2.2.2.6.1 Chaperone activity of PDI 
Disulfide oxidoreductases should only require catalytic concentrations in order to 
facilitate disulfide bond formation or rearrangement. However, PDI exists at 
millimolar concentrations in the ER. Since studies show that PDI is essential for cell 
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viability and pdi1 null mutations of yeast are rescued by mammalian PDI with 
unconventional domain structure, it is possible that another function of PDI is 
essential for yeast viability (Farquhar et al., 1991; Xiao et al., 2001). The isomerase 
activity of PDI somehow requires the preferential recognition of unfolded proteins. 
Direct binding of PDI to unfolded substrates would then facilitate disulfide bond 
rearrangement as well as prevent unfolded proteins from participating in 
unconstructive intermolecular interactions.  
 
LaMantia & Lennarz demonstrated the binding of unfolded proteins by PDI, 
suggesting that the oxidoreductase may demonstrate chaperone activity (LaMantia 
and Lennarz, 1993). Studies with the enzyme lysozyme – which is prone to 
aggregation – demonstrated that PDI did indeed exhibit chaperone activity since the 
recovery of soluble lysozyme – in optimised conditions – was increased in the 
presence of PDI – which prevented lysozyme aggregation (Puig and Gilbert, 1994). 
In addition to this, Puig and Gilbert discovered a novel anti-chaperone activity of 
PDI, where, at higher lysozyme concentrations and substoichiometric PDI 
concentrations, PDI facilitates the formation of large disulfide cross-linked lysozyme 
aggregates. It has been suggested that anti-chaperone activity is a consequence of 
multivalent binding of partially aggregated substrates to PDI (Primm et al., 1996). 
This is perhaps not significant in vivo but it does indicate that the concentration of 
PDI in the ER is key to determining the fate of proteins between an off- and on-
pathway destination. Thus, the unexpectedly high concentration of PDI is perhaps 
necessary to prevent potential anti-chaperone activity and help promote constructive 
oxidative events. 
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2.2.2.6.2 BiP 
Immunoglobulin-binding protein (BiP), also known as glucose-regulated protein 78 
(Grp78) is an abundant ER homolog of Hsp70 (Lee, 2001; Kleizen & Braakman, 
2004; Hendershot, 2004). During translocation of nascent polypeptides into the ER, 
BiP is responsible for gating the translocon on the ER lumenal side, maintaining the 
permeability barrier of the translocon during the initial stages of translocation 
(Hamman et al., 1998). BiP also seals translocons that are assembled even if they are 
not participating in translocation. This serves to preserve the environment in the ER. 
Furthermore, BiP may provide the driving force for post-translational translocation 
by acting as a molecular ratchet since multiple BiP molecules bind substrates at the 
translocon and prevent passive backwards movement through the translocation 
channel (Matlack et al., 1999; Rapoport et al., 1999).  
 
BiP was initially discovered as a binder of immature immunoglobulin precursors 
(Haas & Wabl, 1983; Bole et al., 1986) and later found to be essential for the 
assembly, transport and ultimate secretion of complete immunoglobulin molecules 
Hendershot et al., 1987). Since BiP is a member of the Hsp70 family, it too possesses 
a conserved ATPase domain and hydrolyses ATP to regulate its function (Bukau & 
Horwich, 1998). The ATP-bound BiP molecule is open to protein binding, and 
hydrolysis of ATP to ADP closes the binding site onto the substrate. The ER-resident 
DnaJ ortholog ERdj3 has been detected in a BiP-Ig heavy chain complex, implicating 
it as a candidate BiP co-chaperone. There are several ER localized DnaJ proteins 
including ERdj1, ERdj3, ERdj4 and ERdj5. The nucleotide-exchange factor BiP-
associated protein (BAP) induces ADP release so that ATP can bind, reopening the 
binding cleft (Chung et al., 2002).  
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A key paper by Flynn and colleagues demonstrated the ability of BiP to distinguish 
unfolded and folded proteins (Flynn et al., 1991). They showed that BiP binds to 
linear segments of polypeptides which contain non-native features. They suggested 
that the seven amino acid residues which make up the peptide binding site of BiP 
substitutes for the hydrophobic interior of a native globular protein, allowing the 
recognition of unfolded structures and the protection of exposed sections of newly 
translated polypeptides. 
 
More recently, BiP has been demonstrated to have a key role in the response to the 
accumulation of unfolded proteins in the ER, allowing the detection and transduction 
of ER stress signals across the ER membrane (Malhotra & Kaufman, 2007). This will 
be discussed in further detail later. 
  
2.2.2.6.3 Grp94 
Glucose-regulated protein 94 (Grp94) – also known as Gp96, adenotin and 
endoplasmin – is an ER-resident member of the Hsp90 family. Grp94 has an 
essential role in the folding of a specific subset of client proteins such as Toll-like 
receptors, immunoglobulins and integrins (Melnick et al., 1994; Argon et al., 1999; 
Nigam et al., 1994). Grp94 interacts with unfolded immunoglobulins after interaction 
with BiP to ensure correct folding of the substrate (Melnick et al., 1992; Melnick et 
al., 1994).  
 
Cytosolic Hsp90 activity is aided by the co-chaperone Hsp-organising protein 
(Hop/p60) which mediates the association of Hsp90 with Hsp70 (Scheufler et al., 
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2000). Currently, no Grp94 co-chaperones have been identified although many other 
ER chaperones have been detected in complexes with Grp94. This is not surprising 
since Grp94 lacks the C-terminal KEEVD domain necessary for recognition by TPR 
motif-bearing accessory proteins such as the co-chaperone Hop. 
 
Grp94 does interact with adenosine nucleotides, but this association is very weak. It 
was, therefore, believed that Grp94 does not function as an ATPase (Wearsch & 
Nicchitta, 1997; Rosser & Nicchitta, 2000). The role of adenosine nucleotides in 
substrate binding was recently studied by Rosser and colleagues who demonstrated 
that in the presence of ATP, ADP or geldanamycin, Grp94-Ig heavy chain complexes 
remained stable indicating that the hydrolysis of ATP is not responsible for the 
release of client proteins from Grp94 (Rosser et al., 2004). However, recent evidence 
now suggests that Grp94 does have ATPase activity (Dollins et al., 2007; Frey et al., 
2007). 
 
The crystal structure of the Grp94 N-terminal regulatory domain bound to the 
adenosine derivative NECA shows structural divergence from other Hsp90 family 
members. A 5 amino acid insertion in a subdomain could potentially act as a ligand 
responsive conformational switch, altering the oligomerisation behaviour of Grp94 
(Soldano et al., 2003). Further crystallographic work from nearly full-length Grp94 
has supported this finding (Dollins et al., 2007). Cytosolic Hsp90 complex 
recruitment is regulated by ligand binding, however, indicating potential functional 
similarities between Grp94 and Hsp90 (Whitesell et al., 1994).  
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2.2.2.7 ER-associated Degradation (ERAD) 
Those proteins stuck in off-pathway conformations pose a danger to the cell due to 
the risk of accumulation and aggregation or the binding of wild-type proteins as well 
as causing membrane damage, leakiness of organelles and loss of ion/small molecule 
gradients over these membranes. Although unfolded or misfolded proteins interact 
with ER chaperones to promote constructive folding events, eventually, if they do 
not reach their native conformation they are removed from the ER, possibly by 
retrotranslocation, and degraded in the cytoplasm in a process known as ER-
associated degradation (ERAD) (Kostova & Wolf, 2003; Nakatsukasa & Brodsky, 
2008). These ‘terminally misfolded’ proteins may have arisen as a consequence of 
mutations at translation, lack of co-factors or prosthetic groups or failure to 
oligomerise. In short, the aim of ERAD is to remove terminally unfolded/misfolded 
proteins from the ER to maintain ER homeostasis.  
 
2.2.2.7.1 ERAD substrate recognition 
The first step in the removal of terminally misfolded proteins is their detection. One 
of the key modes of highlighting proteins destined for retrotranslocation – at least for 
glycoproteins – is the trimming of N-glycans by ER-mannosidase I, since inhibition 
or removal of this enzyme halts glycoprotein degradation (Su et al., 1993; Knop et 
al., 1996; Vallee et al., 2000). The Ca2+-requiring enzyme is responsible for 
removing a single mannose residue – or more (Helenius, 1994; Hosokawa et al., 
2003) – from the core oligosaccharide resulting in a GlcNAcMan8Glc0-3 structure 
(Fig. 3). Since mannose removal is a slower process than glucose removal – 
mediated by GI and GII – mannose trimming by ER-mannosidase I acts as a 
countdown timer for glycoprotein folding which, if surpassed, results in degradation. 
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Although essential, the removal of this mannose residue is not sufficient for ERAD 
since correctly folded proteins also require mannose trimming before exiting the ER 
(Byrd et al., 1982). Thus, there must exist other mechanisms – most likely involving 
an interplay between ERAD components, ER folding assistants and the biophysical 
properties of the substrate – to determine if proteins are to be retrotranslocated; 
especially since non-glycosylated proteins are not subjected to mannose trimming.  
 
Once ER-mannosidase 1 has removed a single mannose residue, the efficiency of re-
entry into the calnexin cycle is reduced and the binding of the putative lectin ER 
degradation enhancing -mannosidase-like protein (EDEM) (Htm1/Mnl1 in yeast) is 
favoured. Through interaction with calnexin, terminally misfolded proteins are 
directly handed over to EDEM, diverting these substrates towards ERAD (Molinari 
et al., 2003; Oda et al., 2003; Cormier et al., 2009). Furthermore, overexpression of 
EDEM1 reduces intervals of calnexin binding, accelerates the degradation of 
substrates and inhibits the formation of disulfide-linked dimers and complexes for 
clients of the calnexin cycle, thus maintaining the retrotranslocation competence of 
terminally misfolded proteins and preventing the formation of misfolded aggregates 
(Molinari & Helenius, 2000; Oda et al., 2003; Hosokawa et al., 2006). In a screen for 
EDEM-binding proteins, Ushioda and colleagues illustrated that the disulfide 
isomerase, ERdj5, binds to EDEM and accelerates the ERAD of substrates by 
facilitating the reduction of substrate disulfide bonds (Ushioda et al., 2008). As such, 
EDEM seems to possess a new type of chaperone-like activity, preventing 
unconstructive covalent interactions and aggregation – essential since the misfolded 
protein needs to be retrotranslocated out of the ER – but in order to promote 
degradation rather than constructive folding events. It is unclear however, whether 
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EDEM facilitates degradation through the recognition of misfolded 
conformations/hydrophobic regions in addition to recognising specific 
oligosaccharide side chains. The three members of the EDEM family – EDEM1, 
EDEM2 and EDEM3 – share considerable homology to ER-mannosidase 1 in their 
lumenal domain but seem to lack the enzymatic activity to process -1,2-mannose. 
However, overexpression of EDEM1 was found to result in mannose trimming and 
enhancement of ERAD (Hosokawa et al., 2010). Furthermore, Htm1, the yeast 
orthalog of EDEM, exhibits 1,2-specific exomannosidase activity firstly requiring 
processing of the glycan by GI, GII and mannosidase I (Clerc et al., 2009) and also 
possibly acts as a marker for Yosp9 activity by potentially recognising the presence 
of misfolded structures (Quan et al., 2008). The homology between EDEM and ER-
mannosidase 1 may be responsible for EDEMs ability to preferentially recognise 
mannose-trimmed substrates. EDEM1 is a membrane protein whereas EDEM2 and 
EDEM3 are located in the lumen of the ER (Olivari et al., 2005; Mast et al., 2005; 
Hirao et al., 2006). However, only EDEM3 contains a KDEL ER retention signal; 
EDEMs 1 and 2 lack any discernable retention signal (Hirao et al., 2006). Since 
EDEM does not interact with calreticulin, it is possible that further lectins will be 
discovered that link ERAD to calreticulin-mediated chaperone activity.  
 
In addition to EDEM, a second class of lectin-like ERAD components exist. Yeast 
osteosarcoma 9 protein (Yos9p) – the yeast OS-9 ortholog – possesses a lectin-like 
domain but with similarities to the mannose 6-phosphate receptor (MPR) family – 
indicative of its function in mannose recognition. The protein contains a C-terminal 
HDEL ER retention signal and associates with the ER membrane (Friedmann et al., 
2002). More recent work has identified Yos9p as being able to bind misfolded 
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glycoproteins in an N-glycan-specific manner (Szathmary et al., 2005). A genome-
wide screen initially identified Yos9p as being essential for glycoprotein ER-
associated degradation. This was further supported by the observation that Yos9p co-
immunoprecipitated with the classic ERAD substrate misfolded carboxypeptidase Y 
(CPY) when exhibiting specific oligosaccharide architecture (Buschhorn et al., 2004; 
Bhamidipati et al., 2005; Szathmary et al., 2005). Moreover, Bhamidipati and 
colleagues found that Yos9p could bind misfolded CPY lacking N-glycans. Although 
this seems contradictory to Szathmary and colleagues’ work, Bhamidipati and 
colleagues used different methods. Furthermore, the concentrations of Yos9p used in 
the experiments of the latter reportedly exceed that of physiological Yos9p 
concentration which may have an influence of substrate binding.  
 
The role of Yos9p in ERAD is still not fully understood but the observation that the 
binding of misfolded glycoproteins with Yos9p is reduced in the absence of EDEM 
(Htm1p) in yeast might suggest that Yos9p is part of the same degradation pathway 
as EDEM and perhaps exerts its function downstream of EDEM or forms a complex 
together with Yos9p which is able to stabilise the misfolded protein-Yos9p 
interaction. Due to the observation that altering conserved residues in the lectin-like 
mannose 6-phosphate homology (MRH) domain of Yos9p abolishes its ERAD 
function and that degradation of mutant glycoproteins is dependent on Yos9p, is was 
proposed by the Wolf laboratory that Yos9p-misfolded glycoprotein binding is 
mediated by an MRH-domain-N-glycan interaction (Szathmary et al., 2005). 
However, this theory does not exclude the binding of misfolded glycoproteins to 
Yos9 in an N-glycan-independent manner. Yos9 has two mammalian homologs, OS-
9 and XTP3-B, both of which contain MRH domains (Christianson et al., 2008). OS-
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9 and XTP3-B have been found in a complex with the ubiquitin ligase Hrd1 via the 
SEL1L adaptor protein as well as with ERAD substrates indicating that both 
homologs are involved in the ERAD of proteins in the mammalian system. 
 
2.2.2.7.2 Retrotranslocation and degradation 
Once the recognition of proteins destined for degradation has taken place, these 
ERAD candidates are then targeted to the putative dislocation and ubiquitination 
complex. The pore through which ERAD substrates are retrotranslocated is still 
being debated (Herbert et al., 2010). Sec61, the main component of the protein 
translocation channel responsible for allowing the translocation of newly synthesised 
proteins into the ER, was shown to participate in the retrotranslocation of ER 
proteins. In mammalian cells, Sec61 has been coimmunoprecipitated with MHC 
class I heavy chains directed to ERAD by the cytomegalovirus (CMV) gene products 
US2/US11 (Wiertz et al., 1996). Many further studies support a role for Sec61 in the 
retrotranslocation of ERAD substrates (Pilon et al., 1997; Schmitz et al., 2000; 
Oyadomari et al., 2006; Scott & Schekman, 2008). However, the crystallographic 
structure of SecY/E, an archaeal ortholog of Sec61, revealed that the size limit for 
the pore diameter is small and seems unlikely to accommodate larger 
retrotranslocation substrates (Tirosch et al., 2003; van den Berg et al., 2004). 
Another candidate, Derlin1 (Der1p in yeast), which has four membrane spanning 
domains, has too been shown to be necessary for CMV-induced dislocation of MHC 
class I heavy chains from the ER (Hitt & Wolf, 2004; Lilley & Ploegh, 2004; Ye et 
al., 2004). Overexpression of members of the Derlin protein family accelerated the 
degradation of ERAD substrates further supporting their putative role in 
retrotranslocation (Oda et al., 2006). Derlin1 forms a complex with both ER lumenal 
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components and cytosolic proteins required for efficient ERAD including the 
homohexameric ATPase p97/VCP (cell division cycle 48 (Cdc48) in yeast) and 
VIMP (p97-interacting protein). The yeast system is better characterised and, in 
addition to Cdc48 and Der1p, other components of the retrotranslocation machinery 
have been identified and include: the dimeric cofactor Ufd1/Npl4, the membrane 
adapter protein Ubx2p, which contains a ubiquitin associating (UBA) domain, the E3 
ubiquitin-protein ligase Hrd1p and lastly Usa1p, which stabilises the interaction 
between Hrd1p and Der1p (Lilley & Ploegh, 2004; Ye et al., 2004; Carvalho et al., 
2006; Oda et al., 2006; Bernardi et al., 2008; Christianson et al., 2008; Goder et al., 
2008). Thus, Derlin interacts with components of the ubiquitination and degradation-
targeting machinery. Furthermore, in yeast, Yos9p has been shown to form a 
complex with Kar2 (the yeast homolog of BiP) – which has also been implicated in 
ERAD – and Hrd3p which stabilises Hrd1p in the multimeric ubiquitination complex 
((Plemper & Wolf, 1999; Brodsky et al., 1999; Kabani et al., 2003; Denic et al., 
2006; Hedge et al., 2006). Thus, it has been proposed that Yos9p recruits proteins, 
genuinely designated for ERAD, to the putative dislocation/ubiquitination complex 
providing a link between the recognition of aberrantly folded proteins and their 
retrotranslocation and subsequent ubiquitination as well as helping to eliminate 
indiscriminate, basal levels of degradation. In higher eukaryotes, many other factors 
have been reported to be important in assisting in the retrotranslocation of ER 
components including PDI and BiP (Gillece et al., 1999; Molinari et al., 2002; 
Forster et al., 2006; Heiligenstein et al., 2006; Hosokawa et al., 2008)  
 
Dislocation of ERAD substrates is aided by the Cdc48-Ufd1-Npl4 complex and 
precedes the addition of polyubiquitin to these proteins targeting them towards 
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proteasomal degradation (Ye et al., 2001; Jarosch et al., 2002). Ubiquitination 
requires a sequence of reactions starting with the activation of ubiquitin by the 
ubiquitin-activating enzyme (E1) which then transfers the activated ubiquitin to the 
ubiquitin-conjugating enzyme (Ubc or E2). The E3 ubiquitin ligase is responsible for 
conjugating the ubiquitin – via an isopeptide bond – to a target lysine residue. A 
number of E3 ligases involved in the ubiquitination of ERAD substrates have been 
identified (Kostova et al., 2007). Hrd1p, a putative retrotranslocon, contains a 
cytosolic RING-H2 face that is stabilised by an interaction with the transmembrane 
Hrd3p (Bordallo et al., 1998; Bays et al., 2001). Hrd1p can interact with the E2 
enzymes Ubc1p, Ubc6p or Ubc7p and is responsible for the selective ubiquitination 
of ER lumenal and membrane proteins (Friedlander et al., 2000; Bays et al., 2001; 
Sato et al., 2009). Doa10 – also proposed as an alternative dislocation channel – is a 
further E3 ligase with a much broader a range of substrates than Hrd1p (Kostova et 
al., 2007). 
 
The fact that these E3 ligases are proposed to be putative retrotranslocons seems 
sensible, since housing the retrotranslocation and ubiquitination activities in the same 
enzyme may be the most efficient way of targeting ERAD substrates for proteasomal 
degradation (Vembar & Brodsky, 2008). 
 
Once targeted for degradation, substrates are delivered to the proteasome possibly by 
Cdc48 and several proteasome-interacting factors including UBA domain- and UBL 
domain-containing proteins such as Rad23 and Dsk2, which have been shown to 
increase ERAD efficiency (Verma et al., 2000; Medicherla et al., 2004; Raasi & 
Wolf, 2007). Substrates are then deubiquitinated and degraded by the 26S 
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proteasome which may even be localised to the surface of the ER membrane (Rivett, 
1993; Amerik & Hochstrasser, 2004). 
 
ER-associated degradation of integral membrane proteins is more poorly understood 
than that of ER lumenal proteins (Nakatsukasa & Brodsky, 2008). The ER-
associated, cytoplasmic Hsp40-Hsp70 chaperones have been shown to assist in the 
interaction of integral membrane proteins with E3 ligases, possibly indicating a role 
in their degradation (Nakatsukasa et al., 2008). This is consistent with the several 
other studies which suggest that the cytoplasmic chaperone machinery plays an 
important role in the ERAD of membrane proteins (McClellan et al., 2005; Carvalho 
et al., 2006). However, further research is needed on the degradation of membrane 
proteins with few or no soluble domains. 
 
2.3 Unfolded Protein Response 
In the endoplasmic reticulum, much as in any organelle, an increase in population of 
a folding polypeptide species with persistent non-native interactions can have dire 
consequences for the cell. The accumulation of off-pathway intermediates can lead to 
the formation of intermolecular interactions and the development of protein 
aggregates. I have already discussed the intrinsic properties that chaperones exert on 
constructive protein folding and the prevention of aggregate formation. However, 
due to potential changes in the protein folding demand of the cell as well as the ER’s 
susceptibility to perturbations caused by environmental factors, it is essential that the 
ER possesses a mechanism for detecting the folding competency and status of the 
organelle. Accordingly, the ER contains sensors that detect the folding capacity of 
the organelle and transduce that signal across the ER membrane and, where 
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appropriate, mount a suitable response to maintain ER homeostasis. This signalling 
network is known as the unfolded protein response (UPR).  
 
The capacity of the ER protein folding machinery to meet the folding demand of ER 
proteins is regulated by coordinating the expression of many genes. The UPR 
responds to perturbations in ER homeostasis by coordinating a transcriptional – and 
additionally in higher eukaryotes, a translational – programme to restore protein 
folding efficacy. These perturbations can be the synthesis and accumulation of 
terminally misfolded proteins, environmental stresses such as heat shock or hypoxia 
or a sudden increase in protein synthesis. All of these perturbations result in an 
imbalance between the demand of folding proteins and the folding capacity of the ER 
and can collectively be referred to as ‘ER stress’, which is typically defined as ‘a 
situation where the folding capacity of the ER is exceeded’. At this point, the cell 
must make a ‘decision’ on whether it is beneficial or detrimental to promote survival 
under these conditions. The mechanisms by which the cell switches between 
prosurvival a proapoptotic pathways are not fully understood but the role of the UPR 
in apoptosis and the respective merits of survival and death on the organism will be 
discussed further on in this chapter. 
 
2.3.1 The yeast UPR 
The story of the yeast UPR started with genetic screens of mutants defective in UPR 
carried out in the budding yeast Saccharomyces cerevisiae. As a result, in 1993, two 
separate groups independently isolated IRE1 as a putative ER stress transducer (Cox 
et al., 1993; Mori et al., 1993). Ire1 mutants are unable to activate transcription of 
KAR2 and PDI1 which encode the yeast ER resident proteins BiP and PDI 
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respectively. Furthermore, IRE1 was found to be essential for cell viability under 
stress conditions where unfolded proteins were allowed to accumulate in the ER; 
indicating a direct role for IRE1 in the protection of cells from perturbation in ER 
homeostasis. Sequence data suggested that Ire1p was a single-spanning ER 
transmembrane protein kinase with an N-terminal region in the ER lumen, whilst 
further work illustrated that its cytosolic domain is composed of two functional 
domains, a serine/threonine protein kinase and an RNase L-like endoribonuclease 
domain (Bork & Sander, 1993; Mori et al., 1993 Shamu et al., 1994; Sidrauski & 
Walter, 1997).  
 
Subsequent biochemical analysis of Ire1p revealed that after detecting the 
accumulation of unfolded proteins in the ER, Ire1p forms dimers or oligomers in the 
plane of the membrane inducing its kinase activity and causing trans-
autophosphorylation of Ire1p (Shamu & Walter, 1996; Welihinda & Kaufman, 
1996). This, in turn, induces the endoribonuclease activity of Ire1p (Sidrauski & 
Walter 1997). The sole target of Ire1p RNase activity is the constitutively-expressed 
HAC1 mRNA (Cox & Walter, 1996; Sidrauski et al., 1996; Kawahara et al., 1997). 
Recently, crystal structure evidence for the early-stage formation of Ire1 oligomers 
was published (Lee et al., 2008a; Aragòn et al., 2009; Korennykh et al., 2009; 
Wiseman et al., 2010). These high-order, ‘supramolecular structures’ give rise to Ire1 
foci to which HAC1 mRNA is recruited via a conserved 3’ untranslated region 
(UTR) targeting element which promotes Ire1p activation and Ire1p-mediated UPR 
signalling (Aragòn et al., 2009). Indeed, both HAC1 and the metazoan equivalent, 
XBP1, have a tendency to be found associated with ER membranes (Diehn et al., 
2000; Stephens et al., 2005; Yanagitani et al., 2009).      
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In yeast, Hac1p (Homology to ATF and CREB 1 protein) – identified by three 
independent groups – is responsible for mediating transcription from unfolded 
protein response element (UPRE)-containing promoters (Mori et al., 1996; Cox & 
Walter, 1996; Nikawa et al., 1996). The UPRE is a single 22-bp element which is 
conserved among targets of the UPR and required for transactivation of target genes 
such as KAR2, PDI1, EUG1, LHS1 and ERO1 (Normington et al., 1989; LaMantia et 
al., 1991; Mori et al., 1992; Tachibana & Stevens, 1992; Kohno et al., 1993; Craven 
et al., 1996; Pollard et al., 1998; Frand & Kaiser 1998). The HAC1 gene was 
identified as a homolog of the ATF/CREB family of basic leucine zipper (bZIP) 
transcription factors but unusually, transcripts of the gene vary depending on the 
presence or absence of ER stress (Bork & Sander, 1993; Nojima et al., 1994; 
Sidrauski & Walter, 1997). Under stressed conditions, HAC1 mRNA lacks a 252-bp 
region present in non-stressed cells. The endoribonuclease activity of Ire1p – 
together with an RNA ligase – is responsible for this non-canonical splicing event, 
rather than the conventional splicosome machinery. Removal of this intron takes 
place by Ire1p-mediated cleavage at two specific sites near the 3’ end of the mRNA 
sequence on conserved, predicted stem-loop structures either side of the 252-bp 
fragment – which are then joined by tRNA ligase (Sidrauski et al., 1996; Sidrauski & 
Walter, 1997; Kawahara et al., 1998; Gonzalez et al., 1999). The result of Ire1p-
mediated splicing is the replacement of the 10-amino acid C-terminal tail encoded in 
the intron of unspliced HAC1 mRNA (HAC1u) with an 18-amino acid tail encoded by 
the second exon of spliced HAC1 (HAC1i). The splicing event does not affect the 
220-amino acid N-terminal region which contains the DNA-binding domain.  
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Under non-stressed conditions, constitutively-expressed HAC1u associates with 
polyribosomes to initiate translation but translation stalls on ribosomes possibly due 
to long-range base pairing between the 5’ untranslated region (UTR) and sequences 
within the intron (Chapman & Walter, 1997; Mori et al., 2000; Rüegsegger et al., 
2001). Splicing out of this 252-bp intron prevents this long-range base pairing and 
relieves HAC1 from translational attenuation (Rüegsegger et al., 2001). Moreover, 
Mori and colleagues showed that increased transcriptional activator activity was not 
solely due to an increase in translation efficacy (Mori et al., 2000). They proposed 
that an observed 10-fold increase in the transcription activator activity of Hac1pi over 
Hac1pu was due to the proximity of a C-terminal activation domain (AD) to the 
DNA-binding domain (DBD). However, the C-terminal tail becomes more acidic in 
spliced Hac1pi, leading to transcriptional activity. 
 
Yeast cells that lack HAC1 are unable to mount an unfolded protein response and, 
although viable, are sensitive to pharmacological agents which can induce ER stress 
and tend to die at ordinarily sublethal doses (Mori et al., 1996).  Thus, the 
transcriptional regulation of components involved in the promotion of protein folding 
and the restoration of ER homeostasis – and the regulation of Rpd3 histone 
deacetylase activity – is performed by Hac1pi, which, through Ire1p-mediated 
regulation, and in conjunction with Gcn4p, responds to the protein folding capacity 
of the yeast endoplasmic reticulum (Travers et al., 2000; Patil et al., 2004; Schröder 
et al., 2004).   
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2.3.2 The mammalian UPR 
Whereas yeast cells have a single proximal stress sensor, the UPR in higher 
eukaryotes consists of three distinct pathways modulated through three 
transmembrane stress sensors, IRE1, PERK and ATF6. Similar to the yeast UPR, the 
mammalian UPR responds to perturbations in ER homeostasis and initiates a 
transcriptional programme to meet the requirements of the ER for protein folding. 
Transcriptional activation of specific genes involved in protein folding – such as 
chaperones and folding enzymes – and components of ER-associated degradation 
alleviates ER stress and restore ER homeostasis. Moreover, in addition to yeast, the 
mammalian UPR exerts attenuation of global protein translation to combat ER stress. 
This is achieved by inhibiting translation initiation and serves to decrease the load of 
newly synthesised proteins on the ER.  
 
2.3.2.1 IRE1 
IRE1 is highly conserved in evolution. In mammals, two homologs of yeast IRE1, 
which are encoded by different genes, have been identified (Tirasophon et al., 1998; 
Wang et al., 1998). IRE1 is expressed broadly in a range of tissues whereas IRE1 
is expressed only in the epithelial cells of the gastrointestinal tract, particularly in 
colon and stomach. Deletion of the mouse homolog of IRE1 is embryonic lethal 
whereas IRE1-deficient mice are viable but susceptible to environmental agents that 
promote colitis (Bertolotti et al., 2001; Lee et al., 2002). Similarly to Ire1p, both 
mammalian IRE1 proteins respond to ER stress by trans-autophosphorylation and 
dimerisation – which has recently been confirmed by solving the yeast cytosolic 
domain crystal structure – and can activate downstream target genes (Lee et al., 
2008a). Overexpression of either IRE1 or IRE1 is able to activate the BiP 
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promoter indicating a functional conservation between yeast and mammals – 
although BiP activation might be the result of IRE1/ acting as an unfolded protein. 
Deletion of mouse IRE1 and/or IRE1 does not prevent transcriptional activation 
of BiP or the Hsp90 family-member Grp94, indicating that there are IRE1-
independent pathways that can complement IRE1 in the mammalian UPR target gene 
regulation (Tirasophon et al., 1998; Wang et al., 1998; Urano et al., 2000; Lee et al., 
2002).  
 
The main substrate for the endoribonuclease activity of mammalian IRE1 is the bZIP 
transcription factor X-box binding protein 1 (XBP1) mRNA (Shen et al., 2001; 
Yoshida et al., 2001a; Calfon et al., 2002; Lee et al., 2002) (Fig. 4). Unlike HAC1, in 
which the DNA-binding domain (DBD) and transcriptional activation domain (AD) 
are in the same open reading frame (ORF), the pre-mRNA version of XBP1 (XBP1u) 
only contains the DBD (Yoshida et al., 2001a). Splicing of XBP1u joins two open 
reading frames allowing the translation of both the DBD and AD. The splice-site 
motif of XBP1u is conserved from yeast further indicating that XBP1u undergoes a 
non-conventional splicing event. Unlike HAC1, the intron removed from XBP1u is 
small at only 26-bp compared with 252-bp. This is in line with the fact that apart 
from the DBD, XBP1s and HAC1i share little sequence homology.  
 
Furthermore, in contrast to HAC1u expression, which is subject to translational 
stalling, XBP1u is constitutively translated as a non-functional protein, but is quickly 
degraded by the proteasome (Lee et al., 2003). The purpose of this non-functional 
version of XBP1 – besides providing a cytoplasmic source of a ‘ready’ downstream 
target for IRE1 without de novo transcription – has been investigated recently 
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(Tirosh et al., 2006; Yoshida et al., 2006b; Uemura et al., 2009; Yoshida et al., 
2009). Tirosh and colleagues showed that increasing the stability of XBP1u protein 
augments the transcription of XBP1-specific and -non-specific target genes in 
response to ER stress, indicating that rapid degradation of XBP1u is required to 
prevent uncontrolled activation of the UPR (Tirosh et al., 2006). Yoshida and 
colleagues, on the other hand, demonstrated that XBP1u protein acts as a negative 
regulator of the UPR by promoting the degradation of the transcriptionally active 
XBP1s and ATF6 proteins, preventing residual transcription of ER chaperone and 
ERAD components (such as EDEM) during the recovery phase. Thus, XBP1 mRNA 
seems to encode a positive- and negative-regulator of mammalian UPR in XBP1s and 
XBP1u. 
 
Spliced XBP1 binds to a cis-acting ER stress-response element (ERSE), ERSE II and 
mammalian unfolded protein response element (UPRE) (Yamamoto et al., 2004). 
XBP1 acts alone, as a homodimer, to bind promoter elements – as in the case of 
UPRE – or in heterodimers with other transcriptional activators such as AFT6 or 
NF-Y, which will be discussed in more detail later (Yoshida et al., 1998; Yoshida et 
al., 2001b, Yamamoto et al., 2004; Yamamoto et al., 2007). As a consequence, 
XBP1 transactivates the expression of components of the ER-associated degradation 
system including EDEM, Derlin1 and Derlin2, OS9, HERP and the DnaJ co-
chaperones p58IPK, HEDJ and MDG1, secretory pathway components, SEC23B, 
SEC24C, SEC61A, SEC61G, SRP54 and TRAM1, and condition- and tissue-specific 
targets such as the transcription factor Mist1 (Lee et al., 2003; Yoshida et al., 2003; 
Shaffer et al., 2004; Oda et al., 2006; Yoshida et al., 2006a; Acosta-Alvear et al., 
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2007). Thus, IRE1-mediated splicing of XBP1 regulates a great number of 
downstream targets able to influence the protein folding capacity of the ER. 
 
IRE1 exhibits further features, outside of mediating XBP1 cleavage, which may have 
an influence on protein expression and cell fate. Overexpression of IRE1 can 
promote the cleavage of 28S ribosomal rRNA – although this may only be very 
minor – as well as mRNA encoding IRE1 itself, indicating that, under certain 
conditions, the endonuclease activity of IRE1 might have a wider range of substrates 
(Iwawaki et al., 2001; Tirasophon et al., 2000). This hypothesis was further 
supported by a recent systematic study which concluded that, under stressed 
conditions, IRE1 mediates the rapid degradation of a specific subset of mRNAs 
which encode proteins in the plasma membrane and other secreted proteins (Hollien 
& Weissman, 2006; Iqbal et al., 2008; Han et al., 2009; Hollien et al., 2009). This 
was shown to be a rapid response to ER stress, which takes place much faster than 
expression changes mediated by XBP1. This makes sense since quickly attenuating 
the translation of proteins before they enter the secretory pathway may relieve acute 
ER stress while the XBP1-dependent pathway takes effect. It is not clear however, if 
oligomerisation and formation of IRE foci is necessary for ER-localised mRNA 
decay. 
 
Additionally, IRE1 possesses features which may promote cell death in response to 
ER stress. When cells become stressed, IRE1 binds to the E3 ligase TRAF2 via the 
kinase domain of IRE1 (Fig. 4). This causes the activation of apoptosis signal-
regulating kinase 1 (ASK1/MAP3K5) through the formation of a IRE1-TRAF2-
ASK1 heterotrimer. As a result, the phosphorylation and consequential activation of 
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c-Jun N-terminal kinase (JNK) occurs (Urano et al., 2000; Nishitoh et al., 2002). The 
IRE1-TRAF2 interaction has, however, been demonstrated in the absence of IRE1 
kinase activity indicating that that kinase activity is not essential for IRE1-TRAF2 
heterodimer formation (Kaneko et al., 2003). ASK1-deficient cells are resistant to 
ER stress-induced apoptosis and JNK activation, providing evidence that JNK is 
downstream of ASK1 activation (Nishitoh et al., 2002). ASK1 activation is also 
associated with amyloid beta-induced neuronal cell death further demonstrating how 
important the IRE1-TRAF2-ASK1 signalling pathway is in apoptosis (Kadowaki et 
al., 2005). JNK activation promotes cell death under physiological stresses such as 
UV irradiation, thus JNK activation might too contribute to cell death in response to 
ER stress (Barr & Bogoyevitch, 2001) (Fig. 4). Bcl-2 is phosphorylated by ASK1 
and JNK leading to Bcl-2 inactivation, and Bim, a Bcl-2 family member, is induced 
and phosphylated by JNK leading to the induction of apoptosis (Molton et al., 2003). 
Furthermore, JNK is responsible for the induction of apoptosis by the proteasome 
inhibitor PS-341 through activation of the JNK/AP-1/CHOP signalling by inhibiting 
NF-B and Bcl-2 (Nozaki et al., 2001). The consequences of ASK1 and JNK 
activation, however, are most likely widespread and these factors may also be 
involved in prosurvival as well as proapoptotic pathways (Lin et al., 2008; Kim et 
al., 2008; Choi et al., 2009). These are discussed in more detail in section 2.3.2.5 
Apoptosis vs. Survival. 
 
Integration of IRE1 signalling and activation of the caspase pathway may also 
promote cell death signalling. The caspases are a family of cysteine proteases which 
can act as effectors of apoptosis, mediating apoptotic signalling and inflammatory 
cytokine processing. Upon ER stress and the binding of TRAF2 to IRE1, the 
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TRAF2/procaspase-12 interaction is disrupted, causing the conversion of procaspase-
12 to the mature form (Yoneda et al., 2001). The effect of caspase-12 maturation in 
humans is unclear; however other caspases have been implicated in the ER stress 
response in humans (Hitomi et al., 2004; Xue et al., 2006). Lastly, Bak-/- Bax-/- cells 
are highly resistant to cell death including that induced by ER stress (Wei et al., 
2001; Hetz et al., 2006). BCL-2 homologous antagonist/killer (BAK) and BCL-2-
associated X protein (BAX) are members of the pro-apoptotic BCL-2 family which, 
possibly due to the release of ER lumenal Ca2+, facilitate the exit of cytochrome c 
from the mitochondria into the cytosol, initiating apoptosis (Nutt et al., 2002; Oakes 
et al., 2005; Oakes et al., 2006). Alternatively, the BCL-2 family member BIM may 
contribute to apoptosis as a result of its activation by phosphorylated JNK (Lei & 
Davis, 2003; Putcha et al., 2003). Thus, IRE1 signalling has widespread effects that 
include the downstream regulation of genes involved in protein folding and ERAD, 
the selective degradation of secretory- and membrane-targeted mRNAs and the 
regulation of pro-apoptotic pathways. 
 
A question which has thus far not been addressed in this thesis is how does the N-
terminal region of IRE1 ‘sense’ ER stress? Concurrent with UPR studies on yeast 
was an investigation into the ability of several mutant versions of simian virus 5 
haemagglutinin-neuraminidase glycoprotein to induce the UPR in mammalian 
fibroblast CV-1 cells (Ng et al., 1992). When a mutant version of the glycoprotein – 
which does not bind BiP – accumulated in the ER, no induction of the UPR was 
detected. This is in contrast to other misfolded mutants of the glycoprotein, capable 
of binding BiP, which initiated a UPR. This lead to the hypothesis that UPR 
transducers detect changes in the concentration of free BiP in the ER or in the 
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concentration of BiP bound to unfolded proteins. Furthermore, the overexpression of 
BiP attenuates the induction of the UPR (Dorner et al., 1992; Kohno et al., 1993). 
Thus, the amount of free BiP in the ER negatively regulates the activation of the 
UPR (Shamu et al., 1994; Liu et al., 2003). This model states that, under non-
stressed conditions, BiP is bound to the lumenal domain of IRE1, inhibiting dimer 
and oligomer formation and consequently downstream signalling. Under ER stress 
conditions however, the increased concentration of unfolded/misfolded proteins 
results in these proteins competing with the IRE1 lumenal domain for free BiP which 
will then bind to these off-pathway intermediates to prevent aggregation. This then 
promotes dimer/oligomer formation and IRE1-mediated signalling (Bertolotti et al., 
2000; Okamura et al., 2000; Kimata et al., 2003; Todd-Corlett et al., 2007; Oikawa 
et al., 2009). The relationship between the structural features of the lumenal domain 
of IRE1 and IRE1-mediated signalling is complex and not fully understood. Deletion 
of the subregion of the IRE1 lumenal domain responsible for BiP binding (sub region 
V) is dispensable for activation in the face of ER stress (Kimata et al., 2004; Kimata 
et al., 2007; Oikawa et al., 2007). These results suggest that BiP binding and 
dissociation are not sufficient for IRE1 activation and that BiP may not be the 
primary determinant for activation of the UPR .  
 
The crystal structure of lumenal regions of yeast Ire1 and human IRE1 have recently 
been determined by two separate groups (Credle et al., 2005; Zhou et al., 2006). 
Credle and colleagues determined the presence of a shared central groove in yeast 
Ire1 reminiscent of the peptide binding groove of major histocompatability (MHC) 
molecules. This grove is formed by two -helices positioned on the -sheet 
platforms of each monomer to form the walls of a deep groove that is connected to 
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the groove of the neighbouring monomer. Disruption of groove architecture by 
removing hydrophobic regions buried in the interface (F247A) and introducing bulk 
into the interface (T226W) for example, resulted in reduced in vivo Ire1 activity. This 
led the group to speculate that this groove – created by dimerisation of Ire1 
monomers – might recognise flexible regions of unfolded proteins during Ire1 
activation and that binding of unfolded proteins might contribute to the formation of 
higher-order structures of Ire1 in yeast (Credle et al., 2005). On the other hand, Zhou 
and colleagues, who also detected an MHC-like groove upon IRE1 dimerisation, 
suggested that this groove was too narrow to accommodate peptides. Furthermore, 
the residues that were proposed to be involved in peptide binding are buried in the 
human IRE1 crystal indicating that these residues would not be involved in prptide 
binding. Additionally, the groove was oriented towards the membrane rather than the 
lumen and acess to the groove was blocked by an -helix providing further evidence 
that direct binding of peptides is unlikely. Despite this, they demonstrated that an 
intact groove was necessary for both dimerisation and ER stress-induced UPR 
signalling. In accordance with this finding, other groups have provided evidence that 
IRE1 activation does not depend on the binding of a ligand (Liu et al., 2002; Liu et 
al., 2003; Oikawa et al., 2009). Thus, Zhou and colleagues propose a ligand-
independent model of IRE1 activation where BiP release is sufficient for 
dimerisation via an MHC-like groove while Credle and colleagues’ data support a 
model where, in addition to BiP release, the binding of unfolded proteins to the 
groove of the Ire1 dimer may be required for oligomer formation; a ligand-dependent 
model.  
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Recently a two-step model for IRE1 regulation was proposed which suggested that 
both BiP dissociation and IRE1 binding of unfolded proteins are responsible for 
IRE1 activation (Kimata et al., 2007). The first step in this model is the dissociation 
of BiP from IRE1 which causes oligomerisation of IRE1 while subsequent binding of 
unfolded proteins causes activation. However there is evidence that the enzymatic 
activity of IRE1 is determined by the oligomerisation state of IRE1 which would 
suggest that once oligomerisation has taken place, IRE1 becomes activated. A recent 
paper by Peter Walter’s group, however, suggested that BiP binding to Ire1 
modulates efferent signalling by sequestering inactive Ire1 molecules, which 
prevents oligomerisation and facilitates deactivation if the folding conditions within 
the ER permit (Pincus et al., 2010). Furthermore, they propose that direct sensing of 
unfolded proteins is the primary trigger for Ire1 activation. In low level stress 
situations, BiP binding reduces the system’s sensitivity, ensuring that Ire1 is only 
activated when the stress is sufficient to warrant a response. Thus, BiP-mediated 
modulation of Ire1 activity may allow Ire1 to efficiently counteract a large spectrum 
of stress magnitudes. This work was undertaken in yeast Ire1. However, the structure 
and function of Ire1 is conserved between yeast and mammals and when human 
IRE1 lumenal domain replaces the corresponding domain in yeast Ire1, yeast UPR 
function is retained (Liu et al., 2000). Further work will be required to determine if 
BiP modulates the activation of IRE1 in higher eukaryotes. 
 
Recently, the crystal structure of the cytoplasmic region of IRE1 was resolved, which 
provided an insight into the activation of the endoribonuclease activity of IRE1 (Lee 
et al., 2008a; Korennykh et al., 2009; Yanagitani et al., 2009). The protein that Lee 
and colleagues crystallised had both kinase and endoribonuclease activity, was 
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phosphorylated on the activation loop – which usually occurs by trans-
autophosphorylation – and was loaded with ADP. Thus, the crystallised protein is 
likely to represent activated IRE1. The structure reveals that IRE1 forms a symmetric 
dimer with both kinase and both nuclease domains facing back to back. Additionally, 
nucleotide binding is required for dimer formation Therefore, it is likely that ER 
stress induced dimer formation positions the cytosolic domains in proximity for 
trans-autophosphorylation of the kinase activation loop which then, upon nucleotide 
binding, is reconfigured, leading to the formation of the dimer seen in the crystal 
structure, which can now accommodate substrate mRNA for cleavage in the kinase 
extension nuclease (KEN) domain. Further work will be required to understand the 
relevance of dimer formation in mRNA cleavage. A summary of the IRE1 branch of 
the mammalian UPR is shown in Figure 4.  
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Figure 4. The IRE1 branch of the UPR. An increase in concentration of unfolded 
proteins in the ER causes the titration of BiP away from the lumenal portion of IRE1. 
Direct binding of IRE1 to unfolded proteins may also influence IRE1 activation. Once 
activated, IRE1 forms homodimers leading to activation of its endoribonuclease activity. 
Activation also allows the binding of TRAF2 and ASK to IRE1 which leads to JNK 
phosphorylation and downstream events which may lead to apoptosis. IRE1 is also 
involved in the rapid degradation of mRNA coding for membrane and secretory proteins. 
IRE1 RNase activity targets XBP1 and removes a 26-bp intron which results in the 
translation of an active transcription factor (XBP1). This then travels to the nucleus to 
recognise ERSE I, ERSE II and UPRE promoter elements and upregulate target genes. 
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2.3.2.2 PERK 
The second pathway in the metazoan UPR is the PKR-like endoplasmic reticulum 
kinase (PERK) pathway. PERK, like IRE1, is a type I transmembrane protein located 
in the ER membrane which too senses the accumulation of unfolded proteins in the 
ER lumen (Shi et al., 1998; Shi et al., 1999; Harding et al., 1999; Harding et al., 
2000b; Harding et al., 2001; Liu et al., 2003). The lumenal domain of PERK, despite 
low sequence homology, is supposedly similar to that of IRE1 but the C-terminal 
cytosolic domain contains a eukaryotic translation initiation factor 2 alpha (eIF2) 
kinase domain (Harding et al., 1999; Ma et al., 2002). Regulation of PERK activity 
is similar to that of IRE1 since binding of BiP to the PERK lumenal domain seems to 
keep the kinase in an inactive, monomeric state.  
 
Dissociation of BiP from PERK triggers oligomerisation, then trans-
autophosphorylation of a large number of residues and activation of the cytosolic 
domain (Bertolotti et al., 2000; Ma et al., 2002; Marciniak et al., 2006). 
Phosphorylation of residues that lie in the kinase insert loop of PERK are thought to 
be responsible for selectively recruiting its substrate, eIF2 (Marciniak et al., 2006). 
Further evidence for shared functionality of the IRE1 and PERK lumenal domain 
comes from domain swapping experiments where the PERK lumenal domain can 
replace the yeast Ire1 lumenal region and the lumenal domain of human IRE1 can 
replace the corresponding domain in mammalian PERK (Bertolotti et al., 2000; Liu 
et al., 2000). Ma and colleagues, however, did note an inconsistency with IRE1 
function; their mutant, which lacks the BiP-binding domain (sub-region V) in the 
PERK lumenal region, was constitutively active, suggesting that BiP is essential for 
the negative regulation of PERK activity, contrary to that demonstrated by Kimata 
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and colleagues for IRE1, which may mean that the PERK lumenal domain is unable 
to directly bind unfolded proteins (Ma et al., 2002). 
 
Under ER stress conditions, Perk-/- cells are defective in eIF2 phosphorylation, 
polyribosome deaggregation and inhibition of amino acid incorporation into proteins 
(Harding et al., 2000b). Accordingly, activated PERK phosphorylates eIF2 on a 
serine at position 51, mutations of which (eIF2S51A) leave cells extremely sensitive 
to the lethal effects of ER stress (Scheuner et al., 2001). Phosphorylation of eIF2 
makes it an inhibitor of the GTP exchange factor eIF2B, attenuating the recycling of 
eIF2. The eIF2 complex is essential for the synthesis of new proteins since it recruits 
the initiator methionyl tRNA to ribosomes at the commencement of protein 
translation (Anderson & Kederscha, 2002; Kolitz & Lorsch, 2010). Therefore, Ser51 
phosphorylation of eIF2 inhibits this activity and thus reduces global protein 
translation. As a result, cells are able to confer immediate protection on the ER by 
adjusting the level of new protein synthesis in response to a decrease in folding 
capacity. If eIF2 phosphorylation is not tightly regulated however, protein levels 
could fall below that required for efficient cellular function. Accordingly, growth 
arrest and DNA damage-inducible gene 34 (GADD34), a protein phosphatase 
regulatory subunit, is also induced by activated PERK and its downstream targets 
(Novoa et al., 2001; Jiang et al., 2004; Marciniak et al., 2004). GADD34 
dephosphorylates eIF2 to oppose PERK activity and prevent over attenuation of 
translation or to limit the time window of translational arrest.  
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Whereas during ER stress and consequential eIF2 phosphorylation the majority of 
transcripts undergo translational inhibition, a small subset of transcripts are 
preferentially translated (Harding et al., 2000a; Mikulits et al., 2000; Lu et al., 2004; 
Vattem & Wek, 2004; Yoshimura et al., 2008; Zhou et al., 2008). The stress-
inducible transcription factor ATF4 is the best studied of these preferentially 
translated transcripts. ATF4 contains multiple upstream ORFs that precede the ATF4 
ORF (Harding et al., 2000a). Under non-stressed conditions, when ribosomal 
assembly is efficient, this feature of ATF4 mRNA inhibits its translation since 
ribosomes bind and initiate translation at the decoy ORFs. However, when ribosomal 
assembly is impaired – as is the case in PERK-mediated eIF2 phosphorylation – 
ATF4 translation is enhanced because the ATF4 start codon is favoured over the 
decoy ORFs.  
 
ATF4, like XBP1, is a bZIP transcription factor that recognises specific promoter 
elements and upregulates genes involved in protein folding, ERAD and indeed 
upregulates other bZIP transcription factors (Harding et al., 2003; Oyadomari & 
Mori, 2004). Additionally, ATF4 induces the antioxidant response, protecting cells 
against oxidative stress as well as upregulating genes involved in amino acid 
metabolism (Okada et al., 2002; Harding et al., 2003). Furthermore, ATF4 induces 
the induction of 4E-binding protein 1 (4E-BP1), inhibiting translation through the 
inhibition of the 5’-cap binding protein eukaryotic translation initiation factor 4E 
(eIF-4E) which may contribute to cell cycle arrest during ER stress (Yamaguchi et 
al., 2008). ATF4 can homodimerise or form heterodimers with other bZIP 
transcription factors such as ATF6, XBP1 and other members of the C/EBP family, 
and binds to the nutrient-sensing response element (NRSE)-1 and -2 during both ER 
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stress and nutrient deficiency (Barbosa-Tessmann et al., 2000; Bruhat et al., 2002; 
Chen et al., 2004).  
 
One of the best studied targets of ATF4 transcription activator activity is 
CHOP/GADD153 promoter (Fawcett et al., 1999; Harding et al., 2000a; Scheuner et 
al., 2001; Ma et al., 2002). ATF4, however, is not the only inducer of CHOP 
expression since other components of the UPR as well as other pathways have been 
shown to activate CHOP (Wang & Ron, 1996; Wang et al., 1998; Yoshida et al., 
2000). CHOP is considered a proapoptotic component of the UPR since chop-/- cells 
are protected from the lethal consequences of ER stress (Zinszner et al., 1998; 
Oyadomari et al., 2002b). Moreover, CHOP inhibits the protective, anti-apoptotic 
factor BCL-2, promoting, among other things, formation of the apoptosome 
(McCullough et al., 2001; Ma et al., 2002). In addition, CHOP is responsible for the 
translocation of BAX from the cytosol to the mitochondria as well as the promotion 
of apoptotic caspase activity and the induction of proapoptotic Tribbles related 
protein 3 (TRB3) (McCullough et al., 2001; Gotoh & Mori, 2004; Ohoka et al., 
2005). CHOP also upregulates ERO1 which leads to the promotion of oxidising 
conditions in the ER and a potential increase in the levels of reactive oxygen species 
(ROS) (McCullough et al., 2001; Marciniak et al., 2004). 
 
Interestingly, whereas the induction of CHOP and GADD34 expression by ER stress 
requires PERK, induction by amino acid starvation is PERK-independent. This is 
because amino acid-induced eIF2 phosphorylation requires the eIF2 kinase GCN2 
rather than PERK (Harding et al., 2000b; Novoa et al., 2001). GCN2 is induced by a 
mechanism whereby uncharged tRNA binds to regulatory regions homologous to 
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histidyl-tRNA synthestase (HisRS) enzymes (Wek et al., 2006). Indeed, GCN2 
responds to other forms of stress such as UV irradiation and proteasomal inhibition, 
suggesting that ER stress-transducer-independent pathways of protein translational 
attenuation exist, and that inhibition of protein synthesis is a common response to 
diverse forms of stress (Jiang & Wek, 2005a; Jiang & Wek, 2005b;  Wek et al., 
2006).  
 
Recently, a new target of PERK phosphorylation activity was identified. NRF2, 
under non-stressed conditions, is held in an inactive complex with the cytosolic 
cytoskeletal anchor protein KEAP1. Phosphorylation of NRF2 by PERK results in 
disruption of this complex and NRF2 moves to the nucleus where, in a heterodimer 
with ATF4, activates, among other things, the transcription of antioxidant genes and 
genes involved in protein folding, ERAD and immune responses (Cullien & Diehl, 
2006). 
 
A further mechanism by which PERK-mediated- and GCN2-mediated-eIF2 
phosphorylation can have an effect on transcriptional activity is related to its general 
attenuation of protein synthesis. Besides the many effects that have been discussed, 
translational attenuation can preferentially reduce the expression of regulatory 
components that are rapidly turned over. An example of this is the regulation of the 
transcription factor, and master regulator of inflammation, the immune response, cell 
proliferation and apoptosis, NF-B. Under non-stressed or non-inflammatory 
conditions, NF-B is bound in the cytosol to inhibitors of NF-B (IB) such as 
IB. Triggering of the inflammatory response – due to the detection of cytokines 
such as tumour necrosis factor alpha (TNF) – causes rapid phosphorylation of IB 
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by IB kinase (IKK). The effect of serine 32 phosphorylation is to target the inhibitor 
for ubiquitination and subsequent proteasomal degradation, releasing NF-B and 
facilitating its translocation to the nucleus to regulate target genes. Reduction in 
global protein synthesis is accompanied by a significant reduction in the translation 
of IB (Deng et al., 2002; Jiang & Wek, 2005a). Therefore, eIF2 phosphorylation 
may promote the NF-B-mediated transcriptional activator activity. Furthermore, 
IKK has been demonstrated to form a complex with IRE1 via TRAF2 and IRE1-/- 
cells exhibit impaired ER stress-induced NF-B activation (Hu et al., 2006). Thus, 
NF-B activation may be linked with the IRE1 branch of the UPR, linking ER stress 
with NF-B activation. Activation of NF-B has been demonstrated in response to 
several different cellular stresses including ER stress, UV irradiation and reactive 
oxygen species (Jiang et al., 2003; Deng et al., 2004; Wu et al., 2004; Jiang & Wek, 
2005a; Gloire et al., 2006).  
 
2.3.2.3 ATF6 
The third ER stress sensor unique to metazoans is ATF6, a type-II membrane protein 
containing a lumenal sensing domain and a cytosolic bZIP transcription factor 
domain (Yoshida et al., 1998). Initially, ATF6 was identified as an ERSE-binding 
transcriptional activator (Hai et al., 1989). Further analysis revealed that, activation 
of promoter elements required nuclear factor Y (NF-Y) binding in addition to ATF6 
binding and that, under stressed conditions, ATF6-ERSE binding requires a cleaved 
form of ATF6 (Yoshida et al., 1998; Li et al., 2000; Wang et al., 2000; Yoshida et 
al., 2000; Yoshida et al., 2001b). This cleaved form was identified as the product of 
N-terminal cleavage and named p50ATF6 (Haze et al., 1999). Although full-length 
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ATF6 localised to the ER, p50ATF6 was present in the nucleus. Thus, it was 
predicted that the mechanism behind ATF6 cleavage may be similar to that of the 
bZIP transcription factor sterol response element binding proteins (SREBPs) since, in 
response to low cholesterol levels, ER membrane-bound SREBP is transported to the 
Golgi and cleaved at two sites, releasing the transcription factor domain which is 
involved in the control of cellular sterol levels (Hua et al., 1996; Sakai et al., 1996). 
This was confirmed by Ye and colleagues who demonstrated that, under ER stress 
conditions, ATF6 is transported to the Golgi where it is sequentially processed by 
Site-1/2 proteases (S1P and S2P), liberating the cytoplasmic transcription factor 
domain which then translocates to the nucleus to activate the transcription of ER 
quality control proteins (Ye et al., 2000; Adachi et al., 2008).  
 
The mechanism which regulates the transport of activated ATF6 to the Golgi is not 
fully understood, however, two conserved putative regulatory domains have been 
implicated in ER stress-induced ATF6 transport (Ye et al., 2000; Chen et al., 2002). 
Additionally, recent work has demonstrated that, under non-stressed conditions, the 
lumenal domain of ATF6 is disulfide bonded and exists in monomeric, dimeric and 
oligomeric forms, and that ER stress-induced reduction is required but not sufficient 
for trafficking to the Golgi (Nadanaka et al., 2007). Like IRE1 and PERK, ATF6 
activation is controlled by the ER chaperone BiP (Gething, 1999; Shen et al., 2002). 
However, binding of BiP to the lumenal domain of ATF6 masks the intrinsic Golgi 
localisation signals GLS1 and GLS2 (Shen et al., 2002). Evidence for this comes 
from BiP and ATF6 mutation experiments where a) ER stress-induced BiP release 
was blocked causing the inhibition of translocation and proteolytic processing of 
ATF6 and b) removal of the BiP binding domain from ATF6 caused constitutive 
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activation of ATF6 signalling (Shen et al., 2002; Summer & Jarosch, 2002). Thus, 
the mechanism of negative regulation that BiP exerts on ATF6 may differ to that 
exerted upon PERK and IRE1 monomers.  
 
However, Shen and colleagues recently demonstrated that BiP binds stably to ATF6 
and postulated that BiP-ATF6 dissociation is not a consequence of competition of 
unfolded proteins for BiP but that ER stress-induced dissociation is a consequence of 
an active regulatory mechanism (Shen et al., 2005). Perhaps the active reduction of 
disulfide bonded higher order structures of ATF6 demonstrated by Nadanaka and 
colleagues is important in the dissociation of BiP from ATF6 (Nadanaka et al., 
2007). Since BiP may play a role in modulating the sensitivity of IRE1 to mild 
stresses (Pincus et al., 2010), it might also be possible that the BiP binding to ATF6 
may modulate the activation of ATF6 through other mechanisms, such as direct 
reduction of ATF6 oligomers. The glycosylation status of ATF6 may also contribute 
to its activation since, under non-stressed conditions, fully glycosylated ATF6 is 
retained in the ER by calreticulin binding (Hong et al., 2004). In ER stressed cells 
however, newly synthesised ATF6 is underglycosylated – presumably due to the 
folding capacity of the ER being exceeded – preventing the interaction with 
calreticulin which may, together with BiP dissociation and ATF6 disulfide reduction, 
serve to regulate the transport of ATF6 to the Golgi.  
 
The product of the G13 gene is a transmembrane bZIP transcription factor with 
homology to ATF6. Thus, it was named ATF6 (Haze et al., 2001). Unlike the 
paralog of human IRE1, IRE, ATF6 is ubiquitously expressed. Like ATF6 
(referred to up until now as ATF6), ATF6 is proteolytically cleaved releasing the 
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cytosolic bZIP transcription factor domain (Haze et al., 2001). ATF6 can bind to 
ERSE either as a homodimer or as a heterodimer with ATF6 (Yoshida et al., 
2001b).  However, unlike ATF6, ATF6 possesses weak transcriptional activation 
activity but binds much more stably to promoter elements (Theurauf et al., 2002; 
Thuerauf et al., 2004; Thuerauf et al., 2007). Thus, ATF6 may act as a 
transcriptional repressor of ATF6 activity, fine-tuning the strength of ERSE gene 
activation and cell viability (Theurauf et al., 2007). There is some evidence that full-
length ATF6 might regulate ERSE gene activation since underglycosylation of 
p110ATF6 cannot be proteolytically cleaved, resulting in the loss of its repressor 
function on p50ATF6 (Guan et al., 2009). 
 
Deletion of ATF6, although not lethal, compromises the functionality of the 
secretory pathway during ER stress (Wu et al., 2007). Further evidence supports a 
role for ATF6 in the ER stress response. In cells deficient in S2P or where S1P 
activity was inhibited leading to a failure of ATF6 processing, ER stress-induced BiP 
induction was abolished (Shen et al., 2001; Okada et al., 2003). Additionally, 
dominant negative forms of ATF6 blocked the induction of BiP reporter genes and 
RNAi knock-down of ATF6 levels result in reduced induction of many ER stress-
inducible genes (Wang et al., 2000; Yoshida et al., 2000; Lee et al., 2003). However, 
knock-down of ATF6, only in combination with XBP1 loss, reduced the expression 
of some ER stress-inducible genes and ATF6 knock-down alone did not strongly 
reduce the induction of BiP (Lee et al., 2003). Thus, it appears that the XBP1 and 
ATF6 branches of the unfolded protein response exhibit a level of functional 
redundancy since there is an overlap of transcriptional targets. This is further 
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exemplified by the fact that ire1-/- cells still show comparable levels of BiP mRNA 
induction upon ER stress treatments (Lee et al., 2002). It seems, therefore, that BiP 
expression can be induced upon ER stress by either the ATF6 or IRE1 branches of 
UPR. 
 
2.3.2.4 Other roles of the UPR 
The most well-studied role of the UPR is to respond to the folding demands of the 
ER, however, many studies have highlighted a role for specific branches of the UPR 
in the development of tissues and the maturation and differentiation of cell types. 
XBP1, for example, is highly expressed in developing bone and cartilage cells of the 
developing skeleton and the exocrine glands – both highly secreting cell types – 
during mouse embryogenesis (Clauss et al., 1993). The pattern of XBP1 expression 
in developing skeleton was similar to that of tissue specific genes expressed in 
osteoclasts, indicating that XBP1 may be involved in the regulation of these genes 
(Clauss et al., 1996). Further studies have confirmed a role for XBP1 in myogenesis, 
hepatogenesis and the development of secretory tissues in the mouse embryo and 
adult mouse models (Masaki et al., 1999; Reimold et al., 2000; Iwawaki et al., 2004; 
Blais et al., 2005; Lee et al., 2005).  
 
The most well-studied example of the UPR in secretory cell development comes 
from the differentiation of B lymphocytes into plasma cells. B cell lymphopoesis 
consists of two phases, one in the bone marrow, which is antigen-independent and 
one in the periphery, which is antigen-dependent. Differentiation into high-level Ig-
secreting plasma cells in the periphery is accompanied by a five-fold expansion of 
the ER compartment. Studies using LPS to induce differentiation of B lymphocytes 
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showed that differentiation induces classical UPR target genes such as BiP and 
Grp94 (Gass et al., 2002; Iwakoshi et al., 2003).  Transcription of XBP1 is induced 
during B cell differentiation, and XBP1 splicing can restore Ig production in XBP1-
deficient cells in vitro (Reimold et al., 2001; Iwakoshi et al., 2003).  It is, therefore, 
believed that XBP1 promotes differentiation of B cells by regulating the biogenesis 
and expansion of organelles involved in secretion (Shaffer et al., 2004; Acosta-
Alvear et al., 2007; Sriburi et al., 2007; Hu et al., 2009). However, the ability to 
regulate membrane biosynthesis and organelle biogenesis is most likely not B-cell-
specific. Additionally, XBP1 is essential for the regulation of hepatic lipogenesis 
(Lee et al., 2008b).  
 
Furthermore, IRE1 is required for B cell lymphopoesis, not for ER expansion, but 
for the downstream activation of genes involved in Ig gene rearrangements (Zhang et 
al., 2005). ATF6 activation has been observed during LPS-induced B cell 
differentiation and the overexpression of a dominant negative ATF6 mutant in 
differentiating B cells resulted in a marked decrease in total IgM release (Gass et al., 
2002; Gunn et al., 2004). Enforced expression of constitutively active ATF6 can 
drive ER expansion, even in the absence of spliced XBP1 (Bommiasamy et al., 
2009). However, the role of ATF6 in B cell differentiation is currently unknown. 
There is evidence that B cell lymphopoesis is a PERK-independent process, since 
perk-/- mice show defects in secretory cells of the pancreas and skeletal system but 
not in B cell development (Harding et al., 2001; Zhang et al., 2002; Gass et al., 
2002; Zhang et al., 2005; Zhang et al., 2006, Gass et al., 2008). Taken together, 
these studies demonstrate that the UPR provides a crucial physiological role in 
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professional secretory cell differentiation and suggests the possibility of cross-talk 
between differentiation signals and the UPR. 
 
2.3.2.5 Apoptosis vs. Survival 
Mutations in either the IRE1 branch or ATF6 branch of the UPR are fairly well 
tolerated, but mutations in both branches either prevent the transcriptional activation 
of some target genes or block development in the case of C. elegans (Lee et al., 
2002; Lee et al., 2003; Shen et al., 2005). Thus, there is functional redundancy 
between the IRE1 and ATF6 branches of the UPR. Since these arms of the UPR 
seem to have overlapping targets, does this mean they can be selectively activated or 
are temporally distinct? How the UPR coordinates its response to ER stress is still 
not fully understood, neither are the downstream effects of UPR target gene 
activation. No single branch of the UPR activates solely proapoptotic or prosurvival 
pathways. Thus, a paradox exists where all branches of the UPR are activated in 
response to ER stress but the fate of the cell (i.e. survival or apoptosis) is mutually 
exclusive. 
 
The transcription of apoptotic mediators such as CHOP occurs in response to both 
acute and chronic ER stress. It has been suggested that cell survival in the face of 
acute ER stress is governed by the intrinsic instabilities of mRNAs and proteins 
which promote apoptosis – such as CHOP, ATF4 and GADD34 – and that only 
chronic ER stress can activate transcription of these cell death mediators at levels 
which surpass the threshold for apoptosis (Rutkowski et al., 2006). Thus, cells may 
be able to adapt to low levels of ER stress despite simultaneous activation of both 
proapoptotic and prosurvival programmes.  
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As far as the turning point for the promotion of cell death is concerned, much work 
has focused on CHOP and the phosphorylation of eIF2. Loss of PERK-mediated 
eIF2 phosphorylation sensitises the cell to death (Scheuner et al., 2001). CHOP has 
been implicated in the regulation of phosphorylation of eIF2 since it induces the 
expression of GADD34, which is responsible for dephosphorylating phosphorylated 
eIF2 (Marciniak et al., 2004). It has been suggested that, under chronic ER stress 
conditions, increased levels of CHOP are able to induce the expression of GADD34 
which dephosphorylates eIF2, preventing attenuation of protein synthesis and 
encouraging the recovery of ER load in stressed cells, which might possibly promote 
apoptosis (Marciniak et al., 2004). This theory is supported by the fact that chop-/- 
cells protect against ER stress-mediated cell death. Deletion of CHOP in this instance 
would lead to reduced GADD34 expression meaning the persistence of 
phosphorylated eIF2 and continued translational attenuation. Furthermore, 
salubrinal, a compound shown to attenuate eIF2 dephosphorylation in ER stressed 
cells, also protects against cell death (Boyce et al., 2005).   
 
Additionally, mitochondria-dependent as well as mitochondria-independent 
pathways may also contribute to apoptosis. Regulated Ca2+ release from the ER into 
the cytoplasm is conducted by the proapoptotic BCL-2-related proteins BAK and 
BAX upon ER stress (Scorrano et al., 2003; Zong et al., 2003). This, in turn, 
regulates caspase activity and promotes cytochrome c release from the mitochondria 
(Boya et al., 2002; Danial & Korsmeyer, 2004). CHOP has also been identified as a 
promoter of cell death by repression of the apoptosis inhibitor BCL-2 and induction 
of the proapoptotic BCL-2 family member, BIM (McCullough et al., 2001; 
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Puthalakath et al., 2007). Furthermore, the IRE1/TRAF2 interaction may promote 
apoptosis through caspase-12 activation (Yoneda et al., 2001). However, in plasma 
cell differentiation, CHOP is required for efficient IgM secretion but is dispensable 
for apoptosis, indicating that CHOP exerts tissue-specific roles which can be 
independent of apoptosis (Masciarelli et al., 2010).   
 
Since more than one branch of the UPR is associated with proapoptotic activity, it is 
possible that during long term ER stress induction, there are fluctuations in the 
activity of certain branches of the ER allowing the predominance of branch-specific 
signals. These could potentially be mediated by branch-specific sensory mechanisms 
– in addition to BiP dissociation – of the ER stress sensors. Examples of this may 
include the ability of ATF6 to be regulated by disulfide bond reduction and 
glycosylation and the possibility that IRE1 may directly bind unfolded proteins and 
that BiP may not be the primary determinant for IRE1 activation (Kimata et al., 
2004; Hong et al., 2004; Credle et al., 2005; Nadanaka et al., 2006; Zhou et al., 
2006; Kimata et al., 2007; Oikawa et al., 2007 Lee et al., 2008a). If these events are 
required for activation of individual branches of the UPR, it is possible that, over 
time, signalling by individual branches of the UPR may be attenuated by adaptive 
processes which promote homeostasis. The predominance of certain UPR branches 
may then have an influence on cell fate.  
 
Recently, Lin and colleagues developed assays to examine the molecular behaviour 
of the individual branches of the UPR in human cells in the face of persistent 
pharmacological stress and discovered that the activity of individual arms of the UPR 
varied markedly with time after the onset of stress (Lin et al., 2007). They 
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demonstrated that, after rapid, initial activation of all branches of the UPR, the IRE1 
arm selectively attenuated after around eight hours despite the persistence of stress. 
ATF6 signalling also declined, although after IRE1 attenuation. PERK signalling 
persisted under prolonged ER stress and was still evident 30 hours after the onset of 
stress. When activation of the IRE1 branch was selectively prolonged, cells showed 
increased survival indicating that IRE1 signalling attenuation may be a key step in 
switching fates from a prosurvival to a proapoptotic strategy. The mechanism by 
which IRE1 is attenuated is unknown although BAX-inhibitor 1 (BI-1) has been 
implicated in the negative modulation of IRE1 and possibly ATF6 (Bailly-Maitre et 
al., 2006; Lisbona et al., 2009). So it seems, initially, when all branches of the UPR 
are activated, prosurvival outputs outweigh proapoptotic ones, however, when the 
opportunity to recover from ER stress has passed, the cell may adjust the signalling 
activity of the IRE1 and ATF6 branches leading to a predominance of proapoptotic 
outputs. Prolonged activation of the PERK pathway in isolation impairs both cell 
viability and cell proliferation (Lin et al., 2009). Thus, distinct combinations of 
individual UPR signalling pathways and the duration of individual UPR branch 
activity may determine cell fate in response to ER stress. The relationship between 
the duration of stress and stress severity is further supported by a recent study by 
Pincus and colleagues who demonstrated that the duration of Ire1 activity in yeast, 
rather than the maximum amplitude, correlated with the magnitude of the stress 
(Pincus et al., 2010). This is likely since the Hac1 transcription factor is short lived 
and so the length of activation determines the duration of UPR target gene induction. 
 
Furthermore, Han and colleagues recently showed that the IRE1 branch of the UPR, 
rather than promoting solely prosurvival signals, also has a role in the switch to 
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apoptosis (Han et al., 2009). By using inhibitors and mutant forms of IRE1 in 
mammalian cells, they decoupled the kinase and RNase activities of IRE1 and 
showed that activation of RNase activity promotes the degradation of ER-localised 
mRNAs. This complements the work of Hollien and Weissman who showed that 
IRE1 is required for the rapid decay of ER-localised mRNA in D. melanogaster and 
in mammalian cells (Hollien & Weissman, 2006; Hollien et al., 2009). However, 
Han and colleagues showed that prolonged ER stress resulted in the sustained decay 
of these mRNAs including those secretory proteins involved in protein folding and 
that sustained RNase activity correlated positively with apoptosis (Han et al., 2009). 
They postulated that apoptosis is the result of reduced secretory pathway activities 
due to the sustained decay of ER-localised mRNA. This work is in contrast to Lin 
and colleagues who attributed only prosurvival activities to IRE1, however it has 
been noted that the cells used in these experiments were overproducing kinase-dead 
IRE1 and so did not report the proapoptotic activity seen by Han and colleagues (Lin 
et al., 2009). 
 
2.3.2.6 UPR in disease 
Abnormalities in the UPR, as well as conditions which lead to an increase in ER 
stress due to misfolding, have been linked with a number of different diseases 
including neurodegeneration, cardiovascular disease, ischemia, bipolar disorder and 
type I diabetes (Yoshida, 2007; Lin et al., 2008). Here, I will briefly discuss the role 
of ER stress and the UPR in diabetes mellitus and the neurodegenerative disease 
Alzheimer’s disease. 
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Diabetes mellitus (DM) is a disease characterised by an inability to maintain 
homeostasis of glucose metabolism. In type II diabetes, peripheral tissues develop 
resistance to insulin as characterised by a failure to respond to normal insulin levels. 
In response, the pancreatic islet  cells hypersecrete insulin to compensate for insulin 
resistance and may eventually die (Saltiel & Kahn, 2001). Thus,  cell dysfunction in 
type II diabetes has been linked with ER stress and the UPR due to the large 
secretory burden of these cells (Scheuner & Kaufman, 2008). Indeed, overexpression 
of BiP in  cells subjected to hyperglycemia partially rescues glucose-induced 
suppression of proinsulin levels and improves glucose-stimulated insulin secretion 
(Zhang et al., 2008). Type I diabetes, on the other hand, is the result of a primary 
failure of  cells to secrete sufficient amounts of insulin. This is usually the result of 
an autoimmune attack on the  cells but can be inherited as a monogenetic disease 
(Harding & Ron, 2002; Oyadomari et al., 2002a). 
 
A hereditary form of type I diabetes called Wolcott-Rallison syndrome is the result 
of mutations in the PERK branch of the UPR (Delepine et al., 2000). Similarly,  
perk-/- mice show symptoms characteristic of type I diabetes (Harding et al., 2001; 
Zhang et al., 2002). In both examples, during post-natal development, there is a loss 
of  cells, possibly by apoptosis. It has been suggested that the lack of PERK in these 
cells means they are unable to decrease protein load on the ER in response to high 
secretory demand (Lin et al., 2008). In line with this, mice expressing non-
phosphorylatable eIF2 develop diabetes (Scheuner et al., 2001; Scheuner et al., 
2005). However, recent work has demonstrated that PERK is only required during 
development of  cells and adult mice do not require PERK to maintain glucose 
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homeostasis suggesting that PERK might have more of an important role in 
differentiation than survival (Zhang et al., 2006). However, the levels of ER stress in 
a developing tissue might be significantly higher than in an adult secretory cell. 
Furthermore, expression of the WFS1 gene, mutations in which are responsible for 
Wolfman syndrome (juvenile diabetes), is induced by ER stress and is a PERK-
responsive protein that is mostly expressed in the  cells (Inoue et al., 1998; Strom et 
al., 1998; Fonseca et al., 2005; Ueda et al., 2005).  
 
The Akita mouse model of early-onset/neonatal diabetes contains a missense 
mutation in the insulin 2 gene (Wang et al., 1999). Mutant insulin is misfolded and 
retained in the ER leading to ER stress and possibly subsequent  cell apoptosis 
(Oyadomari et al., 2002b). Knocking-out CHOP expression in these mice delayed 
the onset of diabetes further suggesting a role for the UPR. Indeed, UPR target genes 
are upregulated in the Akita mouse model. BiP, GRP94 and HRD1 are upregulated 
and both ATF6 and XBP1 are activated in the Akita mouse indicating that the UPR 
may play a role in ER stress-induced  cell loss (Allen et al., 2004; Nozaki et al., 
2004). 
 
The neurodegenerative disease, Alzheimer’s disease (AD) is characterised by the 
formation of cerebral neuritic plaques of amyloid -peptide (Mattson et al., 1998; 
Pereira et al., 2004; Lindholm et al., 2006; Zhang & Kaufman, 2006; Roychaudhuri 
et al., 2008). Studies suggest that disease pathogenesis is the consequence of 
accumulation of amyloid -peptide – and possibly tau – in the ER (Schenk et al., 
1999; Lee et al., 2001b). Three genes responsible for AD have been identified: 
amyloid precursor protein (APP), Presenilin1 and Presenilin2. The gene product of 
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APP is a transmembrane protein, the function of which is currently unknown while 
the presenilins are essential components of the -secretase protease. APP is 
sequentially cleaved by a -secretase and -secretase which leads to the accumulation 
of amyloid -peptide (Selkoe, 2001). The role of amyloid -peptide accumulation in 
disease pathogenesis is currently unknown but several reports have implicated the 
UPR in the cytotoxicity of amyloid -peptide. Expression of amyloid -peptide 
increases ER chaperone levels and activates caspase-12 whereas knock-down of 
caspase-4 or knock-out of caspase-12 confers resistance to amyloid -mediated 
cytotoxicity (Nakagawa et al., 2000; Hitomi et al., 2004; Ferreiro et al., 2006).  
 
The IRE1-ASK1-JNK pathway of the UPR has been implicated in amyloid -
mediated cytotoxicity since ask1-/- neurons are resistant to amyloid -mediated cell 
death (Kadowaki et al., 2005). This study also demonstrated that expression of 
amyloid  in rat PC12 cells selectively activated ASK1 and JNK signalling without 
activating other outputs from the IRE1 and PERK branches of the UPR. Thus, 
amyloid -peptide accumulation might cause the selective activation of the UPR 
signalling machinery to mediate cytotoxicity. However, this is in conflict with the 
model of apoptosis discussed earlier which regards IRE1 signalling as short-lived 
and cytoprotective while PERK signalling is long-lived and after time becomes 
apoptotic (Lin et al., 2007). More work will be required to elucidate how the UPR is 
coordinated in amyloid -peptide-expressing neurons. 
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2.4 Ankylosing Spondylitis 
2.4.1 Ankylosing spondylitis and the spondyloarthropathies 
2.4.1.1 Clinical features 
ER stress and the UPR have recently been implicated in the pathogenesis of the 
chronic inflammatory disease ankylosing spondylitis (AS). AS is the major subtype 
of an inter-related group of chronic rheumatic diseases known as the 
spondyloarthropathies or the spondyloarthritides (SpA). The clinical features of 
disease include asymmetrical peripheral oligoarthritis of the lower limbs, 
inflammatory back pain, enthesitis, psoriasis, anterior uveitis, and chronic 
inflammatory bowel disease (Braun & Sieper, 2007). Despite all coming under the 
umbrella of SpA, the disease is divided into five clinical subgroups: ankylosing 
spondylitis (AS), psoriatic spondyloarthritis (PsA), reactive spondyloarthritis (ReA), 
spondyloarthritis associated with inflammatory bowel disease (IBD) and 
undifferentiated spondyloarthritis.  
 
Inflammatory back pain is the most typical presenting symptom of AS characterised 
by stiffness and pain that is worse in the morning or characterised by long periods of 
inactivity and is improved with exercise (Sampaio-Barros et al., 2001; Mansour et 
al., 2006). In addition to lumbosacral pain, patients can experience pain in the gluteal 
region which is indicative of sacroiliac involvement. Loss of mobility and spinal 
stiffness at these sites – the lumbosacral region and sacroiliac joints – is explained by 
spinal inflammation, structural damage, or both (Wanders et al., 2005). Structural 
changes, such as the formation of syndesmophytes – a bony growth caused by 
ossification of a ligament – and ankylosis – the fusion of the bones of a joint – are 
usually caused by osteoproliferation rather than osteodestruction. Peripheral arthritis 
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affects mainly, but not exclusively, the lower limbs and around a fifth of patients 
exhibit arthritis in the hip and shoulder joints; which is commonly asymmetrical 
(Dougados et al., 1991). In addition, around 70% of patients also report neck pain 
and inflammation in the cervical spine (Maghraoui et al., 2003). Radiographs or 
magnetic resonance imaging (MRI) of the affected joints show joint space 
narrowing, erosions with new bone formation, and synovitis (Vinje et al., 1985; 
Mudlinger et al., 1991; Lambert et al., 2004). Enthesitis – inflammation at the point 
at which a tendon, ligament or muscle inserts into the bone – is common in AS 
sufferers at sites such as the Achilles tendon, and both synovial and cartilaginous 
joints, including those within the spine, and is thought to underlie many of the 
skeletal manifestations of the disease (Olivieri et al., 1998; Mansour et al., 2006).  
 
Extra-articular manifestations such as anterior inflammation of the eye (uveitis) – 
seen in up to 40% of patients with AS – and cardiovascular and pulmonary disease 
can be the earliest manifestations of disease but the incidence of these features tends 
to rise with increasing disease duration (Mansour et al., 2006). In addition, AS 
patients can suffer from the inflammatory skin disease (psoriasis) which results in 
psoriatic nail lesions and swollen finger joints (dactylitis). However, development of 
concomitant psoriasis and articular inflammation is usually diagnosed as psoriatic 
arthritis. 
 
Subclinical gut inflammation has been discovered in around a quarter to half of AS 
patients whereas clinically overt inflammatory bowel disease – which includes 
Crohn’s disease and ulcerative colitis, both of which affect the colon – has been 
reported to be present in between 5 and 10% of patients with AS (Leirisalo-Repo et 
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al., 1994; de Vlam et al., 2000). Since increased intestinal permeability has been 
described in AS and IBD, it has been speculated that a disturbed gut/blood barrier 
could facilitate the interaction between bacteria and the immune system and might 
initiate or perpetuate disease pathogenesis (Rudwaleit & Baeten, 2006). 
 
2.4.1.2 Genetics of AS 
A breakthrough in AS and SpA pathogenesis research came in 1973 when the 
association between disease and the possession of the class I major 
histocompatibility complex (MHC) allele HLA-B27 was discovered (Brewerton et 
al., 1973). The MHC class I molecule is involved in the presentation of antigen at the 
cell surface to T-cells for immune surveillance. HLA-B27 is present in the 
overwhelming majority of individuals suffering from ankylosing spondylitis (AS) – 
around 90-95% – and is also associated with reactive arthritis (ReA) and IBD-
associated SpA.  However, possession of the allele alone is not sufficient to cause 
onset of AS since only 5% of HLA-B27-positive individuals develop the disease in 
the absence of family history. 
 
Currently, over 30 HLA-B27 subtypes have been identified. The HLA-B*2705 
subtype is considered the ‘parent’ subtype since it is found in all populations and is 
highly associated with disease. Many of the other subtypes differ from HLA-B*2705, 
and from each other, by only a few amino acids. Most of the more common subtypes 
– which include HLA-B*2705, HLA-B*2702, HLA-B*2704 and HLA-B*2707 – are 
associated with disease whereas HLA-B*2706 and HLA-B*2709 – found in south-
east Asia and Sardinia – do no appear to be associated with disease. The molecular 
differences between HLA-B27 subtypes will be discussed in more detail later. 
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Recently, two further genetic loci besides HLA-B27 have been associated with AS. 
The interleukin 23 (IL-23) receptor (IL-23R) and ARTS1/ERAAP were recently 
identified by SNP analysis (WTCCC, 2007). The IL-23R is involved in the 
inflammatory response through the promotion of expansion and survival of the IL-
17-producing Th17 subset of T-cells suggesting that, in AS patients, these cells 
might expand under the influence of IL-23 (McGeachy et al., 2009; Melis & 
Elewaut, 2009). There is also growing evidence that IL-17 is a crucial 
proinflammatory cytokine since it can act on several cell types including 
macrophages, fibroblasts, endothelial and epithelial cells to upregulate TNF, IL-6 
and IL-1 (Nakae et al., 2003; Kolls et al., 2004). Aside from IL-17, Th17 cells are 
also capable of producing TNF and IL-6 themselves (Cua et al., 2003; Chen et al., 
2006). Thus, it is clear that the downstream effects of Th17 expansion may include 
the production of multiple proinflammatory cytokines. 
 
ARTS1 is an ER-localised aminopeptidase which may trim oligopeptides for antigen 
presentation (Kastelein et al., 2007). Recently, specific ARTS1 gene polymorphisms 
have been associated with HLA-B*2705 in AS patients in a Hungarian population 
(Pazár et al., 2010). Further studies have also linked IL-23R polymorphism with AS 
(Rahman et al., 2008; Rueda et al., 2008). Additionally, the Th17 subset has been 
shown to be present at elevated levels in both AS and rheumatoid arthritis (RA) 
indicating a role for these cells in human inflammatory disease (Shen et al., 2009). 
Further work, however, is required to understand the associations of IL23R and 
ARTS1 polymorphisms with disease as well as the impact of polymorphisms on 
disease pathogenesis. Thus, in addition to HLA-B27, susceptibility to AS may be 
determined by genes which lie outside the MHC. 
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 2.4.1.3 Animal models 
In order to understand the pathogenesis of AS, animal models of AS have been 
developed through the generation of HLA-B27 transgenic rats and mice. Generation 
of transgenic mice was initially met with disappointment since these animals failed 
to exhibit inflammatory disease (Kievits et al., 1987). However, further studies 
revealed that the SpA phenotype could be observed when the endogenous gene for 
mouse 2-microglobulin (2m) – the accessory molecule which stabilises the MHC 
class I heavy chain and is necessary for peptide loading and ER egress – was deleted 
(Khare et al., 1995; Khare et al., 1997; Khare et al., 1998). These transgenic mice 
have lower cell surface expression of mature HLA-B27 because of the lack of mouse 
2m and may implicate free heavy chains in disease pathogenesis (Khare et al., 
1996).  
 
However, the majority of studies have been carried out on the successful and 
reproducible HLA-B27/human 2m transgenic rat model developed by Hammer and 
colleagues (Hammer et al., 1990). This model showed that under certain conditions, 
overexpression of HLA-B27 was sufficient to induce the development of 
spontaneous multisystemic inflammation which resembled that of human SpA. This 
finding was crucial since it was the first piece of evidence that the gene product of 
HLA-B27 was involved in disease. The phenotype exhibited by B27/h2m transgenic 
rats included inflammation of the gastrointestinal tract, similar to that of human 
ulcerative colitis, inflammatory lesions in the skin and nails (resembling psoriasis) 
and peripheral arthritis involving predominantly the hind limbs. Axial inflammation 
was rare and ankylosis of the spine – seen in human AS – was not detected (Taurog 
et al., 1999). However, subsequent studies have demonstrated that further increasing 
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the expression of transgenic h2m in B27/h2m transgenic rats can alter the 
phenotype and result in more severe arthritis and significant axial disease without 
affecting the severity of colitis (Tran et al., 2006). Furthermore, expression of the 
disease phenotype was dependent on the genetic background which implicates the 
significance of other genes in the development of human SpA. 
 
There is strict correlation between the susceptibility to disease and the level of HLA-
B27 transgene expression, which, in turn, is determined by the number of copies of 
the transgene integrated into the rat genome (Taurog et al., 1993). It was also 
discovered that a threshold number of copies of the integrated HLA-B27 transgene 
was required for the disease phenotype. It may also be the case that B27 expression 
has an impact on human SpA since there is evidence of increased expression of B27 
on the cell surface of peripheral blood mononuclear cells (PBMCs) of AS patients 
compared with normal individuals (Cauli et al., 2002). This difference in expression 
was not accompanied by general class I upregulation suggesting that high levels of 
B27 expression may be a contributing factor to disease. The specificity of 
inflammatory disease for a HLA-B27 transgene was established by showing that 
HLA-B*0702/h2m transgenic rats with comparable copy number and expression 
level to the B27/h2m disease model does not develop an inflammatory phenotype 
(Taurog et al., 1999). Taken together, these studies provide direct evidence for a 
causative role of HLA-B27 in disease. 
 
Other contributing factors to disease in transgenic rats include exposure to bacterial 
flora. When disease-prone B27/h2m transgenic rats were reared in sterile 
conditions, both gut and joint inflammation were completely prevented, whereas 
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exposure to normal gut flora – particularly Bacteroides ssp. – triggered gut 
inflammation and arthritis (Taurog et al., 1994; Rath et al., 1996). Despite this, the 
development of skin lesions in these rats was independent of bacterial exposure. 
Germ-free conditions still allowed for the presentation of antigen, therefore it is 
possible that non-viable microorganisms may have played a role in the pathogenesis 
of skin lesions.  
 
In the ANKENT mouse model – which develops ankylosing enthesopathy – the 
enthesitis and ankylosis phenotype are highly dependent on bacterial flora since mice 
bred in germ-free conditions are also protected from disease (Rehakova et al., 2000). 
Thus, enteric bacteria may play a critical role in triggering SpA-like disease in 
B27/h2m transgenic rats and ankylosis and enthesitis in ANKENT mice. If this is 
the case in human disease, the requirement for specific gut flora in triggering disease 
might partially account for the fact that not all B27-expressing individuals develop 
disease. In addition to this, several gastrointestinal and genito-urinary pathogens 
including Campylobacter ssp., Chlamydia ssp., Salmonella ssp. and Shigella ssp. 
have been implicated as triggers of HLA-B27-associated reactive arthritis (Colmegna 
et al., 2004). 
 
2.4.2 MHC Class I molecule 
As demonstrated by the HLA-B27/h2m transgenic rat, the HLA-B27 gene product 
plays a key role in the development of AS. Since the presence of pathogens seems to 
be correlated with disease development, pathogenesis of the disease has been linked 
with the physiological role of the class I molecule. The role of the MHC class I 
molecule in the cell is to present antigenic peptide at the cell surface as part of the 
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innate immune system (Pamer and Cresswell, 1998). Fragments of cellular proteins 
are bound by MHC class I molecules – expressed on all nucleated cells – in the ER 
and transported to the cell surface allowing the cell to display a sample of their 
expressed genes. CD8+ cytotoxic T-cells monitor antigen presented by the MHC 
class I molecules and are capable of mounting an immune response (including the 
promotion of cytotoxicity and the production of cytokines such as interferon- (IFN-
) which promote inflammation and stimulate antigen presentation) when foreign 
antigen – as a result of viral infection for example – occurs. The MHC class I 
molecule comprises a 45-kD heavy chain comprising an 1, 2 and 3 domain 
which is non-covalently associated with a 12-kD soluble accessory molecule called 
2m (which has been previously mentioned). Finally, a short 8-10 amino acid peptide 
is bound in the membrane-distal domains of the heavy chain – known as the peptide 
binding groove – to form the mature MHC class I molecule. Peptides which are too 
large for presentation by class I molecules are subsequently trimmed by the gene 
product of ARTS1/ERAAP, polymorphisms in which are associated with AS (as 
mentioned previously) (Saric et al., 2002; York et al., 2002). Peptide binding 
differences between different alleles of MHC class I are the result of extensive 
polymorphisms, particularly in the amino sequences within the peptide binding 
groove. 
 
2.4.2.1 MHC class I folding events in the ER 
The ER is the site of both class I assembly and acquisition of antigen for 
presentation. The MHC class I molecule must reach its native conformation before 
receiving high affinity peptides for presentation. The class I heavy chain achieves its 
correct structure and acquires peptide whilst within the peptide loading complex 
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(PLC). However, early heavy chain folding events are independent of the PLC. The 
class I heavy chain is a glycoprotein, and, a short time after cotranslational 
translocation into the ER, the nascent class I heavy chain is bound by the 
transmembrane lectin-like chaperone calnexin, which retains the heavy chain in the 
ER, stabilises class I assembly intermediates and may enhance the association of the 
class I heavy chain with 2m (Tector & Salter, 1995; Vassilakos et al., 1996). 
Calnexin, via its extended arm-like domain, or P-domain, is associated with the 
substrate-specific thiol-oxidoreductase ERp57 (mentioned previously) which 
promotes the oxidation of the two highly conserved internal disulfide bonds within 
the heavy chain (Tector et al., 1997; Lindquist et al., 1998; Morrice & Powis, 1998; 
Farmery et al., 2000; Dick, 2004; Russell et al., 2004; Kozlov et al., 2006). ERp57 
has been shown to require the presence of calnexin or calreticulin to promote 
disulfide bond formation in glycosylated substrates in vitro, however, recent 
evidence has demonstrated that ERp57 can catalyse heavy chain disulfide bond 
formation – and substrate specific oxidative folding – in the absence of interactions 
with calnexin and calreticulin (Zapun et al., 1998; Jessop et al., 2007; Zhang et al., 
2009). ERp57 depletion by RNAi delayed heavy chain disulfide bond formation and 
slowed folding of the 3 domain. Taken together, the data implies that ERp57 is 
recruited by calnexin and calreticulin to incompletely folded proteins bearing N-
linked oligosaccharides but that ERp57 may be capable of recognising substrates 
directly (Zhang et al., 2006). 
 
Oxidation of the disulfide bond in the 3 domain has been shown to be fast and 
efficient (Tector et al., 1997). Once this disulfide has been formed, the accessory 
molecule 2m binds to the heavy chain, forming a HC-2m heterodimer. Evidence 
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supporting this comes from 2m-deficient cell lines and in vitro studies which 
showed that in the absence of 2m, the 3 disulfide but not the 2 disulfide is 
formed and that 2m is required for the formation or maintenance of the 2 disulfide 
(Ribaudo & Margulies 1992; Wang et al., 1994). Newly assembled HC-β2m 
heterodimers then enter the PLC in a process typically accompanied by the loss of 
calnexin-ERp57 and its replacement with calreticulin-ERp57 (Sadasivian et al., 
1996). There has been evidence to suggest that complete disulfide oxidation of the 
heavy chain is required for integration into the PLC (Smith et al., 1995; Tector et al., 
1997). Thus, it is possible that the 2 disulfide is unstable and after formation is 
stabilised by 2m association and integration into the PLC, which may protect it from 
reduction (Dick, 2004).  
 
The PLC is a multiprotein complex comprising the HC-2m heterodimer, 
calreticulin, ERp57, the type I transmembrane glycoprotein tapasin and the 
heterodimeric transmembrane protein transporter associated with antigen 
presentation (TAP). The tapasin molecule is key in increasing the peptide loading 
efficiency of the PLC since it acts as a physical bridge between the peptide-receptive 
HC-2m heterodimer and the site of entry of peptides into the ER, i.e. TAP. 
(Sadasivian et al., 1996; Williams et al., 2002; Momberg & Tan, 2002; Tan et al., 
2002). Tapasin also forms a stable disulfide bridge via its Cys95 residue with Cys57 of 
ERp57 (Peaper at al., 2005). In addition, ERp57 is also associated with calreticulin 
in the PLC in the same manner as calnexin (Oliver et al., 1999; Ireland et al., 2008). 
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The TAP transporter transports peptide fragments into the ER lumen and has a 
preference for peptides ~8-16 residues in length (Scholz & Tampe, 2009). In TAP-/- 
mice, class I molecules either lack peptide or are bound with low affinity peptides 
and consequently, CD8+ T-cell responses are impaired (van Kaer et al., 1992). This 
leads to prolonged association of the HC-2m heterodimer with the PLC and the 
relatively few molecules that reach the cell surface dissociate rapidly (Ljunggren et 
al., 1990; Baas et al., 1992). Thus, the binding of high affinity peptides is crucial for 
release from the PLC, ER egress and stable cell surface expression. The absence of 
tapasin results in a decrease in the stability of TAP as well as failure of the class I 
molecule to be recruited to the PLC in the proximity of TAP together resulting in 
decreased peptide transport into the ER lumen, reduced loading of high-affinity 
peptides and thus, reduced cell surface expression (Ortmann et al., 1997; Garbi et al., 
2003).  
 
Several groups have highlighted the importance of tapasin in class I peptide selection 
in addition to its role as a structural component of the PLC. Studies have 
demonstrated that tapasin is involved in optimising the peptides class I molecules 
bind by exchanging abundant low affinity peptides for those which bind more stably 
in a process known as peptide-editing (Williams et al., 2002; Howarth et al., 2004). 
Furthermore, a mutant soluble form of tapasin which does not interact with TAP but 
does bind to class I molecules, presumably via ERp57 and calreticulin, was 
discovered (Lenher et al., 1998). Despite not being located near the source of 
peptide, normal peptide loading and cell surface expression of these class I was 
supported, indicating that tapasin can promote high-affinity peptide binding 
independent of its ability to recruit class I molecules to TAP. Recent work has 
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highlighted the importance of ERp57 in this mechanism. The ERp57-tapasin 
heterodimer was demonstrated to promote efficient loading of high-affinity peptides 
and stabilise peptide-receptive class I molecules where tapasin alone was ineffective 
(Wearsch & Cresswell, 2007).  
 
The role of the ERp57-tapasin disulfide bond in peptide loading is not fully 
understood, however, abolition of the disulfide by mutagenesis results in the loading 
of low affinity peptides, incomplete oxidation, and the ER egress of unstable class I 
molecules (Dick et al., 2002). Tobias Dick’s group demonstrated the possibility that 
the ERp57-tapasin conjugate is directly involved in the isomerisation of the class I 
2 domain disulfide providing further evidence that the class I heavy chain enters the 
PLC in a non-fully native conformation. However, ERp57-deficient mice show that 
ERp57 does not influence the redox state of class I molecules but acts instead as a 
structural component of the PLC (Garbi et al., 2006). Additionally, ERp57 depletion 
seems to have no effect on the redox state of the class I heavy chain or peptide 
loading (Zhang et al., 2006). Mutagenesis experiments to inactivate the two redox-
active sites of ERp57 have demonstrated that the enzymatic activity of ERp57 is not 
required for its functions within the PLC, indicating that it plays a structural role 
rather than a catalytic one within the PLC (Peaper & Cresswell, 2008; Zhang et al., 
2009). These findings have been confirmed by the crystal structure of the ERp57-
tapasin conjugate, published recently, which showed that the two active sites of 
ERp57 are buried in the interaction interface with tapasin (Dong et al., 2009). This is 
further supported by evidence from Kienast and colleagues, who showed that, in the 
absence of tapasin, class I heavy chains were subject to rapid 2 disulfide reduction 
indicating that tapasin restrains the 2-directed redox activity of ERp57 by covalent 
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sequestration (Kienast et al., 2007). The apparent structural role of ERp57 in class I 
folding and peptide loading requires further investigation. 
 
The influence of the HC 2 domain isomerisation on peptide loading has been 
investigated. Recently, PDI was implicated in optimal peptide selection by regulating 
the oxidation of the heavy chain 2 disulfide (Park et al., 2006). Their data 
demonstrated that suboptimal peptide binding renders the 2 disulfide more 
susceptible to PDI-mediated reduction whereas high affinity peptides protect the 
disulfide from reduction. Since oxidation of the 2 disulfide is necessary for optimal 
peptide loading, PDI appears to regulate the binding of high-affinity peptides in this 
regard. Despite this, Kienast and colleagues were unable to detect an interaction of 
PDI with the PLC (Kienast et al., 2007). Thus, there seems to be a complex 
relationship between the redox status of the class I heavy chain and the binding of 
high-affinity peptides, which may involve components outside of the PLC. 
 
Similar to PDI and ERp57, the transmembrane thioredoxin-related protein TMX has 
also been implicated in oxidative protein folding of MHC class I molecules since it 
was found in mixed disulfide intermediates with the class I heavy chain (Matsuo et 
al., 2009). Unlike PDI and ERp57 however, TMX was not essential for normal 
assembly of the MHC class I molecule since TMX knock-down did not affect class I 
cell surface expression. However, in this study, TMX prevented the 
retrotranslocation of misfolded MHC class I heavy chains and, furthermore, TMX-
class I HC complexes were promoted when cells were treated with the ER stress 
inducer tunicamycin. Together, these results indicate that TMX may play a role in 
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regulating the degradation and refolding of misfolded or incompletely folded 
proteins in the ER. 
 
Upon acquiring high affinity peptides, class I molecules are released from the PLC, 
transit through the Golgi and are transported to the cell surface via the exocytic 
pathway. There is some evidence of PLC components being detected in the ER-Golgi 
intermediate compartment (ERGIC)/cis-Golgi as well as peptide-receptive class I 
molecules. This calls into question whether peptide-receptive class I molecules 
remain solely in the ER before acquiring peptide ligand or are recycled back into the 
ER (Garstka et al., 2007). Fully-folded, peptide-loaded class I molecules then present 
peptide at the cell surface to CD8+ T-cells and natural killer (NK) cell bearing certain 
receptor families.  
 
2.4.3 HLA-B27 and AS 
The features of HLA-B27 which distinguish it from other MHC class I alleles have 
provided the basis for investigation into the pathogenesis of AS and SpA. These can 
broadly be separated into two groups relating either to immunological recognition of 
some form of the HLA-B27 heavy chain or to intracellular events.  
 
2.4.3.1 Arthritogenic peptide hypothesis 
The first concept arises from the ability of HLA-B27 to present self-peptide to CD8+ 
T cells. The so-called arthritogenic peptide hypothesis states that disease is a 
consequence of autoreactivity caused when a specific self-peptide presented by 
folded HLA-B27/2m becomes the target of autoreactive CD8+ T-cells because it 
resembles foreign peptide derived from either intracellular bacteria or viruses 
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(Benjamin & Parham, 1990). In this theory, chronic inflammatory disease results 
from T-cell mediated cytotoxicity. This theory is supported by evidence of HLA-
B27-restricted CD8+ T-cell clones with specificity for bacteria which have been 
detected in the synovium and peripheral blood of AS and ReA patients (Hermann et 
al., 1993). Additionally, CD8+ T-cells reacting with collagen-derived self-peptides in 
a B27-dependent manner were detected in the synovium of AS patients (Atagunduz 
et al., 2005). Aside from this, recurrent structural motifs were discovered in T-cell 
receptors of B27-specific T-cells from unrelated individuals (May et al., 2002). 
Despite all of these studies, candidate arthritogenic peptides have not yet been 
identified. However, a self-peptide derived from the cytoplasmic tail of HLA-B27 
and other MHC class I molecules which is constitutively presented by three disease 
associated subtypes (B*2705, B*2702 and B*2704) but not presented by the non-
disease associated subtypes B*2709 or B*2706 was discovered (Ramos et al., 2002). 
This finding showed great promise since this peptide shows much similarity to an 
enzyme found in Chlamydia trachomatis, a member of a genus of gram-negative 
bacteria which can trigger ReA. However, attempts to detect presentation of the 
corresponding chlamydial peptide by HLA-B27 have been unsuccessful (Lopez de 
Castro, 2006).  
 
Comparing HLA-B27-restricted CD8+ T-cell responses from AS patients with 
healthy individuals provides another method for identifying candidate peptides. 
Studies with peripheral blood lymphocytes identified a specific peptide – present in 
both the HLA-B27 heavy chain and enteric bacteria – which is preferentially 
recognised by HLA-B27-restricted CD8+ T-cells in AS patients compared with 
healthy individuals (Schofield et al., 1995; Frauendorf et al., 2003). This finding 
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supports the idea of cytotoxic T-cells being important in disease pathogenesis but 
does not provide direct evidence of an arthritogenic peptide since numerous other 
HLA-A and HLA-B alleles, not associated with AS, also possess this peptide. 
However, the arthritogenic peptide hypothesis remains a popular theory of 
pathogenesis since only a small number of polymorphic HLA-B27 subtypes are 
associated with the disease (Colbert et al., 1994; D'Amato et al., 1995; Lopez-Larrea 
et al., 1995).  
 
This theory is met by a few further problems. If disease associated subtypes of HLA-
B27 present arthritogenic peptides which are unable to be presented by non-disease 
associated subtypes, there is difficulty in explaining the apparent mutual exclusivity 
of the peptide repertoire of HLA-B*2705 and HLA-B*1403 despite both being 
associated with AS (HLA-B*1403 is an example of an AS-associated allotype found 
in B27-negative individuals in Sub-Saharan populations) (Lopez-Larrea et al., 2002; 
Merino et al., 2005). Data from the B27 transgenic mouse model demonstrates that 
SpA-like disease only develops in the absence of 2m and indicates that stable, fully-
formed B27/2m/peptide complexes are not required for disease (Khare et al., 1995; 
Kingsbury et al., 2000). Furthermore, results from B27/h2m transgenic rats where 
CD8+ T-cells have been depleted using antibodies, demonstrate that B27/CD8+ T-
cells interactions might not be necessary for disease since depletion of these cells 
does not affect the development of arthritis or gut inflammation (May et al., 2003). 
Recently, SpA-like disease was detected in CD8 knock-out rats with non-
functional CD8+ T-cells, further indicating that classical MHC class I-T-cell 
interactions are non responsible for disease (Taurog et al., 2009). However, T-cells 
in general are required for inflammatory disease perhaps implicating CD4+ T-cells, 
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or other cell types bearing CD8 such as macrophages and NK cells, in disease 
pathogenesis (Breban et al., 1996; Colonna et al., 1999; Smith et al., 2006).  
 
2.4.3.2 Aberrant cell surface heavy chains 
At the end of the last decade, a feature of HLA-B27 unrelated to antigen presentation 
was described (Allen et al., 1999). Allen and colleagues demonstrated that HLA-B27 
formed disulfide-linked heavy chain homodimers in vitro. These heavy chain 
homodimers form without 2m and are capable of binding peptide. Covalently linked 
heavy chain homodimers are established via the unpaired cysteine residue that HLA-
B27 possesses at position 67 (Fig. 5). The stable homodimers form via an endosome-
dependent recycling pathway when fully folded, but unstable, B27/2m heterodimers 
dissociate at the cell surface (Bird et al., 2003). HLA-B27 heavy chain homodimers 
have been detected at the cell surface of lymphoblastoid cells, rat dendritic cells in 
the HLA-B27 transgenic rat model and HLA-B27 transfected cells (Allen et al., 
1999; Kollnberger et al., 2002; Bird et al., 2003; Kollnberger et al., 2004). 
 
The detection of aberrant forms of HLA-B27 at the cell surface has led to the theory 
that disease pathogenesis might be the consequence of the modulation of leukocyte 
function through the specific recognition of these non-canonical versions of HLA-
B27. Along with T-cell receptors, mature class I molecules have been shown to bind 
several other immunomodulatory molecules including a) members of the killer 
immunoglobulin-like receptor (KIR) family, such as KIR3DL1, which recognises 
HLA-B27 as well as other HLA class I alleles and b) members of the leukocyte 
immunoglobulin-like receptor (LIR) (also known as immunoglobulin-like transcripts 
(ILT)) family (Peruzzi et al., 1996; Andre et al., 2001).  
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However, further studies on immune receptor recognition have led to the discovery 
that KIR3DL1, LIRB2 and LIRA1 all recognise the homodimeric form of HLA-B27 
in addition to B27/2m with bound peptide (Allen et al., 2001; Kollnberger et al., 
2002). Furthermore, the KIR3DL2 receptor binds homodimeric B27 but does not 
bind B27/2m heterodimers (Kollnberger et al., 2002). KIR3DL2 does bind HLA-A3 
and A11 but is dependent on the specific peptide bound by these class I molecules. 
On the other hand, KIR3DL1 and KIR3DL2 binding of homodimeric B27 is 
independent of bound peptide sequence (Chan et al., 2005).  
 
Both KIR3DL1 and KIR3DL2 transmit inhibitory signals through their 
immunoreceptor tyrosine-based inhibitory motifs and expression of KIR3DL2 has 
been linked with increased cell survival of T-cells and NK cells (Young et al., 2001). 
Furthermore, KIR3DL2 is expressed at increased levels in the periphery and 
synovium of AS patients compared with healthy individuals (Chan et al., 2005). 
Since development of AS is not associated with the KIR3DL2-binding HLA-A3 and 
A11 alleles, it is likely that the expansion of KIR3DL2-expressing lymphocytes 
results from unique properties of the B27 homodimer-KIR3DL2 interaction.  
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Figure. 5. The structure of HLA-B27. A, The position of the disulfide bonds of 
HLA-B27 are shown as well as the free cysteines in the extracellular and cytosolic 
domains. B, A ribbon diagram of the extracellular domains of the HLA-B27 heavy chain 
using the crystal structure coordinates; adapted from Bowness et al., 1999. The 1, 2 
and 3 domains are labelled as well as the accessory molecules 2-microglobulin (2m). 
A close-up view of the B-pocket shows the proximity of the free cysteine at position 67 
to the peptide binding groove and to the side chains which are of importance to the B-
pocket and P2 anchor region. 
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Chan and colleagues also demonstrated expansion of CD4+ T-cells in SpA patients 
(Chan et al., 2005). As mentioned previously, depletion of T-cells but not CD8+ 
T-cells prevents SpA-like disease in the transgenic rat model. It has been suggested 
that CD4+ T-cells might be involved in disease pathogenesis since CD4+ T-cells have 
been demonstrated to recognise HLA-B27 which is expressed in cells with defective 
antigen processing pathways – and thus present an array of B27 conformations 
including homodimers – but not classical B27/2m/peptide complexes (Boyle et al., 
2001; Boyle et al., 2004). Recently, it has been demonstrated that dendritic cells, 
from the B27/h2m transgenic rat are dysfunctional since the cell surface expression 
of mature B27 impairs the formation of an immunological synapse with CD4+ T-
cells which may affect the production and/or maintenance of regulatory T-cells, 
contributing to the expansion of pathogenic CD4+ T-cells (Stagg et al., 1995; 
Hacquard-Bouder et al., 2007). Taken together, these studies demonstrate that cell 
surface homodimers of HLA-B27 can interact with several different immune 
receptors that are found on some cell types – such as NK and CD4+ T-cells – which 
are expanded during inflammation. Thus, the expression of aberrant forms of HLA-
B27 at the cell surface may be important for the pathogenesis of AS. 
 
2.4.3.3 HLA-B27 misfolding in the ER 
In 1999, Robert Colbert’s research group demonstrated that, under normal 
physiological conditions, HLA-B27 heavy chains were being degraded shortly after 
synthesis (Mear et al., 1999). ERAD had previously been described as the route for 
the disposal of misfolded MHC class I molecules (Hughes et al., 1997). Furthermore, 
this study revealed the importance of the B pocket region of HLA-B27 on folding 
efficiency. The B pocket, a region of the peptide binding groove which plays a key 
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role in peptide selection, was thought to be important for the arthritogenic phenotype 
since it is conserved among B27 subtypes and thus among those subtypes associated 
with disease (Colbert et al., 1994; Gonzalez-Roces et al., 1997; Lopez de Castro, 
1998). Colbert’s group demonstrated that amino acids located in the 1 domain, 
which ultimately form the B pocket, were responsible for the inefficient folding of 
the B27 heavy chain. This inefficient folding was associated with heavy chain 
dislocation and degradation by the proteasome indicating that B27 heavy chains were 
misfolding – defined as an inability to reach a native conformation or preferentially 
form abnormal conformations – even in the presence of a normal supply of 2m and 
peptide.  
 
Further studies have now revealed that HLA-B27 does indeed form abnormal 
conformations in the ER. Heavy chains spontaneously form misfolded disulfide-
linked complexes in the ER and make up a substantial portion (~25%) of newly 
synthesised heavy chains (Dangoria et al., 2002). However, in this study, the fraction 
of newly synthesised heavy chains that were being degraded was much less than 25% 
indicating that heavy chain homodimers are retained in the ER and may still undergo 
constructive folding events. The ER pool of heavy chain homodimers is distinct from 
those found at the cell surface since cell surface homodimers are the result of fully 
folded, 2m/peptide-associated class I molecules which have become unstable and 
dissociated, whereas the ER pool of homodimers is the result of an inability to 
efficiently reach a native conformation. 
 
Intracellular MHC class I heavy chain dimerisation is not unique to HLA-B27 since 
the mouse class I alleles H-2Ld, H-2Dd and H-2Db have been shown to dimerise 
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(Capps et al., 1993). However, these mouse alleles form ER dimers in the absence of 
2m whilst ER B27 dimers have been demonstrated to form in the presence of 2m 
(Mear et al., 1999). These mouse heavy chains do not possess a free, unpaired 
cysteine in their extracellular domain and form instead via cytoplasmic tail cysteines. 
Consistent with studies of homodimer formation at the cell surface, the unpaired 
cysteine at position 67 – shared by a relatively small number of class I alleles 
including HLA-B14, -B15, -B38, -B39 and -B73 – was shown to be crucial for 
homodimer formation in the ER (Kostyu et al., 1997; Dangoria et al., 2002). A 
mutant form of B27 which folds rapidly and efficiently but does possess an unpaired 
Cys67 does not form homodimers indicating that impaired folding of newly 
synthesised B27 heavy chains leaves the Cys67 residue exposed and therefore prone 
to the formation of aberrant complexes with other heavy chains. However, 
substitution of the unpaired cysteine with alanine in disease associated subtypes 
HLA-B*2704 and B*2705 does not prevent homodimer formation when 
overexpressed (not in conjunction with increased expression of 2m) suggesting that 
these homodimers may form via cytoplasmic tail cysteines (Saleki et al., 2006). This 
is consistent with homodimer formation in the mouse alleles since heavy chain 
homodimer formation in these non-Cys67-possessing heavy chains only occurs in the 
absence of sufficient 2m.  
 
Further evidence for the role of B27 folding efficiency in homodimer formation 
comes from Simon Powis’ group who showed that introduction of Cys67 into rapidly 
folding HLA-A2 did not lead to homodimer formation indicating that Cys67 is not 
sufficient for homodimer formation (Antoniou et al., 2004). Furthermore, they were 
able to mimic an HLA-B27 folding phenotype in HLA-A2 by incubating cells at 
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26oC leading to a decrease in heavy chain folding kinetics and the consequential 
formation of heavy chain homodimers. Incubation at this temperature also enhanced 
homodimer formation in HLA-B27 heavy chains. Moreover, the structural cysteine 
at position 164 also appears to be important for homodimer formation since the 
C164S mutation prevents the formation of B27 homodimers indicating that this 
cysteine may be involved in interchain disulfides or that the Cys101-Cys164 structural 
disulfide is essential for homodimer formation. 
 
The heavy chain misfolding hypothesis should explain the differential association of 
HLA-B27 subtypes with disease. Subtypes not associated with AS, B*2706 and 
B*2709, fold much more efficiently than the disease associated subtypes B*2702, 
B*2704 and B*2705 which is indicative of a relationship between folding properties 
and development of disease (Goodall et al., 2006; Lopez de Castro, 2007; Galocha & 
Lopez de Castro, 2008). However, the B*2707 subtype, which shows association 
with disease, folds as efficiently as non-AS-associated subtypes. Thus, there appears 
to be correlation between inefficient heavy chain folding and AS susceptibility 
except for HLA-B*2707. 
 
Studies with splenocytes from the transgenic rat model of AS also identified B27 
disulfide-linked heavy chain homodimers and higher order multimers (Tran et al., 
2004). Heavy chain homodimers were identified in the B27/h2m transgenic rat but 
not in the B7/h2m transgenic rat, which remains healthy, suggesting a possible 
correlation between heavy chain homodimer formation and disease. Furthermore, in 
line with previous studies, the Cys67 residue was found to be non-essential for 
homodimer formation although the size and number of high molecular weight 
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complexes in C67S mutant spleen cells was altered compared with wild-type B27 
(Dangoria et al., 2002; Tran et al., 2004). B27-C67S/h2m transgenic rats do not 
develop as severe a disease phenotype than wild-type B27/h2m transgenic rats 
which might suggest that B27 heavy chain homodimers formed in the presence of an 
unpaired Cys67 might be more arthritogenic than homodimers formed via alternative 
cysteines (Taurog et al., 1999; Tran et al., 2004). However, the transgene copy 
number in this rat is lower than the wild-type transgenic rat implying that the milder 
phenotype might be the result of a low copy number of B27 or indeed of h2m which 
would result in a high ratio of B27 to 2m. In the study by Tran and colleagues, 
mentioned earlier, additional h2m was introduced by cross breeding and led to an 
increase in severity and duration of arthritis but an absence of colitis and gut 
inflammation. It is interesting to note that in this study B27 heavy chain homodimers 
were abolished (Tran et al., 2006). These results suggest that 1) the expression of 
h2m has an influence on B27 heavy chain misfolding and 2) that B27 misfolding 
and homodimer formation plays a role in gut inflammation but not necessarily in 
arthritis. 
 
The location of heavy chain homodimers from the transgenic rat was not identified 
by Tran and colleagues, but, consistent with findings from Dangoria and colleagues, 
free heavy chains were abundantly immunoprecipitated from B27 transgenic cell 
lysates with anti-BiP, whereas little BiP was found bound to B7 heavy chains 
(Dangoria et al., 2002; Tran et al., 2004). These results suggest that disulfide-linked 
B27 homodimers from the transgenic rat exist as unfolded heavy chains complexed 
with the ER chaperone BiP. One job of the chaperone BiP is to retain misfolded 
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proteins in the ER in order to prevent inefficiently folded proteins from exiting the 
ER into the secretory pathway. Thus, association of BiP with HLA-B27, although a 
quality control measure, may indeed serve to promote aberrant disulfide formation 
since misfolding is a consequence of prolonged retention in the ER.  
 
The observation that HLA-B27 misfolds and forms disulfide-linked homodimers and 
binds stably to the ER chaperone BiP in both transfected cell models and the 
B27/h2m transgenic rat model, led to the proposal that B27 heavy chains 
accumulate in the ER causing ER stress and that consequential activation of the UPR 
might contribute to disease pathogenesis (Mear et al., 1999; Colbert, 2000). This 
theory was bolstered significantly by a key study in 2005 which demonstrated that, in 
bone marrow-derived macrophages (BMDM) from the B27/h2m transgenic rat, 
heavy chain misfolding is associated with activation of the UPR (Turner et al., 
2005). B27-expressing cells exhibited overexpression of the UPR target genes BiP, 
CHOP and XBP1 as well as increased XBP1 splicing.  
 
In line with disease severity in the transgenic rat, UPR activation is dependent on the 
expression level of HLA-B27. There was no UPR detected in spleen or thymus from 
premorbid rats – which all express HLA-B27 – suggesting that ongoing UPR 
activation is not a widespread phenomenon in these animals. However, when cells 
from these animals are treated with IFN-, which induces HLA-B upregulation, UPR 
activation is observed (Taurog et al., 1993; Turner et al., 2005). However, it is 
possible that UPR activation is a consequence of IFN--induced upregulation of 
other gene products. Thus, this study linked, for the first time, increased expression 
of HLA-B27, misfolding and accumulation of its heavy chain in the ER, induction of 
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UPR and B27-associated disease. The absence of a UPR in spleen, thymus and 
macrophages from premorbid rats might be due to many factors including 1) 
insufficient levels of heavy chains expressed in unstimulated cells 2) these cell types 
may express different levels of other class I assembly pathway components or 3) 
these cell types have adapted to chronic misfolding and increased load on the ER.  
 
The role of IFN- in HLA-B27 expression and UPR activation has been addressed by 
several recent investigations. IFN- treatment of B27-expressing BMDMs from the 
B27/h2m transgenic rat is accompanied by increased accumulation of disulfide-
linked heavy chain complexes and binding of these complexes to BiP (Turner et al., 
2005). However, this does not occur in the B7/h2m transgenic rat. IFN- also 
upregulates components of the class I assembly pathway such as components of the 
proteasome, TAP, tapasin, 2m and ARTS1/ERAAP. Thus, B27 misfolding and UPR 
activation occurs despite an increase in source peptides and HC folding machinery 
which may indicate that they may be insufficient to prevent misfolding or that one or 
more of these components may exacerbate heavy chain misfolding (Colbert et al., 
2009). It has also been postulated that IFN expression might be regulated by the 
UPR. Type I IFN and IFN- are only expressed at low levels in BMDMs from the 
transgenic rat model or in cells undergoing pharmacological agent-induced ER stress 
(Lee et al., 2003; Smith et al., 2008). However, when macrophages undergoing a 
UPR are exposed to ligands for Toll-like receptors such as LPS and dsRNA, robust 
synergistic IFN- production occurs (Smith et al., 2008). This synergistic effect 
seems to require the spliced version of XBP1 and suggests a fundamental 
relationship between ER stress and innate immune signalling. Furthermore, HLA-
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B27 homodimers have been detected in dendritic cells upon cell activation by 
PMA/ionomycin and peripheral blood monocyte-derived dendritic cells upon 
stimulation of TLR4 by LPS further indicating a link between immune cell activation 
and/or maturation and B27 homodimer formation (Santos et al., 2008).  
 
The various theories of pathogenesis under consideration are not mutually exclusive 
despite any single theory being able to explain the pathogenesis of HLA-B27-
associated inflammatory disease yet. However, since ER stress and UPR activation 
can be pathogenic (Oyadomari et al., 2002a) and B27-driven UPR activation has 
been demonstrated in activated immune cells (Santos et al., 2008), it is likely that a 
UPR driven by HLA-B27 misfolding has the potential to adversely affect immune 
function and contribute to inflammatory disease. Moreover, if HLA-B27 misfolding 
can mediate inflammation, it seems that a prior event – such as interferon-mediated 
stimulation of B27 expression – is required to exacerbate the accumulation of 
misfolded heavy chains. Furthermore, the contribution of T-cell and leukocyte 
receptor recognition of B27 homodimers and the involvement of other genetic factors 
such as polymorphisms in ARTS1 and IL-23R must also not be overlooked.  
 
 
 
 
 
 
 
 
General Introduction  115 
 
2.5 Thesis aims 
Activation of the UPR is implicated in a number of non-inflammatory and 
inflammatory diseases including ankylosing spondylitis. Activation of the UPR in 
AS is associated with the misfolding of the MHC class I heavy chain HLA-B27. The 
main objectives of this project were: 
 
 To use pharmacological agents to induce ER stress in different cell 
types to investigate the activation of different branches of the UPR. 
 To determine if there are cell-specific differences in the activation of 
the UPR in response to different forms of ER stress. 
 To investigate the consequences of UPR activation on cell survival in 
different cell types. 
 To examine the misfolding of HLA-B7 and HLA-B27 in different cell 
types and investigate the activation of the UPR in these cells. 
 To examine the impact of the tyrosine kinase inhibitor genistein on 
UPR target gene expression. 
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3. Materials and Methods 
 
3.1 Cell Lines, Tissues and Antibodies 
Human cervical carcinoma HeLa cells (a gift from J. Neefjes, NKI, Netherlands) 
were maintained in minimum essential medium (MEM) (22561-021; Gibco, 
Invitrogen), human fibrosarcoma HT-1080 cells (a gift from J. Neefjes, NKI, 
Netherlands) were maintained in Dulbecco’s modified Eagle’s medium (D-MEM) 
(21063-029; Gibco, Invitrogen). Both cell lines were free from mycoplasma as 
determined by the EZ-PCR mycoplasma test kit which detects a conserved, 
mycoplasma-specific 16S rRNA gene region by PCR methods (Geneflow, UK). 
Human lymphoblastoid, WEWAK1, JESTHOM, HOM-2 (all from ECACC, UK) 
and the human monocyte THP1 cells (a gift from J. Robinson, Newcastle-upon-Tyne 
University, UK) were maintained in RPMI 1640 (21875-034; Gibco, Invitrogen). 
Immortalised AS patient lymphocytes (a gift from J Goodall, Cambridge University, 
UK) maintained in RPMI 1640 (21875-034; Gibco, Invitrogen). These cells were 
generated by Goodall and colleagues from peripheral blood mononuclear cells by 
incubation with the supernatant of the Epstein-Barr virus (EBV)-producting cell line 
B95.8 at 37oC for 1 hour. Cells were then cultured in RPMI (Life Technologies Ltd, 
UK), supplemented with 5 % (v/v) FCS (HI FCS; Life Technologies Ltd, UK), 
10mM HEPES (Sigma), 2 mM glutamine (Sigma), 100 g ml-1 streptomycin 
sulphate BP (Evans Medical Ltd, UK) and 100 U/ml benzylpenicillin sodium BP 
(Glaxo, UK) in the presence of 1 g ml-1 cyclosporin A. The cells were passaged at 
weekly intervals with fresh medium supplemented with cyclosporin A until the cell 
line was established, at which time the use of cyclosporin A was discontinued. 
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Untransfected rat thymoma C58 cells and C58 cells stably transfected with HLA-A2, 
HLA-B27, and a HLA-B27.H114D.D116Y mutant (a gift from A. Antoniou, 
University College London, UK) were maintained in RPMI 1640 (21875-034; Gibco, 
Invitrogen). Stable transfectants were generated by electroporation and selected in 
R10 medium (RPMI 1640 plus 10 % (v/v) FCS) plus 1 mg/ml G418. Vectors for 
stable transfection, clone selection and clone characterisation were not disclosed. 
Media for stable transfectants was supplemented with 1 mg/ml G418 (Sigma-
Aldrich) for selection. All cell lines were supplemented with 8 % (v/v) foetal calf 
serum (FCS) (10106-151; Sigma-Aldrich), 2 mM Glutamax (A12860-01; 
Invitrogen), 100 units ml-1 penicillin and 100 g ml-1 streptomycin (15140-122; 
Invitrogen) and propagated at 37oC under 5 % CO2. Sterile cell culture passage took 
place every 2-5 days depended on cell density. Spent medium was removed from 
cells in 10 cm2 cell culture dishes. The cells were then washed with 10 ml warm 
(37oC) PBS and trypsinised with 0.25 ml 1x trysin-EDTA (Invitrogen). Cell culture 
dishes were placed in the 37oC incubator for 5 mins or until the cells had loosened 
from the dish. Cells were then resuspended in 10 ml warm fresh media. One ml of 
this suspension was added to 9 ml warm fresh media and plated into a new cell 
culture dish and placed in the incubator to allow the cells to adhere. 
 
The polyclonal rabbit antisera against PDI (Benham et al., 2000), has been described. 
The mouse monoclonal (mAb) antibody HA-7 (H9658; Sigma-Aldrich) and the anti-
myc mAb 9B11 (#2276; Cell Signalling) are both commercially available. The 
conformation-specific mAb W6/32 (Parham et al., 1979) and the heavy chain-
specific mAb HC10 recognising free B and C allele heavy chains (Stam et al., 1986) 
were gifts from J. Neefjes, Netherlands Cancer Institute, The Netherlands. The rabbit 
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polyclonal antisera against the C-terminus of GRP78/BiP (H-129) (sc-13968), the 
rabbit polyclonal antisera against human ATF6 (H-280) (sc-22799), the rabbit 
polyclonal antisera raised against the N-terminus of PERK (H-300) (sc-13073), the 
rabbit polyclonal antisera raised against human IRE1 (H-190) (sc-20790) and the 
rabbit polyclonal antisera raised against mouse XBP1 (M-186) (sc-7160) are 
commercially available (Santa Cruz Biotechnology). The rabbit polyclonal antisera 
against the phosphorylated Ser51 of eukaryotic initiation factor 2 alpha (eIF2) 
(#9721), the mouse monoclonal antisera against a broad range of tyrosine-
phosphorylated proteins (P-Tyr-100) (#9411) and the rabbit polyclonal antisera 
against GRP94 (#2104) are all commercially available (Cell Signalling Technology). 
The mAb Jol 2, which recognises nuclear lamins A and C, was a gift from R. A. 
Quinlan, University of Durham, UK. The polyclonal sheep antisera against the 
human glycoprotein TGN46 is commercially available (AHP500; AbD Serotec).  
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Table 2 – Antibody concentrations  
 
Antibody 
 
Dilution 
 
HC10 (mAb) 
 
1:200-1:300 (WB) 
 
anti-PDI (pAb) 
 
1:1000 (WB), 1:400 (IF) 
 
anti-HA (mAb) 
 
1:2000 (WB, IF) 
 
anti-myc (mAb) 
 
1:4000 (WB) 
 
W6/32 (mAb) 
 
1:200-1:300 (WB) 
 
anti-BiP (pAb) 
 
1:200 (WB) 
 
anti-ATF6 (pAb) 
 
1:200 (WB), 1:100 (IF) 
 
anti-PERK (pAb) 
 
1:200 (WB) 
 
anti-IRE1 (pAb) 
 
1:200 (WB) 
 
anti-XBP1 (pAb) 
 
1:200 (WB) 
 
anti-eIF2 (Ser51) (pAb) 
 
1:1000 (WB) 
 
anti-P-Tyr-100 (mAb) 
 
1:1000 (WB) 
 
anti-Grp94 (pAb) 
 
1:1000 (WB) 
 
Jol2 (mAb) 
 
1:100-1:200 (WB), 1:100 (IF) 
 
anti-TGN46 
  
 
1:200 (IF) 
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3.2 Constructs 
The pcDNA3-HLA-B2705 construct (confirmed by DNA sequencing) was a gift 
from J. Neefjes, NKI, Netherlands. This plasmid features an intermediate-early 
cytomegalovirus (CMV) promoter which drives high-level expression of the 
transgene in a variety of mammalian cell lines and a bovine growth hormone (BGH) 
polyadenylation signal providing transcriptional termination. The plasmid also 
features an ampicillin resistance gene allowing bacterial selection and a neomycin 
resistance gene allowing mammalian selection and an SV40 replication origin. The 
pCGN-ATF6-HA construct contains an N-terminal influenza virus haemagglutinin 
(HA) epitope tag (SSYPYDVPDYASLGGPSR) (described in Chen et al., 2002 and 
Tanaka & Herr, 1990) and was a gift from R. Prywes, Columbia University, New 
York, USA. This plasmid features a human CMV promoter, an HSV tk gene 5’ 
untranslated leader and initiation codon, rabbit -globulin gene splicing and 
polyadenylation signals and the replication origin of SV40. 
 
3.3 Transfection 
Plasmid DNA for transfection was transformed in DH5 E. coli bacteria, amplified 
using the mini- or maxi-prep kits (Qiagen) and purified by isopropanol precipitation. 
Plasmid DNA concentration was determined by spectrophotometry and diluted to 1 
g/l. Two-3 days pre-transfection, cells were grown in 6 cm dishes to 80% 
confluency. Cells were then transfected with the appropriate construct using either 
the transfection reagent lipofectamine 2000 (11668-019; Invitrogen) or Fugene HD 
transfection reagent (04709705001; Roche). For lipofectamine 2000 transfection, 
cells were initially washed with 2 ml Hank’s balanced salt solution (HBSS) (140 mg 
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l-1 CaCl2, 100 mg l-1 MgCl2-6H2O, 140 mg l-1 MgSO4-7H2O, 400 mg l-1 KCl, 60 mg 
l-1 KH2PO4, 350 mg l-1 NaHCO3, 8000 mg l-1 NaCl, 48 mg l-1 Na2HPO4 and 1000 mg 
l-1 Dextrose)  (14025-050; Gibco, Invitrogen) then 2 ml serum-free optiMEM 
(11058-021; Gibco, Invitrogen). 2.5 l lipofectamine 2000 reagent was diluted in 1 
ml warm optiMEM and allowed to mix for 5 minutes. Separately, 1 g of plasmid 
DNA was added to 1 ml optiMEM before being added to the 
lipofectamine/optiMEM mix. The 2 ml optiMEM/lipofectamine/plasmid DNA 
preparation was allowed to couple for 20 minutes before being added to the cells for 
6 hours at 37oC. Post-incubation, cells were washed with 2 ml warm optiMEM then 
2 ml warm HBSS and replaced with 2 ml fresh complete medium. Cells were then 
lysed 24 hours post-transfection. For Fugene HD transfection, cells were initially 
washed with 2 ml warm PBS and 3.5 ml fresh complete medium was added. 2.1 g 
of plasmid DNA was incubated with 5.25 l Fugene reagent in 175 l serum-free 
optiMEM for 10 minutes before being added drop-wise to the cells containing fresh 
medium. Cells were incubated at 37oC for 24 hours before being washed twice in 2 
ml warm PBS for lysis. Mock transfections were subject to all wash and incubation 
steps but did not receive plasmid DNA or transfection reagent. 
 
3.4 Cell treatments 
HeLa and HT1080 cells were split from confluent 10 cm dishes into 6 cm dishes and 
grown for 2-3 days prior to treatment. To induce the UPR, media was supplemented 
with 10 mM DTT, 1 g ml-1 tunicamycin, 2 M A23187 or 2 M thapsigargin for 
the times stated. The chemicals were obtained from Sigma-Aldrich. Treatments were 
staggered in order to achieve the desired course of treatment, washed with PBS and 
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subjected to MNT or RIPA lysis or lysis in tri reagent for RNA analysis (see section 
3.5 below). For experiments involving a change of media (low glucose (1000 mg/l) 
DMEM (D2429; Sigma-Aldrich), serum withdrawal), cells were washed twice with 
warm PBS before being replaced with fresh media for the times indicated. For serum 
withdrawal, cells were grown in the presence of serum for two days, before the 
media was replaced with media lacking FCS for 6 hours in the presence or absence 
of ER stress inducers. For the genistein (Sigma-Aldrich) experiments, a 35 mM stock 
was made in DMSO (Sigma-Aldrich) and supplied to the cells at 140 M for the 
stated times. A vehicle control was included. 
 
3.5 Cell lysis 
Post-transfection and -treated cells were lysed for protein analysis by SDS-PAGE at 
4 oC in either 300 l MNT lysis buffer (1 % (v/v) Triton X-100, 30 mM Tris-HCl, 
100 mM NaCl, 20 mM MES, pH 7.4) supplemented with 20 mM N-ethylmaleimide 
(NEM) (Sigma-Aldrich) and 10 g ml-1 protease inhibitors chymostatin, leupeptin, 
antipain and pepstatin A (Sigma-Aldrich) or 300 l RIPA lysis buffer (1% (v/v) 
Triton X-100, 50 mM Tris HCl pH8, 150 mM NaCl, 0.5% (w/v) Na-deoxycholate, 
0.1% (w/v) SDS) supplemented with 20 mM NEM, 10 g ml-1 protease inhibitor 
cocktail (containing chymostatin, leupeptin, antipain and pepstatin A) and 1% 
phosphatase inhibitor cocktail 1 (v/v) (Sigma-Aldrich). RIPA lysates were DNase 
treated with benzonase (30 U/ml) (Novagen) for 60 minutes on ice. Alternatively, 
cells were lysed in 1 ml/10 cm2 TRI-reagent (T9424; Sigma-Aldrich) for RNA 
isolation according to the manufacturer’s protocol and subsequent RT-PCR. 
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3.6 RT-PCR 
The concentration of extracted RNA was determined by spectrophotometry using an 
eppendorf biophotometer and diluted to 50 ng/l. 50 ng total cell RNA was subjected 
to reverse transcriptase polymerase chain reaction (RT-PCR) using the AccessQuick 
RT-PCR kit (A1702; Promega). Primers for RT-PCR can be seen in Table 3. Primer 
sets were designed across intron-exon boundries. The RT-PCR cycle used was: 1h 45 
oC, 2 mins 94 oC, (30 sec 94 oC, 1 min 60 oC, 1 min 72 oC) 30x, 5 min 72 oC, 4 oC for 
ever. XBP1 cDNA was then subjected to PstI digest (see below). All cDNA were 
either ran on 1% (w/v) agarose gel (XBP1 before PstI digest) or ran on 2% (w/v) 
agarose gel (after PstI digest) at 100 mV for ~50 mins before exposure to UV light at 
365 nm. 
 
3.7 PstI digestion 
Amplified XBP1 cDNA was subjected to PstI (MBI/Fermentas) digest to detect the 
presence of spliced mRNA. 12.5 l RT-PCR product was digested using 1 l (10 U) 
PstI in a total volume of 15 l at 37oC for 2 h. cDNA was extracted from the 
restriction digest using a PCR purification kit (Qiagen) according to the 
manufacturer’s instructions. Purified cDNA was run on 2% (w/v) ethidium bromide 
agarose gel and visualized by UV light at 365 nm.  
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Table 3 – RT-PCR Primers 
mRNA 
Target 
Product 
Size (nt) 
Forward/
Reverse Primers 
 
Forward 
 
CCTCGATTCCAGCAAAGCACCGC 
ATF4 760  
Reverse 
 
GCTCCTATTTGGAGAGCCCCTGG 
 
Forward 
 
TGATGCCTTGGGAGTCAGAC 
ATF6 890  
Reverse 
 
GTGTCAGAGAACCAGAGGCT 
 
Forward 
 
AGAGCTGTGCAGAAACTCCGGC  
BiP 1092  
Reverse 
 
CCTCTTCACCAGTTGGGGGAGG 
 
Forward 
 
GCTGGAAGCCTGGTATGAGGACC 
CHOP 389  
Reverse 
 
CGCTCGATTTCCTGCTTGAGC 
 
Forward 
 
GAAACTGAAAAACAGAGTAGCAGC 
XBP1 544  
Reverse 
 
GCTTCCAGCTTGGCTGATG 
 
Forward 
 
CCACACCTTCTACAATGAGC 
-actin 823  
Reverse 
 
ACTCCTGCTTGCTGATCCAC 
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3.8 PNGase digestion 
Post-nuclear lysates were denatured using 10x denaturing buffer (5% (w/v) SDS, 0.4 
M DTT) (New England Biolabs Inc.) and boiled at 95 oC for 10 minutes. 1000 U of 
PNGase were added to the lysates together with 10x G7 reaction buffer and 1% (v/v) 
NP-40 and incubated at 37oC for 2 hours before being taken into sample buffer for 
loading on an SDS-PAGE gel. 
 
3.9 SDS-PAGE 
Samples were prepared for SDS-PAGE separation by the addition of 2x Laemmli 
loading buffer (1 M Tris pH 6.8, 20% (w/v) SDS, 5% (v/v) glycerol, 0.01% (w/v) 
bromophemol blue) in the presence or absence of 50 mM dithiothreitol (DTT) 
(Sigma-Aldrich), boiled at 95 oC for 5 min at 95 oC and spun down at 4 oC. All Blue 
Precision Plus protein standard (250-10 kD) (#161-0373; BioRad) was used as a 
protein marker. This marker contained ten protein bands at 10 kD, 15 kD, 20 kD, 25 
kD, 37 kD, 50 kD, 75 kD, 100 kD, 150 kD and 250 kD. Samples were run on 8-10 % 
SDS-PAGE gels (Running gel: 8-10% (v/v) Acrylamide (Sigma-Aldrich), 0.375 M 
Tris pH 8.8, 0.1% (w/v) SDS (Sigma-Aldrich), 0.1%  (w/v) Ammonium persulfate 
(APS) (Sigma-Aldrich) and 0.04% (v/v) N,N,N',N'-Tetramethylethylenediamine 
(TEMED) (Sigma-Aldrich). Stacking: 5% (v/v) Acrylamide, 0.125 M Tris pH 6.8, 
0.1% (w/v) SDS, 0.075% (w/v) APS and 0.075% (v/v) TEMED)  for ~50 min at 15 
mV in 1x Tris-Glycine SDS buffer (Sigma-Aldrich) in order to resolve all proteins. 
The SDS-PAGE gel was cast using BioRad casting apparatus. Initially, the running 
gel was made up, cast and left for 40 mins with a layer of distilled water on top to 
prevent drying out. The water was drawn out using blotting paper and the stacking 
gel was made and cast on top. A 15-well comb was immediately placed in the 
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stacking gel. This was left to set for 30 mins before the gels were removed from the 
apparatus and placed in a BioRad running tank. Running buffer was added to the 
tank and prior to loading the gel, the combs were removed. Once the gel had run, 
PVDF transfer membranes (Millipore) were pre-moistened for transfer in methanol 
and then in 1x transfer buffer (190 mM glycine, 25 mM Tris, 20% (v/v) methanol). 
Gels were then wet transferred in 1x transfer buffer for 2 h at 30 mV. Membranes 
were then blocked in 8 % (w/v) milk in PBST (100 ml dm-3 PBS, 0.1% (v/v) Tween 
20 (Sigma-Aldrich)) or TBST (10 mM Tris pH 8, 150 mM NaCl, 0.1% (v/v) Tween 
20) for 60 min. 
 
3.10 Ponceau S staining 
Post-transfer PVDF membranes are washed in PBS and immersed in Ponceau S 
staining solution (P7170; Sigma-Aldrich) for 5 minutes. Membranes are then washed 
with distilled water to visualise bands and remove background. Membranes can 
either be dried at this point or further washed with distilled water for 5 minutes (or 
0.1 M NaOH for 10-30 seconds) to remove the remaining stain allowing immuno-
detection.  
 
3.11 Western Blotting 
Membranes were incubated with the appropriate primary antibody dilution (see 
Table 2) in 8% (w/v) milk in PBST or 5% (w/v) BSA (A9418; Sigma-Aldrich) in 
TBST (Cell Signalling antibodies only) for 60 minutes before being washed three 
times for five minutes with PBST or TBST. Membranes were then incubated with 
the corresponding secondary antibody (DAKO) at 1:3000 in 8% (w/v) milk in PBST 
or TBST for 60 min then subsequently washed three times for five minutes with 
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PBST or TBST. Proteins were then visualised with 200 l enhanced 
chemiluminescence fluid (Amersham). The solution was prepared from the two 
individual solutions and incubated at RT for 1 min. The solution was applied to air-
dried membranes for 1 min on Saran wrap before removing the excess. Membranes 
were then wrapped in Saran wrap to prevent the membrane drying out and 
luminescent stickers were applied to the Saran wrap to aid visualisation in the dark 
room and to enable alignment of the film with the membrane after exposure. The 
membrane was then exposed to chemiluminescent film (Kodak) for a range of 
exposures and developed using an X-ray developer machine. 
 
3.12 Glycine stripping  
To remove antibodies after Western blotting, membranes were rehydrated in PBST 
and stripped with glycine stripping buffer (15 g/l Glycine, 0.05 % (v/v) Tween pH 
2.5) for 5-10 minutes, washes in PBST for 1 min, stripped again for 5-10 minutes 
with glycine stripping buffer then washed with PBST for 1 min before blocking in 
8% (w/v) milk in PBST for 60 minutes. 
 
3.13 Immunofluorescence 
Cells were grown on 100% ethanol-sterilised cover slips (VWR) in 6 cm dishes 3 
days prior to transfection. Cells on the cover slips were either transfected and/or 
treated as normal before being washed in the dish with 4 ml warm PBS (Gibco, 
Invitrogen). Cover slips were then removed from the dish and were either then fixed 
in 4 ml -20 oC methanol (Fisher Scientific) for 10 minutes or paraformaldehyde-fixed 
in 1 ml 4% (w/v) paraformaldehyde (VWR) in a 6 well dish for 10 minutes at room 
temperature and then placed in 1 ml 10% (v/v) Triton X-100 (T8787; Sigma-Aldrich) 
Materials and Methods  129 
 
for 5 minutes at room temperature in a 6 well dish. Cover slips are then washed in 4 
ml room temperature PBS. Then, individual cover slips are blocked with 75 l 0.2% 
(w/v) BSA at room temperature for 30 minutes before a PBS wash. Cover slips are 
incubated with 50 l of the appropriate primary antibody dilution (in 0.2 % (w/v) 
BSA in PBS) at room temperature for 45 minutes. After washing in PBS, cover slips 
are incubated in the dark with 75 l of either swine anti-rabbit tetramethyl rhodamine 
isomer R (TRITC)-conjugated (R0156; DAKO) or donkey anti-mouse Alexa Fluor 
488 (A21202; Invitrogen) secondary antibody (in 0.2 % (w/v) BSA in PBS) for 30 
minutes. Cover slips are washed with PBS and stained with 75 l 1x DAPI for 5 
minutes in the dark before washing with PBS. Finally, cover slips are mounted on 
slides using hard-setting Vectashield (Vector Laboratories) and analysed by confocal 
microscopy.  
 
3.14 Cell viability assay 
Cells were grown and treated with ER stress inducers in 6 cm dishes for the times 
stated. Cells were washed in PBS, tyrpsinised and diluted in fresh medium. 50 l of 
cells were serial diluted into a cell culture-treated 96-well plate, made up to a volume 
of 200 l with fresh media and grown overnight. Media was then removed; cells 
were washed in PBS before being fixed in 50 l -20 oC methanol for 10 minutes. 
Cells were then washed in PBS, stained with 50 l 1x DAPI in PBS for 10 minutes in 
the dark and washed in PBS again. Cells nuclei were imaged on a Zeiss Axiovert 
200M microscope using the Image Associates’ (IMAS) Axiovision 4.7 program. At 
least three internal repeats were done for each dilution. Cell number was determined 
using Image J.  
Results  130 
 
 
 
 
 
 
 
 
 
4. RESULTS 
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4. 1 Induction of the UPR by pharmacological agents 
 
4.1.1 Introduction 
The UPR is a multifaceted system which monitors the folding capacity of the ER and 
coordinates appropriate transcriptional and translational responses to perturbations in 
ER homeostasis. So-called ER stress can be caused by a number of perturbations 
including the accumulation of unfolded or misfolded proteins – which could be 
caused by elevated secretory protein synthesis or mutant protein production – 
disturbances in Ca2+ storage, changes in redox status, altered glycosylation, hypoxia, 
ischemia and nutrient deprivation. Commonly, pharmacological agents are used to 
induce ER stress conditions in the cell, exploiting the sensitivity of the ER to various 
perturbations.  
 
4.1.1.1 Tunicamycin 
Tunicamycin, a drug first identified and isolated from Streptomyces lysosuperificus, 
was initially studied for its antibiotic/antiviral effects but is now frequently employed 
to induce ER stress in cells by using commercially available tunicamycin which is a 
mixture of similar compounds (Takatsuki et al., 1971; Back et al., 2005). 
Structurally, tunicamycin is composed of uracil, a fatty acid and two glycosidically 
linked sugars – N-acetylglucosamine and tunicamine (Fig. 6). Tunicamycin inhibits 
the first step in the lipid-linked oligosaccharide pathway; the transfer of GlcNAc-1-P 
from UDP-GlcNAc to dolichyl-P by GlcNAc phosphotransferase (GPT) to form 
dolichyl-PP-GlcNAc (Tkacz & Lampen, 1975).  
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Figure 6. The ER stress-inducing agents tunicamycin, thapsigargin and 
dithiothreitol. A, The GlcNAc phosphotransferase (GPT) inhibitor tunicamycin 
PubChem CID: 6433557. B, The calcium ATPase pump inhibitor thapsigargin PubChem 
CID: 446378. C, The action of the reducing agent dithiothreitol (DTT) which reduces 
disulfide bonds PubChem CID: 19001.  
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Inhibition of the transfer of phosphorylated N-acetylglucosamine to dolichyl-P 
prevents N-linked glycosylation of proteins in the ER. If proteins fail to become fully 
glycosylated, their folding becomes inefficient since interaction with resident ER 
proteins, such as lectins, may be abolished and the protein becomes more 
hydrophilic. Inefficient folding of non- or under-glycosylated proteins can lead to 
their accumulation in the ER and saturation of the protein folding machinery. Thus, 
tunicamycin is a good inducer of the UPR since it triggers an increase in the protein 
folding demand. 
 
4.1.1.2 Disruption of cellular Ca2+ levels 
The ER is the cell’s principle Ca2+ store and contains a high concentration of 
sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) pumps which regulate 
cytosolic Ca2+ levels.  Thapsigargin is another commonly-used inducer of the UPR 
and exerts its ER stress-inducing activity by inhibiting intracellular Ca2+ ATPase 
pumps (Campbell et al., 1991; Lytton et al., 1991). SERCA pump inhibition leads to 
depletion of ER Ca2+ levels and causes an increase in cytosolic Ca2+ due to passive 
leakage out of the ER (Thastrup et al., 1990). Extracellular free Ca2+ also influxes 
into the cytosol due to changes in plasma membrane permeability (Parekh et al., 
1993). Perturbation in cellular Ca2+ levels leads to induction of the ER stress 
response and prolonged treatment leads to UPR-dependent and -independent 
apoptosis (Nakagawa & Yuan, 2000; Rao et al., 2001). Thapsigargin is a 
sesquiterpene lactone originally isolated from Thapsia garganica (Rasmussen et al., 
1978) (Fig. 6). Additionally, ionophores such as A23187 (calcimycin) and 
ionomycin, act as mobile carriers of divalent Ca2+ ions – and other cations – 
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elevating the cytosolic Ca2+ concentration and depleting ER Ca2+ levels which results 
in the disruption of ER function (Dedkova et al., 2000; Rao et al., 2004).  
 
4.1.1.3 DTT and glucose starvation 
The ER is the site of disulfide bond formation and harbours a redox environment 
which is favourable for oxidation. Perturbations in the redox environment of the ER 
can lead to reduced protein folding efficiency and retention of proteins in the ER 
(Jämsä et al., 1994). Dithiothreitol (DTT) – also known as Cleland’s reagent – is a 
potent reducing agent which has high propensity to form a six-membered ring with 
an internal disulfide bond (Ruegg & Rudinger, 1977) (Fig. 6). Thus, DTT is used to 
reduce disulfide bonds in the ER causing the accumulation of reduced proteins and 
consequential ER stress. DTT is also used post-lysis to reduce proteins for gel 
electrophoresis. 
 
Glucose starvation was one of the first inducers of the UPR to be studied (Shiu et al., 
1977). Withdrawal of glucose from the growth media most likely results in a 
decrease in the amount of oligosaccharide intermediates used for protein N-
glycosylation as well as depleting ATP, which is required for protein folding. 
Prevention of glycosylation can lead to changes in protein folding efficiency and the 
accumulation of unfolded/misfolded proteins in the ER and activation of the UPR 
(Lee, 2001; Yoneda et al., 2001; Nadanaka et al., 2006).  
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4.1.2 Results 
 
4.1.2.1 HeLa and HT1080 both upregulate BiP in response to ER stress induction 
In order to understand how different cell types coordinate the unfolded protein 
response, I initially studied the effects of a range of pharmacological agents, known 
to induce ER stress, in model established cell lines. The immortalised HeLa cell line, 
derived from Henrietta Lacks in 1951, is a human cervical carcinoma cell line used 
widely in research while HT1080 is an immortalised human cell line derived from 
fibrosarcoma cells established in 1974 (Von et al., 1954; Rasheed et al., 1974). 
These cell lines were chosen primarily for their practicality since they grow rapidly, 
can be successfully transfected and have been used in our laboratory for many years. 
Furthermore, there is a raft of published experimental data pertaining to both these 
cell lines which allows for effective comparison of results. 
 
Immunoglobulin-binding protein, or BiP, negatively regulates the UPR by binding to 
the lumenal domain of the three ER stress transducers IRE1, ATF6 and PERK. 
Detection of the amount of free BiP is important in assessing the protein folding 
capacity of the ER, although ER stress sensors may be able to detect unfolded protein 
directly. However, in response to reduced amounts of free BiP, the UPR is induced 
(Shamu et al., 1994; Liu et al., 2003; Kimata et al., 2007). Accordingly, one of the 
major targets of UPR induction is to increase BiP expression, which serves to restore 
ER homeostasis by increasing the folding capacity of the ER (Lee et al., 2003).  
 
 
 
Results Chapter 1  136 
 
 
 
A 
 
 
B        C            
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
Mock DTT Tm Tg A23187 Low
Gluc.HeLa
R
el
at
iv
e 
Ex
pr
es
si
on
   
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
Mock DTT Tm Tg A23187 Low
Gluc.HT1080
R
el
at
iv
e 
Ex
pr
es
si
on
 
 
 
 
 
 
 
 
 
 
Figure 7. BiP expression in HeLa and HT1080 cells in response to ER stress-
inducing treatment. A, HeLa (H) and HT1080 (HT) cells were subjected to cell 
treatment with the pharmacological agents dithiotheritol (DTT), tunicamycin (Tm), 
thapsigargin (Tg), A23187, low glucose (Low Gluc.) or Mock-treated (-) for 6 hours. Cells 
were lysed with TRIreagent and subjected to RT-PCR using primers designed against 
intron-exon boundaries of BiP and -actin. B and C, Graphical representation of the 
relative expression of BiP in response to the indicated ER stress inducers. BiP expression 
was normalised to -actin and is the average of at least 2 independent RT-PCR 
experiments 
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HeLa and HT1080 cells were treated with 10 mM DTT, 1 g/ml tunicamycin, 2 M 
thapsigargin, 2 M A23187 or mock treated, as suggested by previous literature 
(Duskin & Mahoney, 1982; Pagani et al., 2000). Additionally, mild glucose 
deprivation was also studied by replacing cell media with low glucose (1000 mg/L) 
D-MEM. Cells were treated for 6 hours under these conditions before being washed, 
lysed and subject to RNA extraction. BiP and -actin expression were analysed by 
reverse transcriptase polymerase chain reaction (RT-PCR) and visualised by agarose 
gel electrophoresis (Fig. 7A).  
 
Steady-state expression of BiP in both HeLa and HT1080 cells was similar under 
mock treatment, however, under treatment of the reducing agent DTT, BiP 
expression was upregulated (Fig. 7A, compare lanes 3 and 4 with lanes 1 and 2). 
Treatment with tunicamycin also induced upregulation of BiP in both cell lines, 
although to a lesser extent in HT1080. Treatment of HeLa and HT1080 with 
thapsigargin and A23187, which promote Ca2+ efflux from the ER, significantly 
induced the expression of BiP (Fig. 7A, lanes 7-10). Mild glucose deprivation had 
little or no effect on BiP expression since BiP levels in Fig. 7A, lanes 11-12, were 
comparable to mock treatment in high glucose medium. Glucose starvation can 
induce BiP upregulation (Nadanaka et al., 2006); however this occurs when cells are 
cultured in glucose-free medium. Conversely, exposure of cells to 1000 mg/L 
glucose (low glucose) for 6 hours did not lead to upregulation of BiP in HeLa cells 
(Fig. 7A, lanes 11). Treatment of HT1080 cells in low glucose seemed to slightly 
induce expression of BiP in HT1080 cells (Fig. 7C), however, since BiP expression 
was normalised to -actin levels, the weak -actin control for this sample may be 
misleading. -actin is not a secretory pathway substrate and does not require 
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glycosylation. It is therefore unlikely that weak -actin expression in this sample is 
due to low levels of glucose in the medium. 
 
Relative expression of BiP in HeLa and HT1080 is illustrated in Figure 7B and 7C. 
BiP induction was assessed by calculating the relative density of bands from 
independent RT-PCR experiments in which cells were exposed to ER stress inducers. 
Thus, these results show that when HeLa and HT1080 cells are treated with the same 
concentration of tunicamycin, expression of BiP occurs more strongly in HeLa than 
in HT1080 cells. This is despite the fact that treatments with DTT, thapsigargin and 
A23187 demonstrate very similar effects in both cell lines. 
 
4.1.2.2 Induction of XBP1 splicing by ER stress inducers in HeLa and HT1080  
In order to determine if the UPR was responsible for an increase in the transcription 
of BiP, I examined the IRE1 pathway. The main target of IRE1 RNase activity is 
XBP1 mRNA. I used XBP1 splicing as a readout for IRE1-mediated UPR signalling. 
Since the IRE1-mediated removal of a 26-base intron from XBP1 mRNA eliminates 
a novel PstI site, I differentiated between the two versions of XBP1 by digestion of 
XBP1 cDNA by PstI. This assay was first demonstrated by Calfon and colleagues 
and is illustrated in Figure 8 (Calfon et al., 2002). HeLa and HT1080 cells were 
again treated with ER stress inducers for 6 hours and analysed by RT-PCR using 
primers against XBP1 and -actin. XBP1 cDNA was then digested with PstI 
restriction enzyme and digestion reaction components were removed using the PCR 
purification kit from Qiagen. Spliced XBP1, (XBP1 (S)), was differentiated from 
unspliced XBP1, (XBP1 (U)), since it was resistant to PstI  
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Figure 8. PstI digestion as a technique for analysing XBP1 processing. When inactive 
XBP1 mRNA is spliced, a 26 nucleotide intron is removed containing a unique PstI site. Upon 
digestion of inactive XBP1 RNA, two fragments are generated of 255 and 289 nucleotides (nt) 
due to the presence of the PstI site. Activated (spliced) RNA however is not digested by the 
restriction enzyme due to its removal by IRE1, and thus migrates as a single 518 nt fragment. 
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digestion and thus migrated at a slower rate than the unprocessed product on a 2%  
(w/v) agarose gel.  Without treatment, XBP1 mRNA was expressed at low levels and 
was sensitive to PstI digestion in both HeLa and HT1080. The fast migrating doublet 
represents the 255- and 289-nucleotide digestion products of PstI (Figure 9A, lanes 1 
and 7). Thus, in non-stressed cells, XBP1 exists as an unspliced, inactive transcript.  
 
Upon treatment with the ER stress inducers DTT, tunicamycin, thapsigargin and 
A23187, XBP1 cDNA became resistant to PstI digestion and the 518-nucleotide 
cDNA migrated more slowly than PstI-sensitive XBP1 (Figure 9A, lanes 2-5 and 8, 
10-11). PstI-resistant XBP1 represents the spliced version of XBP1 lacking the PstI-
site-containing intron present in unspliced XBP1. Thus, when ER stress is induced by 
DTT, tunicamycin, thapsigargin and A23187 in HeLa and HT1080 cells, XBP1 
undergoes splicing, presumably by IRE1. The level of XBP1 splicing in HeLa and 
HT1080 is dependent on which ER stress inducer is used. DTT, thapsigargin and 
A23187 induced robust splicing of XBP1. This is in line with the induction of BiP 
which was most robust with thapsigargin treatment and was strongly induced by 
A23187 in both cell lines (Figure 7A).  
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Figure 9. XBP1 is spliced in response to a range of ER stress-inducing agents. 
A, Both HeLa and HT1080 cells were subjected to 6 hours treatment with the 
pharmacological agents indicated. XBP1 RT-PCR products were digested with PstI 
restriction enzyme and cleaned up using a PCR purification kit. The eluate was then run 
on a 2% gel to resolve the spliced (S) and unspliced (S) version of XBP1. Primers against 
-actin were used as a control. B, To identify the nature of the 518-nt+ band observed in 
A, mRNA from Mock (-), and DTT (+DTT) as well as a mixture of mRNA from Mock 
and DTT-treated cells (-/+DTT) was subjected to XBP1 RT-PCR. Like A, RT-PCR 
product was digested with PstI and cleaned up before being run on a 2% agarose gel. -
actin was used as a control. 
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Treatment with tunicamycin induced robust splicing of XBP1 in HeLa cells but was 
considerably less strong in HT1080 cells (Figure 9A, compare lanes 3 and 9). 
Additionally, tunicamycin-induced XBP1 (S) migrated as a doublet with a more 
slowly migrating band in addition to the 518-nucleotide band (which represents 
spliced XBP1 cDNA). Since this slower migrating band was only present in samples 
which contain partially spliced XBP1 and not fully spliced or fully unspliced XBP1 
(Figure 9A, 9B and data not shown), I investigated whether or not this band was the 
product of a hybrid between spliced and unspliced XBP1, which was resistant to PstI 
digestion. Since DTT induced complete splicing of XBP1 in HeLa cells, I PstI-
digested the RT-PCR products of untreated, DTT-treated and a mixture of untreated 
and DTT-treated RNA (Figure 9B).  
 
The 518+ band was not detectable in either the untreated or DTT-treated samples, 
however, when a mixture of unspliced and spliced XBP1 – from the untreated and 
DTT-treated samples – was analysed, it contained both the 518-nucleotide band – 
representing spliced XBP1 – and the 518+ band (Figure 9B, compare lane 3 with 
lanes 1-2). Thus, the more slowly migrating band in these samples may be a PstI-
resistant hybrid of unspliced and spliced XBP1. This finding is supported by the 
work of Shang and Lehrman who identified a similar hybrid of XBP1, detectable 
with mild stress induction (Shang & Lehrman, 2004). 
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Figure 10. HT1080 cells inefficiently process XBP1 in response to tunicamycin 
treatment. A, HeLa cells were treated with a range of ER stress inducers for either 3 or 6 
hours. RT-PCR for XBP1 and subsequent PstI digestion and clean up was carried out. -
actin was used as a control. B, As in A, but treatments were carried out on HT1080 cells.  
Results Chapter 1  144 
 
In order to determine if the IRE1 branch of the UPR responds to some types of ER 
stress in a shorter time frame, I studied XBP1 splicing in HeLa and HT1080 which 
had been treated with ER stress-inducing agents for 0, 3 and 6 hours. In HeLa cells, 
treatment with DTT, tunicamycin, thapsigargin and A23187 strongly induced XBP1 
splicing after 6 hours treatment, as seen previously (compare Fig. 10A, lanes 8-11 
with Fig. 9A, lanes 2-5). With a shorter treatment of 3 hours, the four stress-inducing 
agents all induced XBP1 splicing, albeit slightly less robustly than with a 6 hour 
treatment. Both mock treatment and growing cells in low glucose medium for either 
3 or 6 hours resulted in no XBP1 splicing in HeLa cells. These results suggest that 
HeLa cells can trigger XBP1 splicing within 3 hours of treatment with the ER stress 
inducers DTT, tunicamycin, thapsigargin and A23187. 
 
In HT1080 cells, a 6 hour treatment with DTT, thapsigargin and A23187 resulted in 
XBP1 splicing similar to that seen previously (compare Fig. 10B, lanes 8, 10-11 with 
Fig. 9A, lanes 8, 10-11). However, in this experiment, tunicamycin treatment for 6 
hours resulted in low levels of XBP1 splicing, consistent with the previous 
experiment (compare Fig. 10B, lane 9 with Fig. 9A, lane 9). The slight difference in 
XBP1 splicing levels in these two experiments is most likely due to variation in cell 
density. A shorter 3 hour treatment of HT1080 cells resulted in robust splicing of 
XBP1 with DTT, thapsigargin and A23187 treatment (Fig. 10B, lanes 2, 4-5). 
Treatment with tunicamycin for 3 hours did not induce XBP1 splicing, indicating that 
the IRE1-mediated response to tunicamycin, in HT1080 cells, does not peak in a 
shorter time frame (Fig. 10B, lane 3).  Unlike HeLa cells, the levels of DTT-, 
thapsigargin- and A23187-induced XBP1 splicing in HT1080, after 3 hours, is very 
similar to that after 6 hours, possibly indicating that the RNase activity of IRE1 is 
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maximal by 3 hours treatment under these experimental conditions. Similar to HeLa 
cells, untreated HT1080 and HT1080 cells exposed to low glucose conditions for 
either 3 or 6 hours did not induce XBP1 splicing.  
 
Since XBP1 splicing has been shown to diminish in HEK 293 cells between four and 
eight hours of continuous treatment with tunicamycin at 5 g/ml (Lin et al., 2007), I 
performed a tunicamycin time-course treatment on both HeLa and HT1080 cells to 
investigate the possibility that tunicamycin-induced XBP1 splicing attenuates more 
quickly in HT1080 cells than in HeLa cells (Fig. 11A). Tunicamycin-induced XBP1 
splicing in HeLa cells is evident at the two hour time point; increasing after 3 hours 
and again with 6 hours treatment (Fig. 11A, lanes 1-5). Accordingly, BiP expression 
in HeLa cells started to increase within two hours of exposure to tunicamycin. XBP1 
splicing in HT1080, on the other hand, was not induced by tunicamycin treatment 
throughout the range of the time-course suggesting that the lack of tunicamycin-
induced XBP1 splicing at the two time points seen previously (6 and 3 hours) was not 
due to rapid attenuation of IRE1-mediated signalling in this case (Fig. 11A, lanes 6-
10). Interestingly, BiP expression in HT1080 remained at levels similar to untreated 
HT1080 throughout the time-course. Since BiP expression can be induced in 
response to ER stress in the absence of IRE1 (Lee et al., 2002), tunicamycin 
treatment should still induce BiP upregulation through ATF6 activation (Lee et al., 
2003). These results suggest that there are differences in the way tunicamycin stress 
is sensed by different cell types. 
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Figure 11. HT1080 cells exposed to tunicamycin do not process XBP1, but 
tunicamycin prevents glycosylation of MHC class I heavy chains. A, HeLa and 
HT1080 cells were treated with tunicamycin (Tm) for the indicated time. XBP1 RT-PCR 
and subsequent PstI digestion was carried out in addition to BiP and -actin RT-PCR. B, 
HeLa and HT1080 cells were treated with tunicamycin (Tm) for 6 hours. Cells were then 
lysed in MNT buffer and HeLa cell lysates were treated or not treated with PNGase. 
Lysates were then subjected to reducing SDS-PAGE and subsequent Western blotting with 
the monoclonal antibody (mAb) HC10. The monomeric MHC class I heavy chains were 
detected in addition to the unglycosylated version (*). The PNGase treated lysate acts as a 
control for complete deglycosylation. 
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To rule out cell-specific permeability to tunicamycin being a factor in diminished 
levels of XBP1 splicing in HT1080, I treated both HeLa and HT1080 cells with 
tunicamycin for 6 hours and analysed the effect on glycosylation. The MHC class I 
heavy chain (cI HC) contains an N-linked glycosylation site with an attached 
oligosaccharide at Asn86 in the 1 domain (Parham et al., 1977; Parham, 1996). 
Analysis of the glycosylation status of the cI HC was carried out by Western blotting 
with the pan-cI HC monoclonal antibody HC10 (Fig. 11B). 6 hour treatment with 
tunicamycin resulted in the appearance of an unglycosylated version of the cI HC in 
both HeLa and HT1080 indicating that tunicamycin is effective in preventing 
glycosylation in both cell lines within the time scale used to detect UPR induction. 
Identification of the unglycosylated version of the cI HC was confirmed by PNGase 
treatment of HeLa cell lysates (Fig. 11B, lane 6). Taken together, these results 
suggest that the level of IRE1-mediated splicing of XBP1 is dependent on the 
duration of cell treatment and that there are cell-specific differences in XBP1 splicing 
in response to exposure to tunicamycin.  
 
4.1.2.3 The downstream UPR target CHOP is differentially induced by distinct ER 
stress inducers  
I have demonstrated that UPR activation – at the level of XBP1 splicing – is 
differentially sensitive to tunicamycin exposure in HeLa and HT1080 cells. IRE1-
mediated XBP1 splicing is an upstream event in UPR signalling. In order to 
investigate the downstream effects of ER stress induction by a range of ER stress 
inducers, the expression of the proapoptotic transcription factor CHOP, which is 
induced downstream of PERK activation, and the expression of the PERK-branch 
specific bZiP transcription factor ATF4, was examined.  
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Figure 12. Expression of CHOP is differentially induced by distinct 
pharmacological agents. A, HeLa and HT1080 cells were treated with the indicated ER 
stress-inducers for 6 hours. A ATF4 and CHOP RT-PCR was carried out on extracted 
mRNA from these treatments. -actin was used as a control. B, HT0180 cells were treated 
with the indicated ER stress inducers for 3 hours. Subsequent CHOP RT-PCR on mRNA 
from these treatments was carried out.  
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HeLa and HT1080 cells were treated for 6 hours with the ER stress inducers DTT, 
tunicamycin, thapsigargin and A23187 as well as being exposed to low glucose 
conditions or untreated. RNA from these cells was subjected to RT-PCR with 
primers against ATF4, CHOP and -actin (Fig. 12A). In HeLa cells, DTT, 
tunicamycin and thapsigargin treatment induced robust expression of ATF4 mRNA, 
with thapsigargin treatment being the most effective (Fig. 12A, lanes 2-4). Levels of 
ATF4 expression after A23187 treatment or exposure to low glucose conditions were 
only slightly elevated over the untreated control (Fig. 12A, lanes 5-6). 
Analysis of CHOP levels in HeLa revealed that upon treatment with DTT, 
tunicamycin, thapsigargin and A23187, CHOP expression was induced. When cells 
were untreated or exposed to low glucose media, CHOP was not expressed, as 
expected. (Fig. 12A, lanes 2-5). In HT1080 cells however, strong induction of CHOP 
occurred when cells were treated with DTT, thapsigargin and A23187 but not mock- 
or low glucose-treated cells.  
 
In HT1080 cells, ATF4 expression was upregulated in response to DTT and mildly 
elevated in response to A23187 treatment and with exposure to low glucose medium. 
This is contrary to HeLa cells which did not upregulate ATF4 in response to A23187 
but did elevate ATF4 levels strongly with thapsigargin treatment (Fig. 10A, compare 
lanes 8-12 with lanes 2-6). ATF4 is primarily regulated at the translational level but 
there is evidence to suggest that ATF4 can be regulated at the transcriptional level 
(Dey et al., 2010). ATF4 protein levels are regulated by eIF2 phosphorylation, 
however, these data indicate that HeLa and HT1080 can regulate ATF4 mRNA levels 
differently in response to the same types of stress. HT1080 cells treated with 
tunicamycin exhibited limited CHOP induction (Fig. 12A, lane 9) indicating that an 
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impaired response to tunicamycin-induced ER stress is not limited to the IRE1 
branch of the UPR but may also involve the PERK branch. Thus, there are 
differences in CHOP induction between HeLa and HT1080 cells in response to 
tunicamycin. 
 
In order to investigate the likelihood that tunicamycin can induce rapid CHOP 
induction which subsided by the 6 hour time point, I analysed CHOP expression in 
HT1080 cells after 3 hours exposure to tunicamycin (Fig 12B). Similar to a 6 hour 
treatment, CHOP expression was extremely low when compared to induction by 
DTT, thapsigargin and A23187 (Fig 12B, compare lane 3 with lanes 2 and 4-5). In 
fact, tunicamycin-induced expression of CHOP was comparable to mock-treated 
samples, indicating that at this 3 hour time point, CHOP induction does not occur in 
response to tunicamycin.  
 
4.1.2.4 ATF6 can form higher order structures which are influenced by DTT and 
tunicamycin treatment 
ATF6 is a membrane-tethered transcription factor which, after proteolytic 
liberation, directly influences transcription without any known downstream effectors. 
To further understand the coordination of the UPR in response to ER stress, I studied 
the mechanisms of activation of ATF6. Since ATF6protein is expressed at low 
levels in HeLa cells (Thuerauf et al., 2002) and due to the fact that I was unable to 
detect p90 ATF6 using our -ATF6 antibody (Fig. 13A and data not shown),  I 
used a liposome-mediated cell transfection approach to introduce a tagged version of 
ATF6 into the cell.  
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Figure 13. ATF6-HA transfection in HeLa cells leads to increased ATF6 
transcript and protein. A, No p90 ATF6 was detected using the ATF6 antibody 
either in the absence or presence of ER stress. The anti-lamin A and C antibody Jol 2 was 
used as a control. B, HeLa cells were subjected to liposome-mediated transfection of HA-
tagged ATF6. mRNA from Mock (-) and ATF6-HA-transfected (ATF6-HA) was 
subjected to ATF6 RT-PCR. -actin was used as a control. C, MNT lysates from ATF6-
HA transfected HeLa cells were analysed by HA, ATF6 and PDI immunoblotting 
after separation by SDS-PAGE. Protein marker sizes are shown on the left of the image. 
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Figure 14. Transfected ATF6-HA localises to the ER. A, Mock and ATF6-HA 
transfected HeLa cells were stained with DAPI and antibodies against the HA tag (HA) 
and ATF6 (ATF6) and then fluorescence-conjugated secondary antibodies. A merge of 
DAPI, HA and ATF6 (panels D and H) show colocalisation. B, ATF6-HA 
transfected HeLa cells were stained with HA and PDI and stained with secondary 
antibodies as in A. The merge in panel D shows colocalisation of HA-tagged ATF6 with 
the ER resident protein PDI. Scale bars are 25 m. 
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HeLa cells were either mock transfected or transfected with an N-terminal HA-
tagged version of full length p90 ATF6 (ATF6-HA) using the transfection reagent 
Lipofectamine 2000. Expression of ATF6 was monitored by RT-PCR using 
primers against ATF6 and revealed that transfection of ATF6-HA resulted in an 
increase in transcript (Fig. 13B, lane 2). 
 
ATF6 protein levels were monitored by SDS-PAGE and Western blotting under 
reducing conditions. The HA tagged ATF6 was detected by the -HA monoclonal 
antibody indicating that transfection had been successful (Fig. 13C, lane 2). This 90 
kD protein migrated more slowly through the gel (between 110-120 kD) because of 
the additional HA tag. The -HA antibody detected background bands present in 
both the mock and transfected lysates of HeLa cells at ~48 kD and ~100 kD. 
Additionally, ATF6-HA was detected using the commercially available -ATF6 
polyclonal antibody.  This antibody was raised against amino acids 31-310 of human 
ATF6 and recognised the tagged version of ATF6 also (Fig. 13C, lane 4). Neither 
the -HA or the -ATF6alpha antibodies detected the p50 fragment of transfected 
ATF6-HA. This is not a surprise because these cells received no exogenous stress 
treatment other than transfection-mediated ER stress. Protein levels were controlled 
for using the polyclonal -PDI antibody (Fig. 13C, lanes 5-6). 
 
Expression of ATF6-HA was further confirmed by immunofluorescence (Fig. 14). 
Mock transfected HeLa cells were negative when probed with both the -HA and the 
-ATF6 primary antibodies and secondary donkey anti-mouse Alexa Fluor 488-
conjugated and swine anti-rabbit TRITC-conjugated antibodies respectively (Fig. 
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14A, panels B-C). Upon transfection of ATF6-HA, both the -HA and -ATF6 
antibodies detected the HA-tagged ATF6. In some experiments, transfection 
efficiency was near 100% as evidenced by the detection of ATF6 in every cell – 
determined by DAPI staining (Fig. 14A, panel H). In order to determine the 
localisation of ATF6-HA, cells were antibody-stained with the -HA and -PDI 
primary antibodies which revealed that ATF6-HA colocalised with the ER resident 
protein PDI indicating that ATF6-HA was present in the ER. This was detected in 
several images taken from two independent staining experiments.  
 
I next studied how ATF6 responded to ER stress treatment in both HeLa and 
HT1080 cells. Once again, ATF6-HA was introduced into cells by transfection 
prior to a 6 hour treatment with the reducing agent, DTT or the glycosylation 
inhibitor, tunicamycin. Lysates were then analysed by reducing and non-reducing 
SDS-PAGE and subsequent Western blotting (Fig. 15). Transfection of ATF6-HA 
was successful in both HeLa and HT1080 cells and ATF6-HA was detected using 
the -HA antibody (Fig. 15A, lanes 2 and 6). Under reducing conditions, full length 
ATF6 was detected after treatment with both DTT and tunicamycin but at lower 
levels than mock-treated cells (Fig. 15A, compare lanes 3-4 with lane 2 and lanes 7-8 
with lane 6). Additionally, treatment with tunicamycin resulted in a shift in migration 
(*) of the full length ATF6-HA protein in both cell lines (Fig. 15A, lanes 4 and 8). 
This shift represents the unglycosylated version of ATF6 and was presumably a 
direct consequence of the action of tunicamycin. ATF6-HA existed in a completely  
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Figure 15. p50 ATF6-HA is not detected upon treatment with DTT or 
tunicamycin but the amount of p90 ATF6-HA is diminished. A, HA 
immunoblot of mock and ATF6-HA transfected HeLa and HT1080 RIPA buffer lysates 
under reducing (R) conditions. Cells were either untreated (-) or treated with DTT or 
tunicamycin (Tm). p90 ATF6 and the unglycosylated form of p90 ATF6 (*) were 
detected. B, Reducing Jol 2 (against lamin A and lamin C) and PDI immunoblots. These 
act as controls for nuclear and ER fraction lysis respectively. 
 
(To be completed)  
A 
C 
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unglycosylated form in both cell lines. This is consistent with data from other groups 
which suggest that p90 ATF6 is rapidly turned over and has a half life of ~2 hours 
(Haze et al., 1999). This data also provides further evidence that tunicamycin is 
efficient in inhibiting glycosylation in both HeLa and HT1080 cells.  
 
In the transfected lysates, even in presence of an ER stress inducer, I was unable to 
detect a p50 fragment representing the liberated transcription factor portion of 
ATF6very minor band at ~70kD was detected in response to DTT treatment in 
HeLa cells transfected with ATF6-HA, which may represent the tagged p50 
fragment (Fig. 15A, lane 3 and unpublished data). Detection of the p50 fragment 
with the -HA antibody should be possible since the HA-tag is located in the 
liberated transcription factor portion of ATF6. Accordingly, the decrease in 
detectable full length p90 ATF6 after DTT and tunicamycin treatment may be an 
indirect indication that ATF6 is being proteolytically cleaved since the -HA 
antibody will not recognise  the C-terminal anchored portion of ATF6. However, a 
decrease in steady-state p90 ATF6 may be attributable to translational attenuation. 
In addition, the lysis buffer used was able to solubilise both the ER and nuclear 
fraction, as indicated by Western blotting for the nuclear lamins A and C using the 
monoclonal antibody Jol 2 in addition to the -PDI control (Fig. 15B).  
 
Our inability to detect the liberated p50 transcription factor portion of ATF6 is not 
without precedence. p50 ATF6 occurs in very low amounts and its appearance is 
thought to be transient since it is likely to be degraded quickly (Yoshida et al., 1998; 
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Haze et al., 1999). Furthermore, detection of p50 using the HA-tagged version of 
ATF6 has proven troublesome to other groups (Li et al., 2000). 
 
Interestingly, analysis of ATF6-HA transfection and DTT/tunicamycin treatment 
by non-reducing SDS-PAGE and -HA immunoblotting revealed higher order 
structures of ATF6. Upon transfection of ATF6-HA in HeLa and HT1080, 
ATF6 could be detected in monomeric, dimeric (~250 kD) and oligomeric (>250 
kD) forms (Fig. 16). In both cases, the majority of ATF6 existed as an oligomer. 
This is consistent with the findings of Nadanaka and colleagues who reported the 
formation of dimeric and oligomeric ATF6 in addition to monomeric ATF6 in 
unstressed cells (Nadanaka et al., 2007). Furthermore, they showed that these higher 
order structures were formed via intermolecular disulfide bridges between two 
conserved cysteines in the lumenal domain of ATF6.  
 
The relative magnitude of forms of ATF6 can be influenced by treatment with the 
ER stress inducers DTT and tunicamycin. Treatment with DTT for 6 hours post-
transfection resulted in the majority of ATF6 existing in monomeric form with 
vastly diminished oligomeric ATF6 in both HeLa and HT1080 (Fig. 16, lanes 3 and 
7). This is not a surprise since the higher order structures of ATF6 are likely to be 
disulfide-linked – as suggested by Nadanaka and colleagues. The addition of a 
reducing agent to the media thus resulted in the reduction of intermolecular 
disulfides in ATF6. In addition, treatment with DTT in both cell lines resulted in a 
decrease in dimeric ATF6, presumably also a consequence of DTT-mediated 
reduction (Fig. 16, lanes 3 and 7).  
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Figure 16. The oligomerisation status of ATF6 is influenced by the ER stress 
inducers DTT and tunicamycin. A non-reducing HA immunoblot of ATF6-HA 
transfected HeLa and HT1080 cells which have been either mock treated (-) or treated 
with DTT or tunicamycin (Tm). p90 ATF6 and the unglycosylated version of p90 
ATF6 (*) are detectable. In addition, higher order dimers and oligomers were also 
detected. 
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Treatment with tunicamycin did not decrease the oligomeric pool of ATF6 as 
significantly as DTT but overall, the oligomeric as well as the dimeric form of 
ATF6 was diminished in comparison to the untreated cells (Fig. 16, compare lanes 
4 and 8 with lanes 2 and 6). The monomeric pool of ATF6 was also diminished in 
response to tunicamycin treatment. Reduction of ATF6 upon treatment with 
tunicamycin is unlikely to be a direct consequence of tunicamycin activity. Rather, as 
suggested by Nadanaka and colleagues, reduction may be carried out by one of the 
many ER-localised oxidoreductases (Nadanaka et al., 2007). ATF6 oligomerisation 
in response to tunicamycin was similar in both HeLa and HT1080 cells, indicating 
that the drug had a similar effect on this aspect of the UPR. Thus, both DTT and 
tunicamycin can influence the redox status of higher order structures of ATF6. 
These forms of ATF6, therefore, may be differentially sensitive to different forms 
of ER stress and add an extra layer of regulation to the activation of the ATF6 branch 
of the UPR.    
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4.1.3 Discussion 
The UPR works to either promote the survival of cells undergoing ER stress, or, if 
subjected to prolonged stress, facilitate apoptosis. In order to understand how the 
UPR arrives at these ‘decisions’, we must first understand how the UPR coordinates 
its distinct pathways in response to ER stress and how those pathways are regulated. 
Here, I provide evidence that cell types respond in different ways to distinct forms of 
ER stress but also that these responses vary between cell lines. I report that, despite 
initiating a robust stress response to other forms of pharmacologically-induced ER 
stress such as thapsigargin and A23187, HT1080 does not respond as strongly to 
tunicamycin-induced ER stress. Treatment of HT1080 cells with the glycosylation 
inhibitor tunicamycin only weakly promoted the splicing of XBP1, a key step in the 
IRE1 branch of the UPR (Fig. 9A and 10B). This was in contrast to HeLa cells where 
tunicamycin-induced XBP1 splicing was strong.  
 
Additionally, CHOP expression was not induced in tunicamycin-treated HT1080 
cells (Fig. 12A and 12B). Again, this was in contrast to HeLa cells where CHOP 
expression was strongly induced upon tunicamycin treatment. Moreover, CHOP was 
strongly induced upon treatment with DTT, thapsigargin and A23187 in both HeLa 
and HT1080 cells in line with studies showing that CHOP is induced by a variety of 
ER stress inducers (Price & Calderwood, 1992; Carlson et al., 1993; Halleck et al., 
1997). In HT1080 cells a 3 hour treatment with the stress inducers DTT, thapsigargin 
and A23187 resulted in robust CHOP induction demonstrating that both CHOP 
induction and XBP1 splicing occur with a 3 hour treatment under our experimental 
conditions. Limited induction of CHOP in response to tunicamycin may indicate that 
the PERK branch of the UPR is not activated. Further experiments, such as analysis 
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of eIF2 phosphorylation or ATF4 protein levels, will help determine if HT1080 
cells are activating the PERK branch of the UPR in response to tunicamycin. 
However, low levels of tunicamycin-induced CHOP is not necessarily evidence of a 
lack of PERK signalling since the IRE1 branch of the UPR has been implicated in 
CHOP induction (Wang et al., 1998). The mechanism by which IRE1 mediates 
CHOP expression is currently unknown although it has been postulated that 
downstream signalling of IRE1 may lead to modifications in the ER function which 
might impact on CHOP expression (Wang et al., 1998). However, XBP1 is 
dispensable for CHOP expression, implying that IRE1 may contribute to CHOP 
induction via a mechanism other than XBP1 (Lee et al., 2003). ATF6 is also thought 
to have a role in CHOP induction since a dominant negative of ATF6 blocks the 
induction of CHOP by ER stress (Yoshida et al., 2000). The regulation of CHOP is 
illustrated in Figure 17. 
 
The consequences of limited CHOP induction in HT1080 cells will be explored 
further in chapter 4.3; however, since CHOP is regarded as a proapoptotic 
component of the UPR, inhibition of CHOP induction could be associated with 
increased survival. Moreover, deletion of CHOP protects cells from the lethal 
consequences of ER stress (Zinszner et al., 1998; Oyadomari et al., 2002b; Pennuto 
et al., 2008) indicating that the regulation of CHOP expression may directly 
influence cell fate decisions. Taken together, these results show that HeLa and 
HT1080 cells respond to tunicamycin-induced ER stress in different ways despite 
responding similarly to other forms of ER stress. 
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Figure 17. The regulation of CHOP expression. ER stress results in PERK activation 
by titration of BiP from its lumenal domain. As a consequence, eIF2, which promotes 
protein translation, is inhibited via phosphorylation by PERK. This then prevents eIF2 
inhibition of ATF4 translation, allowing the translation of ATF4 and other mRNAs 
containing multiple upstream open reading frames (ORFs). ATF4 then moves to the nucleus 
to upregulate target genes such as CHOP, GADD34 and ATF3. Since the induction of 
CHOP was limited in tunicamycin-treated HT1080 cells, it is possible that PERK, or events 
downstream of PERK, are not activated. Furthermore, since IRE1 has been implicated in 
CHOP activation, limited CHOP induction could be a consequence of a lack of IRE1 
signalling, as evidenced by low levels of XBP1 splicing.  
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Initially, it was thought that tunicamycin was not entering HT1080 cells as efficiently 
as HeLa cells. However, Western blotting for the glycoproteins MHC class I heavy 
chain and ATF6 post-tunicamycin treatment revealed that the inhibition of 
glycosylation was comparable in both cell lines (Fig. 11B and 15A). The possibility 
exists that HT1080 cells may have a slightly higher concentration of GlcNAc-1-P 
transferase and treatment with tunicamycin at the concentration used might not 
inhibit the whole pool of the enzyme. However, this is unlikely since short-lived p90 
ATF6 is completely unglycosylated after 6 hours tunicamycin treatment in HT1080 
cells (Fig. 15A). If tunicamycin was not in excess, one would expect – in a protein 
with high turnover such as ATF6 – both a glycosylated and unglycosylated pool of 
p90 ATF6.  
 
Despite limited activation of the IRE1 and PERK branches of the UPR – inferred 
from XBP1 splicing and CHOP induction – in tunicamycin-treated HT1080 cells, 
BiP expression was upregulated in response to this treatment (Fig. 7). However, BiP 
expression may not directly equate to an increase in BiP protein level and will, 
therefore, require further investigation. Despite this, it is possible that BiP mRNA 
upregulation in this case is mediated though ATF6. I was unable to detect 
activation of ATF6 in response to DTT and tunicamycin; most likely due to the 
transience and low abundance of p50 ATF6 (Yoshida et al., 1998; Haze et al., 
1999). However, I did note that detection of the reduced form of HA-tagged ATF6, 
using the -HA monoclonal antibody, was diminished upon treatment with DTT and 
tunicamycin (Fig. 15A). Since the -HA antibody does not recognise the remaining 
C-terminal product after proteolysis, the lower ATF6 levels in these treatments 
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might be attributed to the loss of full length p90 ATF6, possibly due to proteolytic 
cleavage.  
 
I also demonstrate that ATF6 forms higher order structures when overexpressed in 
unstressed cells (Fig. 14). Nadanaka and colleagues reported this phenomenon in 
Chinese hamster ovary (CHO) cells and I now report similar findings in both HeLa 
and HT1080 cells. Nadanaka and colleagues showed that dimeric and oligomeric 
disulfide bonded- ATF6 is reduced in response to ER stress. Our data also supports 
this finding. Nadanaka and colleagues reported a decrease in monomeric p90 ATF6 
after treatment with DTT, tunicamycin and thapsigargin. This is correlated with the 
appearance of p50 ATF6, supporting our theory that a diminished p90 ATF6 
levels after treatment might be the consequence of proteolytic cleavage. In line with 
this finding, I report diminished monomeric p90 ATF6 in our non-reducing gel 
upon DTT, and especially, tunicamycin treatment. Since monomeric ATF6 was 
detected in the Golgi upon ER stress and the reduced monomer is a better substrate 
for site 1-protease activity, it has been suggested that reduction of ATF6 is 
necessary for Golgi localisation and efficient cleavage (Nadanaka et al., 2007). 
However, reduction of ATF6 is not sufficient for activation since it has been shown 
by Nadanaka and colleagues that BiP binding retains ATF6 in the ER. 
 
Together, these results demonstrate that there are intrinsic differences in way the 
UPR responds to distinct forms of ER stress. Regulation at the level of transcription 
is one way the cell differentiates between different forms of ER stress. This may 
have implications for inflammatory diseases such as ankylosing spondylitis, since in 
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this disease, only certain cell types exhibit a UPR. Additionally, the regulation of 
higher order structures of ATF6 may play a role in differentiating between different 
forms of ER stress. Both IRE1 and PERK have been reported to oligomerise to 
regulate their function (Bertolotti et al., 2000; Korennykh et al., 2009). However, 
ATF6 appears to deoligomerise in response to ER stress whereas both IRE1 and 
PERK oligomerise demonstrating another difference in the way the separate 
branches of the UPR are regulated.  
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4. 2 HLA-B27 misfolding and the unfolded protein response 
 
4.2.1 Introduction 
Tuner and colleagues’ key paper in 2005 provided the first evidence that HLA-B27 
misfolding is associated with UPR activation in bone marrow-derived cells from the 
B27/h2m transgenic rat (Turner et al., 2005). Differential expression of BiP and 
CHOP was not observed in whole spleen or thymus, or in bone marrow macrophages 
from 4-wk-old premorbid animals. However, transcripts for both BiP and CHOP were 
elevated in bone marrow macrophages from 10-wk-old B27/h2m transgenic rats 
exhibiting inflammatory disease. Furthermore, XBP1 splicing, a key step in the IRE1-
mediated branch of the UPR, was increased by ~5 fold and relative expression of 
XBP1 was increased by ~2.6 fold in 10-wk-old B27/h2m transgenic rats. Thus, B27 
misfolding, determined by SDS-PAGE using the HC10 antibody which recognises 
free class I heavy chains, is associated with the increase transcription of UPR target 
genes as well as an increase in proximal UPR signalling events. This was further 
supported by microarray data which showed that bone marrow macrophages from the 
transgenic rat exhibited a ‘UPR signature’ as determined by treatment with 
tunicamycin (Turner et al., 2005). Furthermore, expression of BiP, CHOP, XBP1 and 
XBP1 splicing increase when bone marrow macrophages from B27-expressing 4-wk-
old premorbid rat cells are exposed to IFN-. This is likely to be due to the ~3 fold 
increase in HLA-B27 transcript levels since IFN- treatment of wild-type cells does 
not alter BiP, CHOP, XBP1 expression or XBP1 splicing.  
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In addition, this study confirmed the increased expression of IFN- in the colon of the 
transgenic rat which had been suggested previously (Taurog et al., 1999). Moreover, 
increased expression of IFN- is associated with increased expression of BiP and 
CHOP in the distal colon of the B27/h2m transgenic rat. However, differences in BiP 
and CHOP expression in transgenic and wild-type tissue were less pronounced than 
the same comparison in macrophages, indicating that high levels of UPR activity 
might be limited to cells with high heavy chain expression. Recently, defects in XBP1 
have been linked with inflammation of intestinal epithelium in mice (Kaser et al., 
2008). Deficiency in XBP1 induces ER stress and this led to a heightened 
proinflammatory response of the epithelium to known inducers of IBD. Furthermore, 
increased BiP expression has recently been documented in IBD patients suggesting 
that ER stress – and associated UPR activity – might be an integral component of gut 
inflammation (Shkoda et al., 2008; Heazlewood et al., 2008). However, the 
contribution of the UPR to gut inflammation requires further study. 
 
Recently, the IL-17-producting subset of T-cells, the Th17 cells, have been implicated 
in a number of autoimmune diseases including SpA. Polymorphisms in the IL-23 
receptor, typical expressed on Th17 cells, have been associated with the development 
of AS and IBD (Duerr et al., 2006; WTCC, 2007; Rahman et al., 2008; Rueda et al., 
2008). The mechanism by which HLA-B27 misfolding and UPR induction are linked 
to IL-23 induction was demonstrated recently (DeLay et al., 2009). This study, using 
B27/h2m transgenic rats, revealed that IL-23 was synergistically upregulated by LPS 
in macrophages undergoing a UPR induced by either pharmacological agents or by 
HLA-B27 misfolding. This study also verified that IL-23 levels were also elevated in 
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the colon of B27/h2m transgenic rats exhibiting gut inflammation, further supporting 
the finding that IL-23R polymorphisms are associated with IBD development. It has 
been suggested that in the gut, low level immune responses to bacterial colonisation 
might result in increased levels of type I and/or type II interferons leading to 
upregulation in MHC class I heavy chain expression – and so in HLA-B27-expressing 
cells, activation of the UPR. Macrophages would then become sensitised to TLR 
agonists, such as LPS, pushing them towards increased production of IL-23 and IFN-
. IL-23 would then drive IL-17 production through committed Th17 cells (Colbert et 
al., 2009). Whether or not the Th17 lineage of T-cells is important for the arthritic 
phenotype in transgenic rats or indeed in human SpA patients will require further 
work. 
 
Taken together, recently published results demonstrate the importance of HLA-B27 
heavy misfolding in UPR induction and the possible influence that ER stress and UPR 
induction might have on driving inflammatory disease in animal models of AS. 
Despite this, the level of UPR induction and UPR target gene activation in cells 
expressing misfolded B27 heavy chains is still not fully understood. Thus, the aim of 
this chapter is to move towards a better understanding of the contribution of B27 
misfolding/misoxidation in UPR induction, to help understand the influence of heavy 
chain homodimer formation in inflammation and identify targets for therapy. 
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4.2.2 Results 
 
4.2.2.1 Transient transfection of HLA-B7 and HLA-B27 into HeLa and HT1080 cells 
causes misoxidation of MHC class I heavy chains 
In order to study the effect of HLA-B27 misoxidation in HeLa and HT1080 cells, I 
transiently transfected HLA-B7 – a class I heavy chain similar to HLA-B27 (Fig. 18) 
but not associated with AS – or the HLA-B27 MHC class I heavy chain into these 
adherent cell lines. Transfected cells were lysed in the presence of the alkylating agent 
NEM (to trap any free disulfides and prevent post-lysis disulfide bond formation) and 
analysed by SDS-PAGE. Immunoblotting with the pan-class I monoclonal antibody 
HC10 revealed that both untransfected HeLa and HT1080 cells endogenously express 
MHC class I heavy chains (Fig. 19A, lanes 1 and 4). Under non-reducing conditions, 
these heavy chains exist as monomers representing free heavy chains (Fig. 19A, lanes 
7 and 10). In transfected cells, the expression of MHC class I molecules increased, as 
expected (Fig. 19A, lanes 2-3 and 5-6). 
  
Under non-reducing conditions, both HLA-B7 and HLA-B27 were resolved as a 
ladder of high molecular weight complexes in addition to the monomeric class I heavy 
chain (cI HC) (Fig. 19A, lanes 8-9 and 11-12). The ladder of bands seen as a 
consequence of HLA-B7 transfection was similar in both HeLa and HT1080 but 
dissimilar to that of HLA-B27 (Fig. 19A, compare lanes 8 and 11 with lanes 9 and 
12). Likewise, transient transfection of HLA-B27 led to a similar make-up of high 
molecular weight complexes in HeLa and HT1080 cells. 
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Figure 18. Protein sequence alignment of HLA-B7 and HLA-B27. The amino 
acid sequence of the HLA-B7 and HLA-B27 heavy chain after removal of the 24-amino 
acid signal peptide. Cysteine residues are highlighted in red. Note the additional cysteine 
residue at position 67. The transmembrane region is highlighted in blue. 
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Figure 19. Transient transfection of HLA-B7 and HLA-B27 causes 
misoxidation in HeLa and HT1080 cells which is accompanied by an increase 
in BiP expression. A, HeLa and HT1080 cells were either mock (-) or HLA-B7- or 
HLA-B27-transfected using the transfection reagent Fugene. Lysates were separated by 
reducing (R) and non-reducing (NR) SDS-PAGE and immunoblotted with HC10. B, An 
HC10 non-reducing blot of HeLa cells transfected with either 1 g or 2.1 g HLA-B7 or 
HLA-B27 DNA. C, As in A, but the lysates were separated by non-reducing (NR) SDS-
PAGE and immunoblotted with anti-BiP antibody H-129 (BiP).  
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In HeLa cells, the formation of high molecular weight complexes did not depend on 
the amount of DNA transfected, since increasing the plasmid concentration to 2.1 
g/dish resulted in a very similar distribution of heavy chain complexes in a non-
reducing blot (Fig. 19B). 
 
Upon the reduction of these samples with DTT, the majority of the high molecular 
weight complexes, observed in the non-reduced samples, resolved as a monomer (Fig. 
19A, compare lanes 2-3 and 5-6 with lanes 8-9 and 11-12). Thus, transient 
transfection of HLA-B7 and HLA-B27 induced the disulfide dependent 
intermolecular misoxidation of MHC class I heavy chains in both HeLa and HT1080 
cells. Misoxidation of cI HC was most likely due to overexpression in the absence of 
sufficient 2m. This is consistent with other published work from our group which has 
shown that overexpression of wild-type and cysteine mutant forms of HLA-B*2705 in 
HeLa cells causes misoxidation of heavy chains and the formation of disulfide-
dependent high molecular weight complexes (Saleki et al., 2006). 
 
HC10-reactive and DTT-resistant bands were resolved at ~90-150 kD in the reducing 
gel of HLA-B7- and HLA-B27-transfected HeLa and HT1080 cells (Fig. 19A, lanes 
2-3 and 5-6). These samples were boiled prior to loading and could either be heavy 
chain dimers that are resistant to reduction by DTT or a non-covalent interaction with 
the ER chaperone BiP which remains stable under reducing conditions (Saleki et al., 
2006). Equally, the bands could be a combination of these two phenomena. The 
appearance of these bands was reproducible but varied between experiments. Since 
BiP has been shown to associate with HLA-B27 when overexpressed (Saleki et al., 
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2006), I immunoblotted the same lysates with the anti-BiP antibody H-129 under non-
reducing conditions (Fig. 19C). BiP was resolved as a monomer at 78 kD but could 
not be detected at higher molecular weights in our experiments. The boiling- and 
DTT-resistant high molecular weight complexes observed in the reducing gel in 
Figure 19A did not correspond to either the molecular weight of BiP (78 kD) or the 
combined molecular weight of BiP and the cI heavy chain together, further indicating 
that these bands might not be BiP-cI HC conjugates. Mass spectrometric analysis of 
HLA-B7 and HLA-B27 co-associating proteins in these lysates is needed to verify the 
identity of components of the high molecular weight complexes.  
 
The number and size of the HC complexes were dependent upon the heavy chain. 
HLA-B7 expression led to the formation of three distinct boiling- and DTT-resistant 
distinct bands while expression of HLA-B27 only led to the formation of one high 
molecular weight band (Fig. 19A, lanes 2-3 and 5-6). Interaction of cI HCs with ER-
resident proteins and peptide loading complex components has been shown to be 
dependent on the 116 residue (Turnquist et al., 2000). Turnquist and colleagues 
showed that TAP interactions – as well as tapasin and calreticulin interactions – were 
improved in the HLA-B7 (Y116D) mutant over wild-type HLA-B7. Furthermore, 
natural subtypes of HLA-B15, which differ in residue identity at position 116, also 
showed disparity in ER-resident protein-interaction. Given that HLA-B7 possesses an 
tyrosine residue and HLA-B27 possesses an aspartic acid residue at position 116, the 
differences in the DTT-resistant band make-up between HLA-B7 and HLA-B27 may 
be, in part, due to the amino acid at this position. 
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It has also been reported that polymorphisms at position 116 in HLA-B27 influence 
conformational homodimer formation (Blanco-Gelaz et al., 2009). Thus, the 
differences in high molecular weight complexes between HLA-B7 and HLA-B27 
seen in the non-reducing blot in Figure 19A might be attributed to the sequence 
differences at this residue between the two molecules. 
 
The transient expression of both HLA-B7 and HLA-B27 in HeLa and HT1080 cells 
increased protein levels of BiP (Fig. 19C). It must be noted, however, that this 
experiment did not have a loading control. Since misoxidation of cI HC is likely to 
have an impact on ER homeostasis, an increase in BiP expression may be attributed to 
the activation of the UPR.  
 
4.2.2.2 Misoxidation of HLA-B7 and HLA-B27 upregulates BiP and induces XBP1 
splicing 
In order to verify the effect of HLA-B7 and HLA-B27 misoxidation on BiP 
expression, and to further study the effect of HC misoxidation on the UPR, I used RT-
PCR to examine both BiP mRNA levels and the splicing of constitutively-expressed 
XBP1 (Fig. 20). RNA was extracted from cells transfected with HLA-B7 or HLA-B27 
and was subjected to RT-PCR using primers against XBP1, BiP and -actin. The 
XBP1 RT-PCR product was digested to differentiate between the spliced and 
unspliced version (See Results Chapter 4.1). Transient transfection of both HLA-B7 
and HLA-B27 induced splicing of XBP1 whereas mock transfection did not induce 
XBP1 splicing. This occurred in both HeLa and HT1080 cells (Fig. 20, compare lanes 
2-3 with lane 1 and lanes 5-6 with lane 4). There was no apparent difference in the 
Results Chapter 2  175 
 
level of XBP1 splicing. Additionally, at the mRNA level, BiP expression was 
upregulated as a consequence of HLA-B7 and HLA-B27 transfection (Fig. 20). This 
supports the data in Figure 19C which shows upregulation of BiP in response to HLA-
B transfection at the protein level. HC misoxidation-induced XBP1 splicing was not as 
much as that induced by DTT treatment of HeLa and HT1080 cells (Fig. 20, compare 
B with A), however, induction of BiP expression was robust when compared to that 
induced by DTT. Thus, misoxidation of MHC class I heavy chains triggers XBP1 
splicing and BiP upregulation in HeLa and HT1080 cells.    
 
When CHOP expression was analysed in HLA-B27-transfected HT1080 cells – which 
trigger XBP1 splicing and upregulate BiP – it was found that CHOP was not induced 
(Fig. 20C, lane 3). DTT treatment of these cells, however, initiated CHOP expression, 
demonstrating that HT1080 cells were capable of inducing CHOP upon ER stress. 
Consequently, while HC induced-misoxidation was able to trigger processing of 
XBP1 and BiP upregulation, it was unable to promote the expression of the apoptotic 
transcription factor CHOP which may have consequences for cell survival. 
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Figure 20. Misoxidation of HLA-B7 and HLA-B27 upregulates BiP and 
induces XBP1 splicing. A, mRNA from mock (-), HLA-B7 and HLA-B27 transfected 
HeLa and HT1080 cells were subjected to RT-PCR for XBP1, BiP and -actin. The 
XBP1 product was digested with PstI and run on a 2% agarose gel to differentiate 
between the spliced (S) and unspliced (U) forms. B, As in A but cells were either mock 
treated (-) or treated with dithiothreitol (DTT) for 6 hours prior to lysis. 
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4.2.2.3 Rapamycin treatment of HLA-B27-expressing cells 
One of the mechanisms the cell uses to degrade ER protein is autophagy. This is a 
catabolic process which degrades and recycles cytosolic or aggregated proteins and 
cellular organelles by delivering them to an autolysosome. Recently, autophagy has 
been shown to have a role in ER protein quality control and DTT and tunicamycin 
have can effectively induce autophagy via Atg1 kinase activity (Berger et al., 2006; 
Kruse et al., 2006; Kamimoto et al., 2006; Yorimitsu et al., 2006; Fujita et al., 2007; 
Ishida et al., 2009). Ishida and colleagues showed that the cell initiates autophagic 
mechanisms in response to the accumulation of cytotoxic aggregates of procollagen 
and that autophagy confers a cytoprotective role on these cells (Ishida et al., 2009). 
The clearance of protein aggregates from the ER has implications for ER homeostasis 
and consequently, cell survival. The role of autophagy is therefore relevant to our 
understanding of diseases which have components of aberrant protein formation in the 
ER. I was therefore interested in the role of autophagy in cI HC misoxidation and the 
consequences of autophagy for the UPR. 
 
The lipophilic antibiotic rapamycin induces autophagy by inhibiting the mammalian 
target of rapamycin (mTOR). Rapamycin binds to the intracellular receptor FK506 
binding protein (FKBP12), forming a rapamycin-FKBP12 complex which binds 
directly to mTOR, a protein kinase involved in regulating the cell cycle (Heitman et 
al., 1991; Lorenz & Heitman, 1995). In yeast, mTOR inhibition by rapamycin leads to 
Atg1 kinase activity which leads to the recruitment of multiple Atg proteins and the 
initiation of autophagosome formation (Cheong et al., 2008; Kawamata et al., 2008). 
Rapamycin treatment has been widely used to induce macroautophagy and, more 
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recently, to counter aggregate formation (Ravikumar et al., 2002; Berger et al., 2006; 
Ishida et al., 2009). 
 
Initially, HeLa cells were transfected with or without the cI HC HLA-B27. Six hours 
prior to lysis, cells were either treated or non-treated with rapamycin at 10 g/ml – the 
concentration used by Ishida and colleagues – for 6 hours. Cells were then lysed and 
analysed either by SDS-PAGE and Western blotting or by RT-PCR (Fig. 21). 
Transfection with HLA-B27 was successful since a ladder of misoxidised heavy 
chains was detected after transfection in HeLa cells (Fig. 21, lanes 3-4). This is 
consistent with previous observations (Fig. 19A). Treatment of non-transfected as 
well as HLA-B27-transfected cells had no effect on the detectable level of heavy 
chain monomers. The ladder of misoxidised, high-molecular weight aggregates of 
HLA-B27 heavy chains was not affected by rapamycin treatment (Fig. 21, compare 
lane 4 with lane 3). It could be that the concentration of rapamycin, despite being 
sufficient for aggregate removal in mouse embryonic fibroblast cells, is not high 
enough to promote autophagy in HeLa cells. Alternatively, it may indicate that 
autophagy doesn’t promote removal of disulfide bonded HC complexes in HeLa cells. 
Further experiments are required to address this issue. 
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Figure 21. The effect of rapamycin on misoxidised MHC cI heavy chains. A, 
HeLa cells were either non-transfected (mock) or transfected with HLA-B27. Six hours 
prior to lysis, cells were treated with 10 g/ml rapamycin to induce autophagy. Cells were 
lysed and analysed under non-reducing (NR) and reducing (R) conditions with the pan 
class-I HC antibody HC10.  
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4.2.2.4 XBP1 processing in HLA-B27 stable transfectants 
Since overexpression of non-disease associated MHC cI heavy chains by transient 
transfection leads to different misoxidation patterns (Fig. 19A), it is likely that a high 
expression level of heavy chains in the absence of 2-microglobulin is not solely 
responsible for oxidative misfolding. Therefore, I asked whether cells that were stably 
transfected with MHC class I heavy chains activated a UPR and if mutations thought 
to improve the folding kinetics of HLA-B27 had an effect on UPR induction.Fussell 
and colleagues recently showed that a single amino acid substitution in HLA-B27 led 
to an increase in resistance to DTT-induced reduction of HC monomers (Fussell et al., 
2008). In their experiment, C58 rat thymoma cells were stably transfected with a 
mutant form of HLA-B27 containing an amino acid substitution of Asp for His at 
position 114. This B27.H114D mutant was more susceptible to reduction by the 
reducing agent DTT.  
 
Susceptibility to reduction is dependent on cysteine residue exposure. Therefore, 
forms of HLA-B27 that are resistant to reduction exist as fully folded, compact class I 
molecules with their cysteine residues buried. On the other hand, forms of HLA-B27 
which are sensitive to reduction are poorly folded. Conformations with exposed 
cysteines could result from low-affinity peptide binding or slow folding kinetics 
(Williams et al., 2002; Antoniou et al., 2004). Thus, mutating a key structural residue 
in the F-pocket (p114) of the peptide-binding groove – which determines the 
requirement for the accessory molecules tapasin – can result in an improvement in 
folding and can lead to a more compact heavy chain, as indicated by resistance to 
reduction (Williams et al., 2002; Antoniou et al., 2004). Thus, in addition to 
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monitoring XBP1 processing in HLA-B27 stable transfectants, I wished to examine 
the effect of improved folding of the B27.H114D.D116Y mutant over wild-type B27.  
 
C58 cells stably expressing HLA-A*0210, HLA-B*2705 and HLA-
B*2705.H114D.D116Y were given as a gift from Antony Antoniou. The cells were 
cultured in medium containing 1 mg/ml G418 to maintain the resistant cells. Cells 
were either non-treated or treated with DTT or tunicamycin then lysed and RNA-
extracted before undergoing RT-PCR analysis for XBP1 splicing and -actin levels as 
a control (Fig. 22). Untransfected C58 cells exhibited negligible levels of XBP1 
splicing without ER stress inducer-treatment (Fig. 22, lane 1). Untreated C58.A2, 
C58.B27 and C58.B27.H114D.D116Y cells also exhibited low levels of XBP1 
splicing. Thus, stable transfection of MHC cI heavy chains in C58 cells did not induce 
splicing of XBP1. The H114D.D116Y mutation did not cause an HLA-B27 induction 
of XBP1 splicing under these experimental conditions. Each cell line responded to 
DTT and tunicamycin indicating that these cell lines are capable of initiating XBP1 
splicing in response to ER stress. However, transfection of A2, B27 and 
B27.H114D.D116Y all caused an increase in the ratio of spliced:non spliced XBP1 in 
response to tunicamycin when compared to the untransfected C58 cells. (Fig. 22, 
compare XBP1 (S):XBP1 (U) in lanes 6,9,12 with lane 3). Thus, tunicamycin did not 
have as strong an effect in C58 cells which have been subjected to stable transfection 
with MHC class I heavy chains compared to untransfected C58 cells. This may 
suggest that chronic overexpression of MHC class I molecules “pre-sensitises” cells to 
some secondary stress events. 
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Figure 22. XBP1 processing in C58 stable transfectants. Stable transfectants were 
maintained in RPMI at 10% FCS with 1 mg/ml G418. Lysates of each cell line were 
subjected to RNA extraction and subsequent RT-PCR analysis for XBP1 and -actin. 
Samples were then run on a 1 or 2% agarose gel. 
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4.2.2.5 Lymphocytes from SpA patients exhibit HLA-B27 misoxidation 
Analysis of cells from patients suffering from AS gives us an insight into the 
physiological condition of cells involved in disease. Oxidative misfolding has been 
demonstrated in splenocytes from HLA-B27/h2-microglobulin transgenic (B27-Tg) 
rats, which spontaneously develop an inflammatory disease similar to human AS 
(Turner et al., 2005). HLA-B27 heavy chains from these cells formed disulfide-linked 
complexes in the ER, with prolonged BiP binding and inefficient folding.  
 
I received a selection of immortalised lymphocytes taken from spondyloarthropathy 
patients expressing the HLA-B27 allele as well as healthy controls (kind gift from J. 
Goodall, Cambridge). To ask whether these immune cells also exhibited oxidative 
misfolding, I analysed the lysates from these cell populations by Western blotting.  
 
Alkylated proteins from lysates were separated by SDS-PAGE under reducing and 
non-reducing conditions to disrupt or preserve any disulfide-linked complexes. Heavy 
chains were detected using the monoclonal antibody HC10 (Fig. 23). Under reducing 
conditions, cI HCs from a healthy individual not expressing HLA-B27 migrated as a 
single band (Fig. 23, lane 5). HLA-B27-positive lymphocytes from reactive and 
psoriatic arthritis patients exhibited stronger and more diffuse HC bands, which may 
be due to higher MHC class I expression. An additional faster-migrating band below 
is likely to represent the unglycosylated form of the HC (Fig. 23, lanes 7-8).  
 
Analysis of the non-reducing gel revealed that HLA-B27-negative lymphocytes from 
a healthy individual migrated as a single monomeric HC. In contrast, a healthy 
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individual possessing the HLA-B27 allele exhibited a high molecular weight complex 
in addition to the monomeric form of HC. It is likely that this is a disulfide-linked 
complex since reduction of this sample disrupted the slower-migrating band.  
 
The HCs of HLA-B27-positive patients presenting disease also exhibited disulfide-
linked complexes (Fig. 23, lanes 3-4) unlike the HCs in the HLA-B27 negative cell 
line (Fig. 23, lane 1) and the HCs in untransfected HT1080 and HeLa cells (Fig 19A). 
Thus, in these individuals, possession of the HLA-B27 allele is associated with MHC 
class I “misoxidation”. However, whether MHC class I molecules in these cells are 
truly misfolded requires further investigation. Rather more dimers were detected in 
the diseased patients (Fig. 23, lanes 3 and 4), although the presence of HC dimers in 
the healthy patient suggests that dimers per se are not a causal link with AS. However, 
it remains possible that the dimers are not B27-B27 homodimers, or that dimers are a 
precursor of disease, with other events being required for disease to occur. These 
samples only represent a population of cells from an individual and there is likely to 
be variation in HC oxidation dependent on cell type, HLA-B27 subtype and severity 
of disease. However, these data indicate that B27 misoxidation can occur in cells from 
a variety of genetic backgrounds. 
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Figure 23. HLA-B27 misfolding in AS patient lymphocytes.  Immortalised 
lymphocytes were lysed and analysed under non-reducing (NR) and  reducing (R) conditions 
and subjected to Western blotting with HC10. HLA-B27-positive (+) and negative (-) cells are 
indicated. A population of unglycosylated cI HCs are also indicated (*).  
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4.2.3 Discussion 
High expression levels of HLA-B27 influence disease susceptibility in the B27-Tg rat 
(Taurog et al., 1993). However, the transgene copy number and expression level of 
the HLA-B7/h2-microglobulin transgenic rat – which does not develop disease – is 
similar to that of the B27-Tg rat, indicating that a disease phenotype is not simply an 
artefact of high HLA-B expression but represents an HLA-B27-specific effect 
(Hammer et al., 1990; Taurog et al., 1999).  
 
Previously, in work which led to the completion of my Masters thesis, I showed that 
HLA-B27 misoxidises when transfected into HeLa cells (Lemin, A. J. MSc Thesis 
2007). Here, I provide evidence that overexpression of HLA-B27 and the non-disease 
associated HC HLA-B7 by transient transfection in HeLa and HT1080 cells is 
sufficient to induce oxidative misfolding (Fig. 19A). Transient transfection of HLA-B 
heavy chains may therefore be a useful model for analysing how misfolded membrane 
proteins in general are handled by the ERAD and UPR systems. A model for how the 
cell might respond to heavy chain misfolding is proposed in Figure 24. This illustrates 
the interplay between ERAD, the peptide loading complex and the UPR in HC 
misfolding. HLA-B27 misoxidation in the B27-Tg rat has been linked with activation 
of the UPR (Turner et al., 2005; Turner et al., 2007). I studied the IRE1-mediated 
splicing of XBP1 – a key step in the IRE1 branch of the UPR – in cells exhibiting 
misoxidation of cI HCs to determine if HC misoxidation is correlated with UPR          
f 
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Figure 24. The consequences of heavy chain misfolding for the ER. Newly 
synthesised MHC class I heavy chains (cI HC) enter the ER and are bound by the ER 
chaperone BiP (1.). In order to reach a fully formed state, the heavy chain must bind the ER 
lectin calnexin (not shown) and enter into the peptide loading complex (PLC) where it will 
acquire peptide and 2-microglobulin. Alternatively, HCs terminally bound by BiP may be 
actively removed by ER-associated degradation. If misfolded HCs are not removed by ERAD 
they may form HC dimers or oligomers which accumulate in the ER. One of the responses to 
the accumulation of misfolded HCs is the release of BiP by IRE1 – which binds HCs to 
prevent aggregation (2.). This in turn causes activation of the RNase activity of IRE1 which 
results in the splicing of full length XBP1 (XBP1 (S)) (3.). XBP1 then enters the nucleus and 
recognises specific promoter elements upregulating target genes, such as BiP, in order to 
combat HC accumulation. TAP = Transporter associated with antigen processing. UPRE = 
Unfolded protein response element. ERSE = ER stress response element.  
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induction. I demonstrate that cells transiently transfected with both HLA-B27 and 
HLA-B7 exhibit moderate XBP1 splicing and increased transcript levels of BiP as 
well as an increase in BiP protein levels (Fig. 20A and 19B).  Although, in order to 
state that the increase in BiP protein levels observed here are relevant, a more 
quantitative approach, utilising a loading control, will be required.  
 
Consistent with the observation of B27 upregulation in the macrophages of B27-Tg 
rats, the magnitude of BiP upregulation and XBP1 splicing correlated with HC 
expression level (data not shown) (Turner et al., 2007). This was demonstrated in both 
HeLa and HT1080 cells indicating that this response may be conserved between 
different cell lines. XBP1 splicing was more sturdy in HeLa and HT1080 with DTT 
treatment than HC misoxidation. This is expected since DTT will have a global 
reducing effect whereas the effect of HC misoxidation on the ER as a whole will be 
more limited. Thus, in the transient transfection model, XBP1 splicing and BiP 
upregulation is correlated with cI HC misoxidation and is independent of heavy chain 
disease association. Therefore, it is likely that UPR induction in this regard is a 
consequence of overexpression-induced misoxidation – in the absence of a 
concomitant increase in 2m expression. 
 
Further analysis of HT1080 transiently transfected with HLA-B27 showed that 
despite moderate XBP1 splicing and BiP upregulation, CHOP was not induced in 
these cells (Fig. 20C). I have previously shown that HT1080 cells do not induce 
CHOP expression in response to tunicamycin treatment (Fig. 10). However, 
tunicamycin treatment only induces very mild levels of XBP1 splicing in these cells. 
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The consequences of limited CHOP induction may include increased cell survival 
since CHOP has been demonstrated to promote apoptosis (Oyadomari & Mori, 2004). 
Increased survival of B27-expressing pro-inflammatory cells could have implications 
for disease pathogenesis including increased cytokine production and exacerbation of 
the inflammatory response. Whether or not attenuated CHOP expression in response 
to HC misoxidation is demonstrable for other cell types – including more 
physiologically relevant cells types such as the professional antigen presenting cells 
like macrophages and dendritic cells – remains to be seen. 
 
C58 cells stably expressing HLA-B27 had negligible levels of XBP1 processing; 
comparable to background XBP1 splicing in untransfected C58 cells (Fig. 22). Non-
disease associated HLA-A2-expressing C58.A2 cells also showed extremely low 
levels of XBP1 splicing. Since I have observed that the level of XBP1 splicing is 
correlated with HC expression levels, it is possible that these stably transfected cell 
lines do not express HCs at as high a level as transiently transfected cells. 
Alternatively, long-term expression of cI HCs in stable transfectants may have led to 
adaptation and the attenuation of IRE1-mediated UPR signalling. The IRE1 branch of 
the UPR has been demonstrated to selectively attenuate during persistent ER stress 
whereas PERK signalling continued during this time (Lin et al., 2007). However, Lin 
and colleagues demonstrated that persistent IRE1 signalling promoted cell survival 
and suggested that the attenuation of IRE1 signalling may represent a switch in fate 
from prosurvival to proapoptotic pathways. Analysis of PERK and ATF6 signalling in 
C58 stable transfectants would help determine if attenuation of UPR signalling is 
occurring in these cells. 
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 The oxidative status of transfected cI HCs can tell us much about the way HCs 
behave when expressed at various concentrations. However, analysis of lymphocytes 
from SpA patients – and healthy individuals – can tell us about the physiological 
status of the cells after disease is triggered. I demonstrate that lymphocyte populations 
from HLA-B27-expressing individuals exhibit some degree of oxidative misfolding of 
cI HCs. This finding was independent of disease presentation since lymphocytes from 
the healthy B27-expressing individual exhibited HC misoxidation.  This suggests that 
oxidative misfolding may be a feature of HLA-B27 expression in these individuals. 
Since fewer than 5% of B27-expressing individuals develop disease – in the absence 
of a family history - it is clear that the genetic susceptibility to pathogenesis is 
complex. 
 
The consequence of HC misoxidation in the patient cells shown in Figure 23 is 
unknown but previous work from our group determined that the HLA-B27-expressing 
lymphocytes WEWAK1, HOM-2 and JESTHOM cells may display elevated levels of 
baseline XBP1 splicing which may indicate that HC misfolding in the patient cells 
presented here may be associated with XBP1 splicing (Lemin et al., 2007). The 
presence of unglycosylated HCs in lymphocyte populations from the individuals 
presenting ReA or PsA may further indicate that HCs undergo inefficient folding 
events in the ER. Moreover, inappropriately oxidised HCs could be caused by free HC 
homodimerisation at the cell surface of B27-expressing cells. Further work will be 
required to identify the molecular basis for the differences in HLA-B heavy chain 
oxidative misfolding between patients presenting disease and healthy individuals. 
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In addition, I explored the relationship between HC misoxidation and UPR activation 
by manipulating the degradation of HC aggregates through the promotion of 
autophagy. The effect of rapamycin, an inhibitor of mTOR, on HeLa cells transiently 
transfected with HLA-B27 was minimal, indicating that either autophagy was 
insufficiently activated in HeLa cells or that autophagy is not involved in removing cI 
HC aggregates from the ER. It should be noted that the conclusions from this 
experiment are limited since no positive control for the detection of autophagy 
induction is included. An appropriate control for the induction of autophagy is the 
conversion of microtubule-associated protein 1 LC3 from the free version (LC3-I) to 
the membrane-bound (LC3-II) version (Kabeya et al., 2000).  LC3 is a mammalian 
homologue of yeast ATG8, an ubiquitin-like protein which is involved in vesicle 
formation during macroautophagy. Therefore, further work is required to elucidate the 
role of autophagy in cI HC removal.  
 
Together, our results indicate that HC misoxidation – evident  in HLA-B27-
expressing cells – and promoted by high expression levels in the absence of 2m, 
contributes to the activation of XBP1 processing and BiP upregulation. Future work 
on the physiological significance of ER stress signals and how UPR target genes 
promote and maintain the inflammatory response is needed. In addition, the role of 
oxidative stress and ROS production in UPR signalling and inflammation also 
requires further study.  
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4. 3 Context dependent activation of the unfolded protein 
response 
 
4.3.1 Introduction 
Protein tyrosine kinase signalling cascades play an important role in the regulation of 
cell proliferation, cell differentiation and signalling processes in the immune system, 
including the activation of inflammatory cells (Page et al., 2009; Lemmon & 
Schlessinger, 2010). Consequently, tyrosine kinase inhibitors have been considered 
for their potential anti-inflammatory activity (Sahu & August, 2009; Cohen & 
Fleischmann, 2010). Recent work – using the tyrosine kinase inhibitor genistein – has 
linked tyrosine kinase signalling with the UPR (Hong et al., 2005). This is of special 
interest when considering inflammatory diseases such as ankylosing spondylitis, as it 
may provide novel targets for therapy. 
  
The transcriptional activation of the stress-response gene grp78/BiP is induced by a 
number of well documented pharmacological agents which disrupt ER function (see 
General Introduction and Results Chapter 4.1). In mammals, tyrosine- and 
serine/threonine kinases were demonstrated to be important for grp78 transactivation 
since treatment with the potent tyrosine kinase inhibitor genistein is able to reduce 
thapsigargin-induced induction of grp78 mRNA levels whereas the serine-threonine 
kinase phosphatase inhibitor okadaic acid enhances thapsigargin induction of grp78 
(Price et al., 1992; Cao et al., 1996). The mechanism by which genistein regulates the 
gene expression of grp78 was addressed in a key paper by Zhou and Lee in 1998 
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(Zhou & Lee, 1998). They demonstrated that genistein specifically inhibits the 
induction of HSP70 and GRP78 through interference of the CCAAT binding factor 
(CBF)/NF-Y and the proximal CCAAT site – part of the ER stress response element 
(ERSE) – of the hsp70 and grp78 promoters. However, the mechanism by which the 
DNA binding property of CBF/NF-Y is regulated by genistein is unknown. 
 
Furthermore, the recently identified multifunctional transcription factor TFII-I has 
been implicated in the regulation of GRP78 and as a potential target of genistein-
mediated stress response gene suppression (Hong et al., 2005). TFII-I demonstrates 
enhanced binding to the GC-rich motif in the ERSE of the grp78 promoter following 
thapsigargin treatment and stimulates the ERSE-binding activity of ATF6 (Parker et 
al., 2001; Yoshida et al., 2001b). The activity of TFII-I is regulated by 
phosphorylation at serine/threonine and tyrosine residues and it has been 
demonstrated that the tyrosine kinase c-Src – activated by thapsigargin-induced ER 
stress – is required for the phosphorylation of tyrosine residues at positions 248 and 
611 (Novina et al., 1998; Cheriyath et al., 2002; Hong et al., 2005). Since tyrosine 
phosphorylation is not required for the DNA binding property of TFII-I, it is possible 
that phosphorylation of these residues regulates the formation of transcription factor 
complexes which, in turn, regulates the stability of these complexes at the promoter 
(Novina et al., 1998; Hong et al., 2005). A role for TFII-I tyrosine phosphorylation in 
the regulation of the stress response is illustrated by the evidence that a dominant 
negative mutant of c-Src attenuates thapsigargin stress induction of the grp78 
promoter whereas overexpression of c-Src activates the grp78 promoter (Hong et al., 
2005). Since TFII-I undergoes considerable tyrosine phosphorylation after ER stress 
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and tyrosine phosphorylation is required for activity, coupled with the fact that 
genistein treatment of thapsigargin stressed cells suppresses grp78 induction, it has 
been suggested that TFII-I is the target for the inhibitive effect of genistein on the ER 
stress response. Thus, TFII-I is an ER stress-regulated transcription factor which links 
a tyrosine kinase pathway with UPR activity. 
 
The induction of glucose regulated proteins – and specifically GRP78 – has been 
linked with resistance to apoptotic cell death; the maintenance of cell viability under 
stressed conditions; survival during development as well as the formation of tumours 
and resistance to cell mediated toxicity in cancerous cells (Sugawara et al., 1993; 
McCormick et al., 1997; Dong et al., 2004; Luo et al., 2006; Lee, 2007). Thus, the 
induction of GRP78 is a double-edged sword, providing an adaptive, prosurvival 
function in stressed cells but also affording dangerous tumorigenic or neoplastic cell 
resistance to apoptosis. Levels of GRP78, and indeed GRP94, are elevated – and 
correlated with malignancy – in several cancer cell lines and solid tumours and human 
cancer biopsies (Fernandez et al., 2000; Lee et al., 2001). Therefore, targeted 
suppression of GRP induction or function in cancer cells might offer a novel approach 
to cancer therapy. Indeed, suppression of GRP78 induction by overexpressing 
antisense GRP78 mRNA inhibits tumour progression and increases cytotoxicity 
(Koong et al., 1994; Jamora et al., 1996).  
 
Selective targeting of genistein to leukaemia cells results in tyrosine kinase inhibition 
and apoptotic cell death (Uckun et al., 1995). In addition, administration of genistein 
to neonatal rats affords prevention against the development of mammary tumours 
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following carcinogen treatment later in life (Lamartiniere et al., 1995). Moreover, 
genistein is considered a potential anti-inflammatory agent since genistein treatment 
confers a cytoprotective effect on an IL-1- and IFN--treated rat pancreatic -cell 
line, thus preventing cytokine-mediated cytotoxicity (Kim et al., 2007).  
 
This chapter aims to investigate the role of genistein on the pharmacologically-
induced ER stress response as well as examining the effect of serum withdrawal on 
cell viability of HeLa and HT1080 cells. 
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4.3.2 Results 
 
4.3.2.1 Serum withdrawal promotes XBP1 processing by tunicamycin in HT1080 
cells. 
Previously, I have shown that HT1080 cells are relatively insensitive to tunicamycin 
despite exhibiting XBP1 splicing in response to other stimuli (see Chapter 4.2). In 
order to determine if this was a general defect in ER to cytoplasm signalling, I 
subjected HT1080 and HeLa cells to treatments with tunicamycin in the presence or 
absence of foetal calf serum and analysed XBP1 splicing (Fig. 25A). Serum 
withdrawal is known to activate several intracellular signalling pathways including 
those linked with UPR activation (Allsopp et al., 2000; Kilic et al., 2002). Cells were 
grown in complete media and then replaced with either serum-free medium or 
complete medium in the presence or absence of tunicamycin for 6 hours before 
subsequent lysis and analysis. Both HeLa and HT1080 cells did not initiate XBP1 
splicing when mock-treated even in the absence of serum (Fig. 25A, lanes 1-2 and 5-
6). Tunicamycin treatment of HeLa cells resulted in XBP1 splicing, as expected, but 
was not further augmented by the absence of serum. HT1080 cells exhibited 
negligible XBP1 processing in response to tunicamycin, as seen previously (Fig. 9A, 
10B and 11A) but, unlike HeLa cells, HT1080 displayed extensive splicing in the 
absence of serum. Thus, in HT1080 cells, serum withdrawal in the presence but not in 
the absence of tunicamycin leads to activation of the UPR and splicing of XBP1 (Fig. 
25A, lane 8).  
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Figure 25. Serum withdrawal in the presence of tunicamycin promotes XBP1 
splicing and BiP and CHOP upregulation in HT1080. A, HeLa and HT1080 cells 
were either mock- or tunicamycin (Tm)-treated either in the presence of FCS (-) or in the 
absence of FCS (+) before being subjected to RT-PCR for XBP1 to resolve the spliced (S) 
and unspliced (U) versions. -actin is shown as a positive control. B, As in A, but cells 
were either treated in MEM (M), DMEM (D) or in DMEM preconditioned in HT1080 cells 
overnight (PD) or in MEM preconditioned in HeLa cells overnight (PM). In addition, RNA 
was used as a template to detect the expression of BiP and CHOP. 
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The data from Figure 25A suggests that, in HT1080, XBP1 splicing in response to 
tunicamycin might be regulated by a signal which originates from outside the ER. 
One possible source of this signal might be a secreted factor that is released into the 
medium which might either have an activatory or inhibitory role in signalling. To 
address this, I subjected each cell line to the environment of the other cell line by 
swapping the growth media. Cell media were preconditioned either by HeLa cells 
(destined for HT1080 cells) or HT1080 cells (destined for HeLa cells) over night in 
the presence or absence of serum. After preconditioning, the filtered media was 
swapped over onto the opposite cell line and cells were subsequently cultured with or 
without tunicamycin for 6 hours. The cells were then analysed by RT-PCR for XBP1 
splicing, BiP, CHOP and -actin expression (Fig. 25B). When HeLa cells were 
cultured in the absence of serum either in their native medium (MEM) or DMEM in 
the absence of tunicamycin, no XBP1 splicing or CHOP induction was observed (Fig. 
25B, lanes 1 and 2). This was also the case for mock-treated HeLa cells cultured for 
the 6 hour period in preconditioned DMEM either in the presence or absence of serum 
(Fig. 25B, lanes 5 and 6). DMEM is a modified version of MEM which contains an 
increased concentration of vitamins, amino acids and glucose. It should be noted that 
HT1080 cells cultured in MEM alone did not initiate XBP1 splicing and were 
therefore unlikely to be sensitive to the decrease in glucose concentration or amino 
acid availability. This is consistent with previous experiments which showed that both 
HeLa and HT1080 cells do not initiate a UPR when exposed to diminished glucose 
conditions (Fig. 10 and 12). 
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As seen previously, when HeLa cells were grown in MEM in the presence or absence 
of serum, XBP1 splicing is induced upon tunicamycin treatment. This is accompanied 
by upregulation of BiP and CHOP induction (Fig. 25B, lanes 3 and 4). Serum 
withdrawal, in this case, has a negligible effect on BiP and CHOP induction. In 
addition, HeLa cells cultured in preconditioned DMEM lacking serum (from HT1080 
cells) in the presence of tunicamycin induced XBP1 splicing and BiP and CHOP 
induction (Fig. 25B, lane 7). The level of XBP1 splicing in these cells was comparable 
to that induced by tunicamycin treatment in serum-negative or -positive MEM.  Thus, 
preconditioning the media in the environment of HT1080 cells does not lead to 
potentiation of XBP1 splicing in non-tunicamycin-treated HeLa cells (Fig. 25B, lane 
6) and, in the presence of tunicamycin, does not augment further XBP1 splicing (Fig. 
25B, lane 7).  
 
As seen previously, when HT1080 cells were treated with tunicamycin in the presence 
of serum, XBP1 splicing was not activated (Fig. 25B, lane 10). Tunicamycin treatment 
also failed to induce CHOP expression or upregulate BiP expression beyond the level 
induced by mock treatment (Fig. 25B, compare lane 10 with lanes 8 and 9). 
Tunicamycin treatment in the absence of serum however, induced robust XBP1 
splicing which was accompanied by strong upregulation of BiP and induction of 
CHOP. Culturing of HT1080 cells in serum-withdrawn and non-serum withdrawn 
preconditioned media from HeLa cells in the absence of tunicamycin did not induce 
XBP1 splicing or BiP or CHOP induction. When HT1080 cells were cultured in 
serum-withdrawn, preconditioned media in the presence of tunicamycin, however, 
XBP1 splicing was induced although not as strongly as with tunicamycin treatment in 
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serum withdrawn DMEM (Fig. 25B compares lane 14 with lane 11). Surprisingly, 
BiP and CHOP expression were not strongly induced under these conditions. Thus, 
although the potentiation of the stress response in HeLa cells is largely unaffected by 
preconditioning of the media in HT1080 cells, when HT1080 cells are treated with 
tunicamycin in preconditioned, serum-starved HeLa medium, XBP1 splicing and BiP 
and CHOP induction is attenuated. This may be due to some factor that HeLa is 
secreting which might regulate downstream UPR target gene induction. This factor 
might be viewed as ‘prosurvival’ since culturing of HT1080 cells in this medium 
prevents strong induction of the proapoptotic factor CHOP. Furthermore, HeLa may 
suffer from more severe nutrient deprivation than HT1080 cells or elevated 
production of toxic mertabolic waste products by HeLa cells. However, further work 
will be required to determine if there are any associated differences in cell survival 
between tunicamycin-treated, serum-starved HT1080 cells grown in DMEM or in 
preconditioned media from HeLa cells. 
 
4.3.2.2 The magnitude of tunicamycin-induced UPR induction correlates with cell 
viability in HeLa and HT1080 cells. 
The induction of the transcription factor CHOP is associated with the promotion of 
apoptosis (Zinszner et al., 1998; McCullough et al., 2001; Oyadomari et al., 2002b; 
Ma et al., 2002). However, many other components of the UPR influence cell 
viability and cell fate (McCormick et al., 1997; Scheuner et al., 2001; Yoneda et al., 
2001; Scorrano et al., 2003; Zong et al., 2003; Rutkowski et al., 2006; Lin et al., 
2009).  
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In the presence of serum, HT1080 cells do not induce CHOP in response to 
tunicamycin treatment (Fig. 25B, lane 10). This suggests that under these conditions, 
HT1080 cells would be resistant to cell death. In order to determine this, I examined 
the viability of HeLa and HT1080 by reseeding cells after exposure to tunicamycin in 
the presence or absence of serum. Cells were seeded in 6 cm dishes and left to grow to 
about 80% confluency (~5 x 105 cells) before being treated. After treatment, cells 
were trypsinised, and resuspended in the same volume of fresh medium before being 
diluted by a factor of 4 into the 96-well plates. The cells were then left to grow 
overnight before being washed, fixed and DAPI stained, in order to identify cell 
nuclei. The number of viable cells was then determined by photographing the wells 
under a fluorescence microscope and analysing the images with Image J software. An 
example of the images obtained from DAPI staining cells treated with tunicamycin 
can be seen in Figure 26A. The number of cells in untreated HeLa and HT1080 wells 
was similar (Fig. 26A). However, the number of viable HeLa cells, which had 
previously undergone tunicamycin treatment, was less when compared to the same 
treatment in HT1080 cells. This is represented in Figure 26B which shows that 
tunicamycin-treated HeLa cells were comparatively less viable than HT1080 cells 
compared to untreated (Fig. 26B).  
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Figure 26. Tunicamycin-treated HT1080 cells remain comparatively 
resistant to cell death. A, After 6 hours tunicamycin treatment, HeLa and HT1080 
cells were reseeded on a 96-well plate and left to grow overnight. Cells were then 
washed and stained with DAPI to visualise nuclei. B, HeLa and HT1080 cells were 
subjected to mock or tunicamycin (Tm) treatment either in the presence or absence (SS) 
of FCS for 6 hours. The cells were then trypsinised, reseeded in 96-well plate and 
grown overnight. Cells were then methanol fixed and DAPI stained before being 
photographed. Cell number was then determined and an average of 3 wells was 
calculated. The error bars refer to the results from at least 2 individual experiments.  
HeLa +Tm HT1080 +Tm 
HeLa Mock HT1080 Mock 
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Serum starvation of HeLa cells did not affect cell viability whilst serum starvation of 
HT1080 cells decreased HT1080 viability by ~30% (Fig. 26). The error bars are the 
standard deviation of at least two separate experiments, the data from each individual 
experiment being the average of four or more duplicates. Tunicamycin treatment of 
HeLa cells decreased cell viability by over a third whilst similar treatment of HT1080 
cells only reduced viability by ~20%. Under these conditions, HeLa cells initiate 
XBP1 splicing, BiP upregulation and CHOP induction whereas HT1080 cells do not. 
Thus, this crucial difference in UPR induction may be responsible for HT1080 cells 
being ~20% less sensitive than HeLa cells to tunicamycin-induced cell death.  
 
 
When cells were serum starved concomitantly with tunicamycin treatment, cell 
viability, in both cell lines, was reduced further, to under a third (Fig. 26). However, 
despite identical cell treatments, viability between cell lines differed with HT1080 cell 
viability at almost half that of HeLa cells. Since serum-starved, tunicamycin-treated 
HT1080 cells exhibit stronger induction of CHOP and XBP1 splicing in comparison 
to HeLa cells, these results indicate that cell viability may be in part determined by 
the level of UPR signalling. However, since serum withdrawal of tunicamycin-treated 
HeLa cells decreased viability without any apparent effect on UPR induction over 
tunicamycin-only-treated HeLa cells, it is likely that other mechanisms such as the 
IRE1/TRAF2 pathway and mitochondria-dependent pathways influence cell viability 
also (Yoneda et al., 2001; Boya et al., 2002; Danial & Korsmeyer, 2004). 
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4.3.2.3 Genistein suppresses the expression of BiP and XBP1 in HeLa cells 
undergoing different forms of ER stress. 
Our observation that HT1080 cells induced XBP1 splicing in response to serum 
withdrawal concomitant with tunicamycin treatment lead us to investigate whether 
tyrosine kinases might be involved in XBP1 activation since growth factor receptors 
have been shown to have intrinsic protein tyrosine kinase activity (Pawson, 2004). 
Initially, I treated HeLa and HT1080 cells with genistein and analysed XBP1 
processing, and BiP expression in order to confirm that there is no associated UPR 
induction with general tyrosine kinase inhibition (Fig. 27A).  
 
As seen previously, serum-starved HeLa cells induced XBP1 splicing and BiP 
induction upon tunicamycin treatment (Fig. 27B, lane 1 and Fig. 25B, lane 3). As 
expected, when HeLa and HT1080 cells were treated with genistein, XBP1 processing 
and BiP expression levels were similar to those obtained by mock-treatment. Next, 
HeLa and HT1080 cells which were subjected to serum starvation and tunicamycin 
treatment were simultaneously treated with genistein – which specifically inhibits 
protein tyrosine kinases. When these cells were simultaneously treated with genistein, 
XBP1 splicing was attenuated and BiP levels decreased (Fig. 27B, lane 2). This is in 
line with published data demonstrating that genistein inhibits UPR-driven 
transcription of BiP/GRP78 in mammalian cells exposed to thapsigargin (Cao et al., 
1995). 
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Figure 27. Genistein suppresses BiP expression in serum-starved HeLa and 
HT1080 cells exposed to tunicamycin. A, HeLa and HT1080 cells were either mock 
treated (-) or exposed to 140 M genistein (+) for 6 hours in the absence of any ER stress 
inducer (Mock). B, Serum-starved (SS) HeLa and HT1080 cells were treated with 
tunicamycin (Tm) for 6 hours either in the absence (-) or presence (+) of genistein.  
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Genistein treatment of serum-starved, tunicamycin-treated HT1080 cells resulted in a 
decrease in – but not an abolition of – XBP1 splicing and BiP expression (Fig. 27B, 
lane 4). Taken together, these results indicate that genistein treatment is able to 
suppress tunicamycin-induced UPR target gene upregulation and proximal UPR 
signalling events in serum-starved HeLa and HT1080 cells.  
 
In order to determine if this effect was limited to tunicamycin-induced ER stress, I 
investigated the effect of genistein on HeLa and HT1080 cells treated with DTT and 
compared this with tunicamycin. These experiments were conducted in the presence 
of serum in order to examine the effect of genistein on UPR regulation under normal 
serum conditions. In addition to XBP1 splicing and BiP expression, CHOP expression 
was also monitored under these conditions. As previously reported, tunicamycin 
treatment of HeLa cells resulted in splicing of XBP1 and upregulation of BiP and 
CHOP whereas in HT1080 cells, tunicamycin treatment showed no effect when 
compared to mock treatment (Fig. 28A, compare lane 2 with lane 1 and lane 7 with 
lane 6). DTT treatment of HeLa cells also resulted in XBP1 splicing and BiP and 
CHOP upregulation. In HT1080 cells, DTT treatment resulted in XBP1 splicing, 
CHOP upregulation and limited BiP upregulation. When tunicamycin- and DTT-
treated HeLa cells were subjected to genistein treatment, BiP levels were 
downregulated but CHOP levels remained constant. In addition, XBP1 expression was 
decreased although splicing remained at a similar level. These results indicate that, in 
HeLa cells, genistein can suppress the UPR-driven transcription of both BiP and 
XBP1 but does not inhibit XBP1 splicing. Furthermore, genistein exerted this effect 
when the UPR was initiated by a number of different mechanisms such as prevention 
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of glycosylation by tunicamycin and global disulfide reduction by DTT in addition to 
depletion of ER Ca2+ caused by thapsigargin shown by other groups.  
 
Treatment with genistein in tunicamycin- and DTT-treated HT1080 cells, on the other 
hand, led to contrasting results. Genistein treatment of HT1080 cells promoted, rather 
than prevented XBP1 splicing as well as BiP and CHOP upregulation by tunicamycin 
in the presence of serum (Fig. 28A, compare lane 8 with lane 7).  Fig. 28A provides 
further evidence that tunicamycin is bio-available to HT1080 cells, since in the 
presence of serum and genistein, tunicamycin can activate XBP1 splicing. These 
results are in contrast with genistein treatment of tunicamycin-treated HT1080 cells in 
the absence of serum, in which genistein downregulates XBP1 and BiP expression, 
confirming that genistein is bio-active at this concentration (Fig. 27B, lane 4).  
 
Under serum-starved, tunicamycin-treated only conditions, XBP1 splicing and BiP 
were upregulated in HT1080 cells (Fig. 27B, lane 3). This was in contrast to 
tunicamycin treatment in the presence of serum which did not promote XBP1 splicing 
or BiP upregulation (Fig. 28A, lane 7). In HT1080 cells exposed to DTT, however, 
genistein treatment did not lead to changes in XBP1, BiP or CHOP expression (Fig. 
27C, compares lane 10 with lane 9). Together these results indicate that under normal 
serum conditions, genistein treatment of HT1080 cells can promote XBP1 splicing 
and BiP and CHOP upregulation with concomitant tunicamycin but not DTT 
treatment.  
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Figure 28. Genistein suppresses transcriptional activation of XBP1 and BiP 
induced by a range of ER stress inducers. A, HeLa and HT1080 cells were mock-, 
tunicamycin (Tm)- or dithiothreitol (DTT)-treated either in the absence (-) or presence 
(+) of genistein for 6 hours. B, HeLa and HT1080 cells were either mock- or 
thapsigargin (Tg)-treated in the absence (-) or presence (+) of genistein for 6 hours. 
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To further investigate how genistein regulates UPR-driven transcription, I studied 
thapsigargin-induced XBP1 splicing and BiP upregulation in HeLa and HT1080 cells.  
Thapsigargin-induced ER stress has been used previously to investigate the 
transcriptional regulation activity of genistein (Zhou & Lee, 1998). Treatment of both 
HeLa and HT1080 cells with thapsigargin resulted in increased expression of BiP and 
induction of XBP1 splicing (Fig. 28B, lanes 2 and 5). However, whereas concomitant 
treatment of thapsigargin and genistein decreased both XBP1 and BiP expression in 
HeLa cells, there was no further effect on expression levels of XBP1 and BiP upon 
treatment of genistein in HT1080 cells. These results further strengthen our conjecture 
that expression of XBP1 – in addition to BiP – is also suppressed by genistein in HeLa 
cells and that this mechanism is independent of the type of stress experienced by the 
cell. These results also indicate that the synergistic effect of genistein and tunicamycin 
treatment demonstrated in HT1080 cells (Fig. 28A, lane 8) is specific to tunicamycin.  
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Figure 29. Genistein can suppress XBP1 and BiP transcriptional activity or 
promote XBP1 splicing at early time points. HeLa and HT1080 cells were mock- 
or tunicamycin (Tm)-treated in the absence (-) or presence (+) of genistein for either 1 or 
3 hours. 
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Figure 30. The UPR-driven protein expression of GRP94 is suppressed by 
genistein in HeLa cells. A, HeLa and HT1080 cells were either mock- or tunicamycin 
(Tm)-treated in absence (-) or presence (+) of genistein for 6 hours. Cells were then lysed 
and subjected to SDS-PAGE and Western blotting using the Grp94 antibody. B, A Jol 
2 control. C, GRP94 expression levels from A, calculated by optical density of each band 
using TINA. 
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Our experimental approach thus far was to treat cells with genistein for the duration of 
ER stress exposure; usually 6 hours. However, the effects of genistein on HeLa and 
HT1080 cells can be seen as early as 3 hours (Fig. 29). HeLa cells treated with 
tunicamycin for 3 hours induce XBP1 splicing and upregulate BiP. However, 
genistein can suppress this effect at the 3 hour time point (Fig. 29, compare lane 5 
with lane 4). The synergistic effect of tunicamycin and genistein in promoting XBP1 
splicing in HT1080 cells can be detected as early as 1 hour (Fig. 29, lane 8). However, 
a 3 hour treatment with tunicamycin and genistein is insufficient to upregulate BiP 
expression in HT1080 cells – although a 6 hour treatment is sufficient (Fig. 28A, lane 
8). Thus, the synergistic induction of BiP by tunicamycin and genistein is in HT1080 
cells is slower than the inhibition of tunicamycin-induced BiP expression by genistein 
in HeLa cells.  
 
Since, in response to stress in mammalian cells, BiP expression is coordinately 
induced at the transcription level with grp94 (Liu & Lee, 1991), I investigated the 
effect of genistein treatment on GRP94 protein levels (Fig. 30). HeLa and HT1080 
cells were subjected to tunicamycin treatment only, or tunicamycin and genistein 
treatment together. Tunicamycin treatment resulted in a mild increase in GRP94 
levels in HeLa cells at steady state (Fig. 30A, compare lanes 1 and 2).  
 
In the presence of genistein, protein levels of GRP94 in HeLa were decreased to near 
mock-treated levels (Fig. 30A, lane 3 and Fig. 30C). Conversely, for HT1080, 
tunicamycin treatment did not measurably induce GRP94 (Fig. 30A, compare lane 5 
with lane 4 and Fig. 30C). This behaviour is contrary to that of BiP which is 
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transcriptionally induced – albeit less robustly than in HeLa – in tunicamycin-induced 
HT1080 cells (Fig. 7). Although I have not analysed the induction of GRP94 message 
levels, this result provides further evidence of HT1080 cells being unable to launch a 
strong tunicamycin-induced UPR. Genistein treatment of tunicamycin-treated 
HT1080 cells, however, resulted in a small decrease in GRP94 protein levels. Taken 
together, these results indicate that genistein may be able to suppress UPR-dependent 
and -independent grp94 expression, but further work will be required to clarify this.  
 
 4.3.2.4 Genistein regulates the transcriptional activation of BiP and XBP1. 
Since tyrosine phosphorylation has been implicated in the regulation of transcription 
factor complex formation (Novina et al., 1998; Hong et al., 2005), I investigated 
whether the tyrosine kinase inhibitor activity of genistein might be responsible for its 
ability to suppress ER stress target gene induction. I studied the tyrosine kinase 
inhibitor activity of genistein by comparing its ability to regulate transcription with 
the isoflavonoid diadzein. Diadzein is a phytoestrogen antioxidant which is also found 
in dietary soy products (Wiseman & Duffy, 2001). It is a structural analogue of 
genistein, however, it lacks the tyrosine kinase inhibitor activity (Akiyama et al., 
1987).  
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Figure 31. Diadzein does not suppress the UPR-driven transcriptional 
activity of XBP1 or BiP in HeLa cells. A, HeLa cells were either mock- or 
tunicamycin (Tm)-treated in the absence (-) or presence (+) of either genistein or 
diadzein for 6 hours. B, As in A but cells were treated for either 1 or 6 hours. 
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HeLa cells were either mock- or tunicamycin-treated in the absence or presence of 
genistein or diadzein for the duration of the 6 hour treatment. When HeLa cells were 
subjected to diadzein treatment only, there was minimal XBP1 splicing and BiP 
induction when compared to non-treated cells (Fig. 31A, compare lane 3 with lane 1). 
When tunicamycin-treated HeLa cells were exposed to diadzein, XBP1 splicing as 
well as the expression level of XBP1 and BiP remained comparable to tunicamycin-
only treatment (Fig. 31A, compare lane 4 with lane 2). As previously seen, exposure 
of tunicamycin-treated HeLa cell to genistein resulted in decreased XBP1 and BiP 
expression. Since the effects of genistein on tunicamycin-treated cells can be 
demonstrated at early time points (Fig. 29), I investigated the effects of diadzein on 
tunicamycin-induced XBP1 and BiP expression in HeLa cells at both 1 hour and 6 
hours in order to rule out any early inhibitory effects on transcription (Fig. 31B).  
 
Analysis of concomitant diadzein and tunicamycin treatment after 1 hour revealed 
similar expression levels of XBP1 and BiP compared to diadzein-only treatment (Fig. 
31B, compare lane 7 with lane 6). Taken together, these results indicate that diadzein 
has no effect on tunicamycin-induced BiP and XBP1 expression with short- or long-
term treatment in HeLa cells. Thus, it is probable that the tyrosine kinase inhibitory 
activity of genistein confers an ability to regulate UPR-driven transcriptional 
activation of BiP and XBP1. These results are supported by published data which 
suggest that tyrosine phosphorylation is essential for efficient transcriptional 
activation of BiP, at least in HeLa cells. 
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4.3.2.5 Genistein treatment does not strongly suppress MHC class I misoxidation-
induced XBP1 or BiP expression. 
I have shown that XBP1 and BiP expression can be attenuated with genistein 
treatment in the face of pharmacologically induced ER stress. An interesting question 
arising from these observations is whether ER protein misfolding/misoxidation is 
influenced by genistein. Since I am interested in how the UPR is coordinated in 
response to misoxidation, I investigated whether genistein treatment could suppress 
XBP1 and BiP expression induced by HLA-B27 misoxidation. HLA-B27 was 
transiently transfected into HeLa cells and treated with or without genistein 6 hours 
prior to lysis. Lysates were analysed for heavy chain misoxidation by HC10 Western 
blotting under reducing and non-reducing conditions and for XBP1 and BiP 
expression by RT-PCR (Fig. 32). Transfection of the HLA-B27 heavy chain resulted 
in extensive misoxidation and the formation of high molecular weight complexes in 
the non-reducing HC10 blot (Fig. 32A, lane 2). Post-transfection treatment with 
genistein did not appreciably affect heavy chain misoxidation (Fig. 32A, lane 3).  
 
Analysis of XBP1 and BiP expression levels revealed that genistein treatment 
decreases misoxidation-induced XBP1 expression only very mildly whereas BiP 
expression was not suppressed by genistein under these conditions. Whereas 
previously I had treated cells with genistein for the duration of the stress period 
(usually 6 hours), this procedure only allowed the presence of genistein several hours 
into the stress period. 
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Figure 32. Genistein does not suppress MHC class I heavy chain 
misoxidation-induced transcriptional activation of XBP1 or BiP in HeLa 
cells. A, HeLa cells were either mock transfected or transfected with HLA-B27 (HLA-
B27), grown overnight and then either treated without (-) or with (+) genistein for 6 
hours. Cells were then lysed and analysed reducing (R) and non-reducing (NR) SDS-
PAGE and subsequent Western blotting with the anti-MHC class I HC antibody HC10. 
B, As in A but cells were analysed by RT-PCR for XBP1 splicing and BiP and -actin 
expression. 
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Prolonged ER stress induced by protein misfolding may trigger a UPR response that 
is fundamentally distinct – in so much as it may utilise different branches of the UPR 
– from short term ER stress. Thus, genistein might be unable to suppress mechanisms 
of XBP1 and BiP upregulation that arise from prolonged ER stress. Note that BiP 
levels and XBP1 splicing was mildly activated in the mock treated cells of this 
experiment (Fig. 32B, lane 1), and that untransfected cells will also be present in the 
transfected dish. Thus, this experiment may under-represent the extent of stress 
signalling in response to ER protein misoxidation. Overexpression of heavy chains by 
transient transfection may not mimic physiological stress, in which case genistein 
treatment might still be able to suppress UPR-driven transcriptional activation in cells 
from the HLA-B27 transgenic rat model for example (Tran et al., 2004). However, 
there are likely to be tissue- and cell-specific differences in UPR-driven 
transcriptional activation, so the ability of genistein to suppress transcriptional activity 
may vary dependent on cell types. Further work will be required to determine if 
genistein can attenuate UPR-driven upregulation of XBP1 and BiP in animal model 
systems and in the clinic.  
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4.3.3 Discussion 
I demonstrate that genistein can suppress UPR-driven upregulation of BiP in response 
to tunicamycin, thapsigargin and DTT treatment but not MHC class I heavy chain 
misoxidation by transient transfection (Figs. 27, 29 and 32). Thus, I provide evidence 
of the transcriptional regulation activity of genistein in response to various types of 
ER stress. However, genistein treatment does not downregulate basal BiP expression 
(Fig. 27A). This is in line with published work which shows that genistein has no 
effect on basal BiP promoter activity (Cao et al., 1995; Zhou & Lee, 1998).  
 
The isoflavonoid genistein is a potent inhibitor of tyrosine kinase activity but does not 
inhibit the activity of serine and threonine kinases (Akiyama et al., 1987). Although 
originally isolated in Pseudomonas sp., genistein, as well as other isoflavonoids such 
as diadzein, is present in large concentrations in soy products – such as tofu – which is 
a fundamental part of the Chinese and Japanese diet. Studies using an 
immunoconjugate of genistein and the monoclonal antibody B43 – which targets 
genistein to the B-cell-specific receptor CD19 – demonstrated that, in B-cell precursor 
(BCP) leukaemia cells, genistein selectively inhibited CD19-associated tyrosine 
kinases leading to rapid apoptotic death of these cells (Uckun et al., 1995). Thus, it 
was postulated that protein tyrosine kinase inhibitors may have therapeutic potential 
in the treatment of haematological malignancies. Since then, tyrosine kinase inhibitors 
such has erlotinib, which specifically targets the epidermal growth factor receptor 
(EGFR) tyrosine kinase, have been developed for the treatment of non-small cell lung 
cancer (Perez-Solder et al., 2004; Amann et al., 2005). 
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Furthermore, genistein has been shown to downregulate cytokine-induced signal 
transduction events and, through its protein kinase inhibitor activity, impairs humoral 
immunity by blocking B-cell receptor mediated signalling (Lane et al., 1991; Kim et 
al., 2007). The tyrosine kinase inhibitor activity of genistein also downregulates the 
expression of the ER chaperone grp78/BiP which has implications for cell survival, 
and may therefore have therapeutic implications particularly for tumorigenic cells. 
Fazlul Sarkar’s group showed that genistein can inhibit NF-B activation in prostate 
cancer cells through Akt signalling, which is important in controlling the balance 
between cell survival and apoptosis (Davis et al., 1999; Li & Sarkar, 2002; Song et 
al., 2005; Banerjee et al., 2008). This indicates that genistein might regulate cell 
survival via the NF-B and Akt signalling pathways. Since NF-B is implicated in 
inflammatory diseases such as inflammatory bowel disease, a component of 
spondyloarthritis (Tak & Firestein, 2001; Chang et al., 2009), these findings may 
provide an approach to therapy for inflammatory disease. The preferential survival of 
certain cell types may contribute to inflammatory disease, since if certain cell types, 
such as cells which express high levels of IFN- exhibit increased survival in the face 
of ER stress, this might lead to an increase in cytokine signalling and be a 
contributing factor to chronic inflammation. 
 
I demonstrate that XBP1 expression, but not XBP1 splicing, might also be regulated 
by genistein treatment. UPR-driven expression of XBP1 was consistently low when 
cells were exposed to genistein (Figs. 27B, 4, 5 and 7). XBP1 mRNA expression is 
induced in response to ER stress by ATF6 (Yoshida et al., 2000; Yoshida et al., 
2001a). However, ATF6-mediated stimulation of the grp78 promoter activity is 
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resistant to genistein treatment suggesting that ATF6 does not contribute to genistein-
mediated suppression of transcriptional activity (Li et al., 2000). The transcription 
factor TFII-I, which is a downstream target of genistein tyrosine kinase inhibitor 
activity, interacts with ATF6 (Parker et al., 2001). Since tyrosine phosphorylation of 
TFII-I is essential for transcription factor complex formation, genistein treatment 
might prevent TFII-I-ATF6 complex formation leading to suppression of ATF6 UPR 
target genes. Moreover, there is some evidence to suggest that UPR-driven 
upregulation of XBP1 may occur by ATF6-independent mechanisms (Lee et al., 
2003). Alternatively, UPR-driven ATF6 expression might be suppressed by genistein 
which would then have consequences for XBP1 induction. Further work will be 
required to verify if UPR-driven XBP1 induction can be suppressed by genistein and 
the mechanism that underlies its transcriptional regulation. Additionally, our results 
also suggest that protein levels of GRP94, an ER chaperone which is coordinately 
induced with BiP, may also be downregulated by genistein (Fig. 30).  
 
Studies by Amy Lee’s group have highlighted the importance of c-Src-mediated 
phosphorylation of TFII-I in BiP expression and suggested that c-Src is a potential 
target of genistein tyrosine kinase inhibitor activity (Parker et al., 2001; Hong et al., 
2005). However, Bruton’s tyrosine kinase (BTK) – which is important in B-cell 
maturation – and Janus kinase 2 (JAK2) also directly phosphorylate tyrosine residues 
on TFII-I. Our studies comparing a structural analogue of genistein, diadzein, also 
point to tyrosine kinase inhibition as important for the attenuation of BiP expression. 
Diadzein, like genistein, is a phytoestrogen but lacks its tyrosine kinase inhibitor 
activity. I demonstrate that diadzein has no effect on tunicamycin-driven BiP or XBP1 
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upregulation either at short (1 hour) or long (6 hour) time points (Fig. 31). This is 
contrary to genistein treatment, which suppresses tunicamycin-induced XBP1 and BiP 
upregulation. Thus, this finding supports the hypothesis that the tyrosine kinase 
inhibitor activity of genistein is responsible for suppression of grp78 transcriptional 
activation although further work is required to analyse the phosphorylation of TFII-I 
and determine the tyrosine kinase targets of genistein. 
 
Our studies reveal that different cell types can respond to the same stimuli in diverse 
ways. I show that cell viability is reduced in HT1080 cells to a lesser extent than 
HeLa cells in response to tunicamycin treatment (Fig. 26). This finding was consistent 
although further investigation into cell viability using other methods such as crystal 
violet staining would further validate this finding. Furthermore, I establish that 
genistein can differentially activate XBP1 in a cell specific manner. Whereas exposure 
of tunicamycin-treated HeLa cells to genistein suppresses transcriptional activation of 
BiP, the same treatment in HT1080 cells potentiates BiP expression and XBP1 
splicing (Fig. 28A and 5). This synergistic effect was only observed with tunicamycin 
treatment. Furthermore, DTT- and thapsigargin-induced XBP1 splicing and BiP 
expression was not suppressed by genistein in HT1080 cells. However, genistein is 
capable of suppressing UPR-driven transcriptional activation in serum-starved 
HT1080 cells exposed to tunicamycin (Fig. 27B) indicating that the mechanism by 
which genistein attenuates transcriptional activation in HeLa cells may be functional 
in HT1080 cells. A summary of cell-specific differences in UPR regulation can be 
seen in Figure 33. 
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Figure 33. Cell-specific differences in UPR regulation between HeLa and 
HT1080. Each individual treatment is indicated on the left. Cells were treated with 
tunicamycin (Tm), genistein (Gen) or/and serum starved. The corresponding outcome in 
HeLa and HT1080 is indicated on the right compared to the previous treatment. An 
increase in expression, or activation in the case of XBP1 splicing, is represented by and 
up-arrow. A decrease is represented by a down-arrow and no effect is represented by a 
dash. All outcomes are based on data from this chapter or Results Chapter 4.1. 
Results Chapter 3  224 
 
Unusually, HT1080 cells, when treated with tunicamycin only, do not initiate XBP1 
splicing or strongly upregulate BiP or CHOP (Figs. 25, 28A, 29 and Results Chapter 
1). Initially, this was thought to be the consequence of tunicamycin being less 
available to the cell, but the observation that tunicamycin can activate XBP1 splicing 
in the presence of genistein in HT1080 cells and that tunicamycin treatment can 
prevent glycosylation of MHC class I heavy chains demonstrates that tunicamycin is 
bio-available to HT1080 cells (Figs. 28A and 29 and Fig. 9B). Genistein is unlikely to 
activate tunicamycin import to or prevent tunicamycin export from HT1080 cell since 
vesicle assays have shown that genistein stimulates the ATPase activity of multi-drug 
resistance protein (MRP) transporters (Hooijberg et al., 1997). Therefore, if MRPs 
were involved in tunicamycin transport in HT1080, genistein should decrease, rather 
than increase, its bioavailability.  
 
I also demonstrate that the weak response to tunicamycin in HT1080 cells can be 
overcome by serum starvation and that HT1080 cells treated with tunicamycin are 
relatively resistant to cell death (Fig. 25 and 26). Therefore, I propose that there is a 
molecular regulator of XBP1 activity in HT1080 cells. A candidate protein which may 
play a role in regulating XBP1 activity and the response to stress-inducing stimuli is 
the apoptotic regulator in the membrane of the endoplasmic reticulum 
(ARMER)/ARL6IP1, which protects HT1080 cells from apoptosis when exposed to a 
variety of stimuli which can cause ER stress (Pettersson et al., 2000; Lui et al., 2003). 
ARMER has been shown to protect cells from tunicamycin-induced apoptosis by 
modulating caspase-9 activity. ARMER interacts with ADP-ribosylation-like factor-6 
(ARL6), a member of the Ras superfamily, which interacts with a component of the 
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SEC61 channel, SEC61 (Ingley et al., 1999). Moreover, ARMER is a direct target of 
C/EBP, which possesses strong apoptotic activity; is involved in the regulation of 
cell growth and is controlled by a complex network or pathways which differ in 
different cell types (Wang et al., 2008). Thus, a possible role for regulation of XBP1 
and the UPR by the ARMER/C/EBP pathway deserves further exploration. 
 
The results of our studies have particular relevance to inflammatory disease which is 
becoming increasingly linked with UPR activation. The effect of genistein on the 
immune system is cell type-dependent (Sakai & Togiso, 2008). Our results suggest 
that these differences may be linked to the control of XBP1, or of BiP induction, by 
genistein. This work provides an explanation for differences in tunicamycin 
responsiveness between cell lines, and provides a framework for identifying novel 
regulators of the UPR. 
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5. Final Discussion 
 
Recently ankylosing spondylitis has been linked to the misfolding of the MHC class I 
heavy chain HLA-B27 (Turner et al., 2005). Increased expression levels of HLA-B27, 
induced by IFN-, in the B27/h2m transgenic rat result in activation of the UPR and 
an associated increase in disulfide linked B27 complexes (Turner et al., 2007). I show 
that overexpression of HLA-B27 by transient transfection leads to the formation of 
disulfide linked B27 complexes and associated activation of XBP1 and upregulation 
of BiP (Fig. 19 and 20). This is relevant to AS since XBP1 activation has been linked 
with intestinal inflammation, a key component of AS. Furthermore, I demonstrate that 
different cell types are differentially sensitive to certain forms of ER stress which may 
impact upon cell survival and death (Fig. 10, 12, 26 and 28). I show that while 
tunicamycin treatment of HeLa cells leads to XBP1 splicing and induction of the 
proapoptotic component CHOP, tunicamycin treatment of HT1080 cells does not 
(Figs. 9-12). This is important in the context of AS since apoptosis of certain synovial 
cells, such as synovial fibroblasts, can lead to tissue damage and may contribute to 
disease pathogenesis (Yang et al., 2007). Furthermore, soluble tumour necrosis factor 
(TNF)-related apoptosis-inducing ligand (TRAIL) is upregulated in AS patients 
indicating that apoptosis may be important in disease (Yang et al., 2007). Thus, the 
work in results chapter 2 has implications for inflammatory disease and AS.  
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5.1 Coordination of the UPR in response to diverse ER stimuli 
The unfolded protein response (UPR) is a multifaceted system for relieving ER stress 
and restoring ER homeostasis. The three branches of the UPR were originally thought 
to be activated in the same manner, by titration of BiP away from the lumenal 
domains of the three stress inducers, but recent studies have determined that certain 
UPR branches might be subject to further regulation, such as disulfide reduction in 
ATF6, or have additional activities related to activation, such as IRE1-mediated 
mRNA degradation, IRE1 clustering and mRNA targeting to IRE1 (Hollien & 
Weissman, 2006; Nadanaka et al., 2006; Nadanaka et al., 2007; Aragon et al., 2009; 
Korennykh et al., 2009; Schindler et al., 2009; Yanagitani et al., 2009; Kohno, 2010). 
Furthermore, direct binding of IRE1 to unfolded proteins has been suggested to be 
necessary for activation, which may allow the discrimination of certain conformations 
(Credle et al., 2005; Kimata et al., 2007; Pincus et al., 2010). Thus, the individual 
branches of the UPR, aside from having distinct downstream effects – although some 
functional redundancy does exist – might also be activated by distinct mechanisms in 
addition to the common mechanism of negative regulation by BiP.  
 
In the first results chapter, I analysed the induction of the UPR using pharmacological 
agents. For the ATF6 branch of the UPR I demonstrate that ATF6 can form higher 
order structures and, in addition, show that upon treatment with DTT and 
tunicamycin, the ratio of oligomeric and dimeric to monomeric ATF6 is changed 
leading to an increase in the monomer pool of ATF6(Fig 16). Tunicamycin is less 
efficient in inducing ATF6 oligomer/dimer reduction than DTT, suggesting stimuli-
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specific regulation of ATF6. DTT is likely to reduce disulfide-bound ATF6 
directly, but this begs the question of how tunicamycin treatment induces ATF6 
reduction. Could ATF6 reduction be caused by PDI, the most abundant 
oxidoreductase in the ER? Since PDI can act as a chaperone, in a situation where 
misfolded proteins have accumulated in the ER one might expect there to be less free 
PDI available since it will be found bound to substrates. One theory is that the 
increase in protein folding machinery brought about by UPR activation could increase 
the concentration of potential reductants in the ER which may possibly favour ATF6 
reduction. However, increased free oxidoreductases might initiate the restoration of 
ER homeostasis and so continued UPR signalling through ATF6 would be counter 
intuitive. Thus, further work, such as pulse-chase experiments to study 
deoligomerisation over time, or analysis of ATF6 cysteine mutants will be required 
to determine the significance of ATF6 reduction in activation of the ATF6 branch of 
the UPR. Further studies to identify potential molecules involved in the reduction of 
ATF6 are also required. Our results are supported by those of Nadanaka and 
colleagues who showed that under non-stressed conditions ATF6 exists as disulfide-
bonded dimers and oligomers in addition to the monomeric form (Nadanaka et al., 
2007).  
 
Our results show that in response to different ER stress-inducing stimuli, cells 
upregulate the UPR target gene BiP but not all to the same degree (Fig. 7). Using 
pharmacological agents which prevent glycosylation (tunicamycin) and cause 
perturbation in ER Ca2+ levels (thapsigargin) led to the biggest increase in BiP 
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expression (Fig. 7). However, processing of XBP1, which also exhibited diverse levels 
of activation dependent on stimuli, did not show the same pattern since disruption of 
disulfides with DTT caused the most robust splicing of XBP1 (Figs. 9 and 10). Thus, 
different ER-stress-inducing stimuli may induce distinct patterns of UPR activity at 
both the activatory (XBP1 splicing) and downstream transcriptional activity (BiP 
expression) level. Although BiP upregulation is a target of XBP1(S), the discrepancy 
in activation pattern between BiP upregulation and XBP1 splicing is most likely to be 
due to the influence of p50ATF6, which also upregulates BiP.  
 
The work of Lin and colleagues took steps towards understanding how the UPR is 
coordinated in response to stress and how coordination of the UPR branches 
contributes to cell survival (Lin et al., 2007; Lin et al., 2009). They showed that there 
is temporal regulation of UPR signalling by demonstrating that XBP1 splicing levels 
decline after long periods of prolonged ER stress whereas PERK signalling is 
sustained over time. They suggest that this may sensitise the cell to apoptosis after 
chronic ER stress resulting in the enhancement of PERK-dependent CHOP expression 
and a decrease in IRE1-mediated prosurvival signalling through XBP1. Lin and 
colleagues showed that, in HEK293 cells, XBP1 splicing is detectable at 4 hours post 
treatment (Lin et al., 2007). This is consistent with our work since I demonstrate that, 
in HeLa cells, XBP1 splicing starts to occur between 3 and 6 hours (Fig. 11A). 
 
Here, I also show that different cell types respond differently to distinct forms of ER 
stress. I report that the HT1080 fibrosarcoma cell line, despite upregulating BiP, 
CHOP and XBP1 splicing in response to treatment with DTT, thapsigargin and 
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A23187, are selectively resistant to UPR induction by tunicamycin (Figs. 9-12). Thus, 
HT1080 cells do not upregulate CHOP or activate XBP1 splicing in response to 
tunicamycin. I demonstrate that the weak response to tunicamycin in HT1080 cells 
can be overcome by serum starvation (Fig. 25). However, tunicamycin-treated 
HT1080 did upregulate BiP to levels comparative to that induced by DTT (Fig. 7). 
Although on other occasions I have detected less robust BiP induction in response to 
tunicamycin (Fig. 11A). Investigating the activity of tunicamycin in HT1080 cells 
revealed that tunicamycin was preventing glycosylation indicating that it was being 
taken up by the cells (Fig. 11B and 15). Furthermore, I show that HT1080 cells are 
relatively resistant to cell death indicating that increased cell survival is linked with 
low level UPR activity (Fig. 26). The proapoptotic UPR component CHOP is not 
induced in tunicamycin-treated HT1080 cells. Since the deletion of CHOP protects 
cells from the lethal consequences of ER stress, it is possible that failure to induce 
CHOP in HT1080 cells is responsible for increased cell survival (Zinszner et al., 
1998; Oyadomari et al., 2002; Pennuto et al., 2008). However, since IRE-mediated 
JNK activity has been linked with apoptosis, further work is needed to verify if the 
IRE1-JNK pathway similarly fails to activate in HT1080 cells (Urano et al., 2000; 
Nishitoh et al., 2002). This is important in the context of inflammation, which may be 
caused in part by the preferential survival of cells that promote inflammation. 
 
5.2 MHC class I heavy chain misfolding-driven UPR activation 
Recently HLA-B27 misfolding has been linked with activation of the UPR in the 
B27/h2m animal model of AS (Turner et al., 2005). These rats express high levels of 
class I heavy chain due to a high copy number of the B27/h2m transgene. High 
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expression levels of B27 have been linked with disease in the transgenic rat, mouse 
and in human SpA sufferers (Taurog et al., 1993; Khare et al., 1995; Khare et al., 
1997; Cauli et al., 2002). Thus, I used transient transfection to overexpress different 
MHC class I heavy chains in HeLa cells to determine the level of misfolding and 
investigate the comparative level of UPR induction induced from disease associated 
and non-disease-associated heavy chains (Ch. 4.2). 
 
I demonstrate that overexpression of both HLA-B7 and HLA-B27 – in the absence of 
increased expression of 2m – in HeLa cells is sufficient to induce 
misfolding/misoxidation defined by the presence of disulfide-linked, high molecular 
weight complexes (Fig. 19). Misfolding of both heavy chains was sufficient to induce 
upregulation of BiP protein levels as well as XBP1 splicing and increased 
transcription of BiP (Fig. 19 and 20). The levels of B27-driven UPR induction was 
lower than those induced by pharmacological agents. This has been described in the 
literature relating to the transgenic rat model where UPR associated with B27 
misfolding is less than that observed with tunicamycin treatment (Turner et al., 2005). 
This is not surprising since misfolding of a single protein species is unlikely to lead to 
as much cellular disruption as the global effect of disulfide reduction (as with DTT) or 
prevention of glycosylation (as with tunicamycin). Thus, in this transient transfection 
model, XBP1 splicing and BiP upregulation is correlated with cI HC misoxidation and 
is independent of heavy chain disease association In contrast, stable transfection of 
HLA-B27 and HLA-A2 in C58 cells did not result in XBP1 splicing levels beyond 
background levels (Fig. 22). Since I have observed that the level of XBP1 splicing is 
correlated with HC expression levels, it is possible that these stably transfected cell 
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lines do not express HCs at as high a level as transiently transfected cells, although 
further work will be required to clarify this. However, a lack of XBP1 splicing in these 
cells could indicate that they have adapted and attenuated the IRE1 prosurvival arm of 
the UPR. Studying the UPR activity of these cells from initial transfection through to 
becoming established stable transfectants would give an insight into how coordination 
of the UPR occurs in cells undergoing prolonged ER stress. 
 
XBP1 activation is becoming increasingly linked with inflammatory disease in vivo 
and especially intestinal inflammation (Kaser & Blumberg, 2010). Conditional 
deletion of XBP1 in the intestinal epithelium of mice leads to the spontaneous 
development of intestinal inflammation showing great similarity to IBD (Kaser et al., 
2008). Indeed, hypomorphic XBP1, that is XBP1 with reduced gene activity, actually 
results in ER stress determined by upregulation of BiP. Thus, it seems that intestinal 
inflammation, a key component of SpA and of inflammatory disease in the B27/h2m 
transgenic rat model, is linked with ER stress activation and XBP1 activity.  
 
Consistent with our novel findings that HT1080 cells do not induce CHOP expression 
in response to tunicamycin treatment (Fig. 12), B27 misfolding did not induce CHOP 
expression either. Given that B27 misfolding induces a milder UPR than tunicamycin 
treatment in the transgenic rat, it is not a surprise that HT1080 cells, which are 
unresponsive to tunicamycin, do not induce CHOP in response to B27 misfolding.  
 
Activation of NF-B, a master regulator of inflammation, has long been associated 
with ER dysfunction and ER stress (Pahl, 1999; Deng et al., 2004; Zhang & Kaufman, 
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2008). The contribution of NF-B signalling to inflammatory disease is currently 
unknown although the expression of HLA-B27 markedly enhances NF-B activation 
and TNF secretion in monocyte cells in response to LPS, suggesting that B27 may 
modulate NF-B activation in response to infection (Penttinen et al., 2002). However, 
gene expression analysis of bone marrow macrophages from the B27/h2m transgenic 
rat model did not reveal a strong NF-B-dependent transcriptional response (Turner et 
al., 2005). Turner and colleagues postulated that under prolonged IFN- stimulation, a 
more robust UPR with NF-B activation might be observed. Thus, the contribution of 
NF-B to inflammatory disease is worthy of further exploration. Levels of the 
inhibitor of NF-B, IB as well as immunoprecipitation studies to reveal the extent of 
IB-bound NF-B in our transient transfection model might give an insight into the 
consequences of B27 misfolding on NF-B activation.  
 
5.3 The integration of genistein activity with the UPR 
Genistein is an isoflavone with tyrosine kinase inhibitory activity. It has previously 
been demonstrated to regulate ER-stress induced BiP upregulation through 
interference with transcription factor complex assembly and interaction with the BiP 
promoter. I demonstrate that genistein can suppress tunicamycin- and DTT-induced 
BiP upregulation in HeLa cells (Fig. 28). Consistent with this observation, 
thapsigargin-induced BiP/Grp78 upregulation is suppressed by treatment with 
genistein in Chinese hamster ovary cells (Cao et al., 1995). Furthermore, I establish 
that ER stress-driven expression of XBP1 but not CHOP is also suppressed by 
genistein in HeLa cells (Fig. 28). Thus, I provide evidence of the transcriptional 
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regulation activity of genistein in response to various types of ER stress. XBP1 
expression is driven by ATF6, yet ATF6-mediated stimulation of the Grp78 promoter 
activity is resistant to genistein treatment suggesting that genistein activity regulates 
the activity of more than one branch of the UPR (Lee et al., 2000; Yoshida et al., 
2000; Yoshida et al., 2001a). Further work is required to verify if genistein is able to 
suppress upregulation of XBP1 or indeed other UPR target genes. 
 
Genistein activity appears to be cell specific, since genistein can differentially activate 
XBP1 in HT1080 cells exposed to tunicamycin (Fig. 28 and 29). This further 
highlights the diversity of activity of tunicamycin-driven UPR in HT1080 and HeLa 
cells. Genistein does not suppress thapsigargin-induced BiP upregulation – or indeed 
XBP1 upregulation – in HT1080 cells (Fig. 28). Unsurprisingly, BiP expression is not 
attenuated in genistein- and tunicamycin-treated HT1080 cells since tunicamycin does 
not induce BiP upregulation in HT1080 cells in the absence of genistein.  Rather, 
genistein treatment in the presence of tunicamycin – and not DTT or thapsigargin – 
promotes XBP1 splicing in HT1080 cells (Fig. 28). 
 
Genistein does suppress UPR-driven transcriptional activation in serum-starved 
HT1080 cells exposed to tunicamycin (Fig. 27). Thus, the mechanism by which 
genistein attenuates transcriptional activation in HeLa cells may be functional in 
HT1080 cells. Therefore, I propose the presence of a molecular regulator of XBP1 in 
activity in HT1080 cells. One candidate is the apoptotic regulator ARMER which 
protects HT1080 cells from apoptosis when exposed to various stimuli including 
tunicamycin. Gene silencing of ARMER in HT1080 cells combined with analysis of 
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UPR induction in response to a wider variety of ER stress inducers, including those 
which disrupt the glycosylation machinery, would provide an insight into the potential 
influence of ARMER on HT1080 UPR induction and determine if a failure to respond 
to certain stimuli is dependent on the nature of that stimulus. Furthermore, recent 
work has highlighted HSP72 as a regulator of ER stress-induced apoptosis (Gupta et 
al., 2010). HSP72 protected PC12 cells from ER-stress induced apoptosis by 
increasing the amplitude of IRE1-XBP1 signalling via a direct interaction, thus 
promoting survival. Although I do not observe increased XBP1 signalling in HT1080 
cells exposed to tunicamycin, HSP72 has been reported to inhibit CHOP and TNF-
induced apoptosis (Gotoh et al., 2004). Therefore, diminished UPR signalling in 
HT1080 cells might be the consequence of direct modulation of ER efferent 
signalling. 
 
The pathogenesis of AS is likely to be a complex interaction of innate and adaptive 
immune responses. The influence of HLA-B27 misfolding on disease pathogenesis is 
irrefutable; however, it is likely that other mechanisms such as CD4+ T-cell 
recognition of cell surface homodimers may influence disease. Recent analysis of 
genetic susceptibility to AS has highlighted the IL-23 receptor. Furthermore, IL-23R 
polymorphisms have been implicated in Crohn’s disease and other inflammatory 
phenotypes (Duerr et al., 2006; Cargill et al., 2007). Rather than contributing to T-cell 
differentiation, IL-23 favours the expansion and maintenance of Th17 cells suggesting 
that, in SpA patients, these cells might expand under the influence of IL-23 
(McGeachy et al., 2009; Melis & Elewaut, 2009). There is also growing evidence that 
IL-17 is a crucial proinflammatory cytokine since it can act on several cell types 
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including macrophages, fibroblasts, endothelial and epithelial cells to upregulate 
TNF, IL-6 and IL-1 (Nakae et al., 2003; Kolls et al., 2004). Aside from IL-17, Th17 
cells are also capable of producing TNF and IL-6 themselves (Cua et al., 2003; Chen 
et al., 2006). Thus, it is clear that the downstream effects of Th17 expansion may 
include the production of multiple proinflammatory cytokines. The influence of HLA-
B27 misfolding on IL-23 production, Th17 cell expansion and IL-17 production may 
provide novel insights into the pathogenesis of AS and other inflammatory diseases 
associated with a misfolding phenotype. 
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